[{"lang":"en","id":"347691268773646336","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":106,"end":128,"url":"http://t.co/yZXtyAPbYh","expanded_url":"http://pulsmedycyny.pl/3187966,82639,urpl-zaleca-ograniczenie-stosowania-kodeiny-u-dzieci","display_url":"pulsmedycyny.pl/3187966,82639,…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-20T12:23:52.000Z","possibly_sensitive":false,"text":"RT @GCessak: Medicine Pulse | Polish medicines agency recommends limiting the use of codeine in children: http://t.co/yZXtyAPbYh","conversation_id":"347691268773646336","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"347675033809850368","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":87,"end":109,"url":"http://t.co/N9xoMQEydA","expanded_url":"http://tinyurl.com/ku2gwyr","display_url":"tinyurl.com/ku2gwyr"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-20T11:19:22.000Z","possibly_sensitive":false,"text":"RT @URPLWMiPB: Statement on the safety of the medicinal product Trobalt (retigabine):  http://t.co/N9xoMQEydA","conversation_id":"347675033809850368","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"347674844139233281","entities":{"mentions":[{"start":3,"end":15,"username":"CPME_EUROPA","id":"440810430"}],"urls":{},"hashtags":[{"start":17,"end":32,"tag":"ClinicalTrials"},{"start":34,"end":49,"tag":"MedicalDevices"},{"start":51,"end":59,"tag":"Tobacco"},{"start":61,"end":75,"tag":"HealthyAgeing"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-20T11:18:36.000Z","possibly_sensitive":false,"text":"RT @CPME_EUROPA: #ClinicalTrials, #MedicalDevices, #Tobacco, #HealthyAgeing. CPME Newsletter may now be accessed here: http://t.co/oSWexNwy…","conversation_id":"347674844139233281","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347674676056707072"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"347673865012527106","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-20T11:14:43.000Z","possibly_sensitive":false,"text":"RT @innovationunion: Creating life-saving drugs from deadly venom: When faced with a scorpion, poisonous snake, jellyfish or... http://t.co…","conversation_id":"347673865012527106","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347673692580487169"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"347656277297594368","entities":{"mentions":[{"start":3,"end":19,"username":"ESEndocrinology","id":"221055586"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-20T10:04:50.000Z","possibly_sensitive":false,"text":"RT @ESEndocrinology: Read article: Decreased ovarian function &amp; obesity after childhood cancer. M. M. van den Heuvel-Eibrink et al.\nLink: h…","conversation_id":"347656277297594368","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347649458902806528"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"347645911020736512","entities":{"mentions":[{"start":0,"end":10,"username":"URPLWMiPB","id":"556679074"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-20T09:23:38.000Z","possibly_sensitive":false,"text":"@URPLWMiPB The link in your tweet isn't working.","conversation_id":"347644692155994112","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"347644692155994112"}],"in_reply_to_user_id":"556679074","attachments":{"media_keys":{}}},{"lang":"en","id":"347645330617143296","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":84,"end":99,"username":"VaccinesEurope","id":"1262320285"}],"urls":[{"start":61,"end":83,"url":"http://t.co/6mA2KBI2Th","expanded_url":"http://bit.ly/144gLtX","display_url":"bit.ly/144gLtX"}],"hashtags":[{"start":15,"end":23,"tag":"Vaccine"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-20T09:21:20.000Z","possibly_sensitive":false,"text":"RT @EFPIA: HPV #Vaccine Lowering Infection Rates Among Girls http://t.co/6mA2KBI2Th @VaccinesEurope","conversation_id":"347645330617143296","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347643619840233473"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"347644786095824897","entities":{"mentions":{},"urls":{},"hashtags":[{"start":49,"end":54,"tag":"Borg"},{"start":71,"end":91,"tag":"veterinarymedicines"}],"annotations":[{"start":21,"end":26,"probability":0.8935,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-20T09:19:10.000Z","possibly_sensitive":false,"text":"RT @IFAHEurope: IFAH-Europe pleased Commissioner #Borg @ roundtable on #veterinarymedicines legislation review - Check statement: http://t.…","conversation_id":"347644786095824897","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347638732645605377"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"347644629350506496","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":110,"end":132,"url":"http://t.co/jPTo6unfiG","expanded_url":"http://tnij.org/v36e","display_url":"tnij.org/v36e"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-20T09:18:33.000Z","possibly_sensitive":false,"text":"RT @URPLWMiPB: Information on the recommendation on suspension of infusion solutions incl hydroxyethyl starch http://t.co/jPTo6unfiG","conversation_id":"347644629350506496","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"347644076851617792","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":111,"end":133,"url":"http://t.co/2ET2eCMK3B","expanded_url":"http://urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-w-sprawie-zalecenia-ograniczenia-stosowania-u-dzieci-kodeiny-jako-leku-przeciwbolowego","display_url":"urpl.gov.pl/aktualnosci/in…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-20T09:16:21.000Z","possibly_sensitive":false,"text":"RT @URPLWMiPB: Information on the recommendation on restricting the use of codeine as a painkiller in children http://t.co/2ET2eCMK3B","conversation_id":"347644076851617792","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"347643834244689920","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":101,"end":123,"url":"http://t.co/9eycKnmHEc","expanded_url":"http://urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-w-sprawie-ograniczenia-stosowania-produktow-leczniczych-zawierajacych-flupirtyne","display_url":"urpl.gov.pl/aktualnosci/in…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-20T09:15:23.000Z","possibly_sensitive":false,"text":"RT @URPLWMiPB: Information on the restriction of the use of medicinal products containing flupirtine http://t.co/9eycKnmHEc","conversation_id":"347643834244689920","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"347643625489985537","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":103,"end":125,"url":"http://t.co/3GFbbT0xfc","expanded_url":"http://urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-o-srodkach-ostroznosci-zalecanych-przy-stosowaniu-produktow-leczniczych-zawierajacych-niesteroidowy-lek-przeciwzapalny-nlpz-","display_url":"urpl.gov.pl/aktualnosci/in…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-20T09:14:33.000Z","possibly_sensitive":false,"text":"RT @URPLWMiPB: Information about the precautions recommended when using products containing diclofenac http://t.co/3GFbbT0xfc","conversation_id":"347643625489985537","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"347387674895724544","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":89,"end":111,"url":"http://t.co/l5K44z5s85","expanded_url":"http://bit.ly/19iFvSR","display_url":"bit.ly/19iFvSR"}],"hashtags":[{"start":21,"end":26,"tag":"MERS"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-19T16:17:30.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: Updated #MERS-CoV guidance and epi situation in ECDC Rapid Risk Assessment: http://t.co/l5K44z5s85","conversation_id":"347387674895724544","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347387107632898048"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"347387581723443201","entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":{},"hashtags":[{"start":41,"end":46,"tag":"MERS"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-19T16:17:08.000Z","possibly_sensitive":false,"text":"RT @ECDC_Flu: As of 17 June, 64 cases of #MERS-CoV reported worldwide, incl 38 deaths. Updated guidance and assessment for EU: http://t.co/…","conversation_id":"347387581723443201","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347387518993453056"}],"attachments":{"media_keys":{}}},{"lang":"pt","id":"347378975418486784","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"hashtags":[{"start":48,"end":54,"tag":"Brain"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-19T15:42:56.000Z","possibly_sensitive":false,"text":"RT @innovationunion: Workshop on Flagship Human #Brain Project: \"A roadmap for Portugal\": The Fundação para a Ciência e Tecnologia and... h…","conversation_id":"347378975418486784","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347372714543157250"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"347378828936613888","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-19T15:42:21.000Z","possibly_sensitive":false,"text":"RT @innovationunion: Finding and treating the cause of inherited blindness: European scientists have made a major breakthrough in the... ht…","conversation_id":"347378828936613888","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347372713175822336"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"347378739841216512","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-19T15:42:00.000Z","possibly_sensitive":false,"text":"RT @innovationunion: Empowering children in clinical trials: There is evidence that over 50 percent of medicinal products developed... http…","conversation_id":"347378739841216512","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347372711674265600"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"347353564273844224","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":16,"end":30,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":103,"end":125,"url":"http://t.co/nCgs7xlEz9","expanded_url":"http://bit.ly/12VdQbI","display_url":"bit.ly/12VdQbI"}],"hashtags":[{"start":37,"end":44,"tag":"pharma"},{"start":92,"end":102,"tag":"medicines"},{"start":126,"end":136,"tag":"antitrust"}],"annotations":{}},"public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-19T14:01:57.000Z","possibly_sensitive":false,"text":"RT @EU_Health: .@EU_Commission fines #pharma companies for delaying market entry of generic #medicines http://t.co/nCgs7xlEz9 #antitrust","conversation_id":"347353564273844224","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347349301959213056"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"347333145122721792","entities":{"mentions":{},"urls":[{"start":77,"end":99,"url":"http://t.co/5GHHMF3Jkt","expanded_url":"http://bit.ly/14ieMmh","display_url":"bit.ly/14ieMmh"}],"hashtags":[{"start":46,"end":57,"tag":"veterinary"},{"start":69,"end":74,"tag":"CVMP"}],"annotations":[{"start":0,"end":11,"probability":0.9162,"type":"Person","normalized_text":"Dr Anja Holm"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-19T12:40:49.000Z","possibly_sensitive":false,"text":"Dr Anja Holm has been re-elected chair of our #veterinary committee (#CVMP): http://t.co/5GHHMF3Jkt","conversation_id":"347333145122721792","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"347332512898486274","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":99,"end":121,"url":"http://t.co/phmhGdLdy3","expanded_url":"http://www.urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-w-sprawie-ograniczenia-stosowania-produktow-leczniczych-zawierajacych-flupirtyne","display_url":"urpl.gov.pl/aktualnosci/in…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-19T12:38:18.000Z","possibly_sensitive":false,"text":"RT @GCessak: Information on the restriction of the use of medicinal products containing flupirtine http://t.co/phmhGdLdy3","conversation_id":"347332512898486274","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"347332247747174401","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":117,"end":139,"url":"http://t.co/heD4X1e7Fj","expanded_url":"http://www.urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-o-zaleceniu-zawieszenia-pozwolenia-na-dopuszczenie-do-obrotu-roztworow-infuzyjnych-zawierajacych-hydroksyetyloskrobie","display_url":"urpl.gov.pl/aktualnosci/in…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-19T12:37:15.000Z","possibly_sensitive":false,"text":"RT @GCessak: Information on the recommendation to suspend the license of infusion solutions incl hydroxyethyl starch http://t.co/heD4X1e7Fj","conversation_id":"347332247747174401","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"347297594604654592","entities":{"mentions":[{"start":3,"end":19,"username":"IlariaPassarani","id":"1106659014"},{"start":32,"end":46,"username":"EU_Commission","id":"157981564"}],"urls":{},"hashtags":[{"start":21,"end":31,"tag":"Antitrust"},{"start":53,"end":62,"tag":"Lundbeck"},{"start":75,"end":82,"tag":"pharma"},{"start":122,"end":134,"tag":"genericmeds"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-19T10:19:33.000Z","possibly_sensitive":false,"text":"RT @IlariaPassarani: #Antitrust @EU_Commission fines #Lundbeck &amp; other #pharma companies for delaying market entry of #genericmeds http://t…","conversation_id":"347297594604654592","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347297403424108545"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"347289391229714432","entities":{"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"},{"start":86,"end":94,"username":"unibern","id":"60514114"},{"start":95,"end":108,"username":"ERC_Research","id":"467551928"}],"urls":[{"start":63,"end":85,"url":"http://t.co/UF9egO27d8","expanded_url":"http://owl.li/m69gT","display_url":"owl.li/m69gT"}],"hashtags":[{"start":55,"end":62,"tag":"cancer"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-19T09:46:57.000Z","possibly_sensitive":false,"text":"RT @myCORDIS: New biomarker to help detect early stage #cancer http://t.co/UF9egO27d8 @unibern @ERC_Research","conversation_id":"347289391229714432","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347289110236512256"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"347288186491392000","entities":{"mentions":{},"urls":[{"start":76,"end":98,"url":"http://t.co/5GHHMF3Jkt","expanded_url":"http://bit.ly/14ieMmh","display_url":"bit.ly/14ieMmh"}],"hashtags":[{"start":4,"end":15,"tag":"veterinary"},{"start":27,"end":32,"tag":"CVMP"}],"annotations":[{"start":49,"end":60,"probability":0.8754,"type":"Person","normalized_text":"Dr Anja Holm"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-19T09:42:10.000Z","possibly_sensitive":false,"text":"Our #veterinary committee (#CVMP) has re-elected Dr Anja Holm as its chair: http://t.co/5GHHMF3Jkt","conversation_id":"347288186491392000","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"347264425041989635","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/dQraEiWksC","expanded_url":"http://bit.ly/14I3iKV","display_url":"bit.ly/14I3iKV"}],"hashtags":[{"start":61,"end":72,"tag":"veterinary"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-19T08:07:45.000Z","possibly_sensitive":false,"text":"Our policy on minor uses minor species / limited markets for #veterinary medicines is about to change: http://t.co/dQraEiWksC","conversation_id":"347264425041989635","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"347264060359835648","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":83,"end":105,"url":"http://t.co/qZNTzy5jvQ","expanded_url":"http://bit.ly/11n7EpY","display_url":"bit.ly/11n7EpY"}],"hashtags":[{"start":52,"end":62,"tag":"Parkinson"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-19T08:06:18.000Z","possibly_sensitive":false,"text":"RT @euparkinsons: Developing the Next Generation of #Parkinson’s Disease Therapies http://t.co/qZNTzy5jvQ","conversation_id":"347264060359835648","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347263219431243776"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"347018139575406592","entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/dQraEiWksC","expanded_url":"http://bit.ly/14I3iKV","display_url":"bit.ly/14I3iKV"}],"hashtags":[{"start":71,"end":82,"tag":"veterinary"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-18T15:49:06.000Z","possibly_sensitive":false,"text":"We're revising our minor-use-minor-species / limited-market policy for #veterinary medicines: http://t.co/dQraEiWksC","conversation_id":"347018139575406592","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"347016931750051840","entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":{},"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":107,"end":115,"tag":"Zyprexa"}],"annotations":[{"start":51,"end":53,"probability":0.9016,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":37,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-18T15:44:18.000Z","possibly_sensitive":false,"text":"RT @FDA_Drug_Info: #FDA Drug Safety Communication: FDA is investigating two  deaths following injection of #Zyprexa Relprevv http://t.co/xR…","conversation_id":"347016931750051840","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347014401192247297"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"347012695494639616","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-18T15:27:28.000Z","possibly_sensitive":false,"text":"RT @MHRAmedicines: Drug Alerts: Class 1 Medicines recall (Action Now – including out of hours): AmBisome 50mg Powder for Soluti... http://t…","conversation_id":"347012695494639616","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347009755115573252"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"347012657079009281","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":100,"end":122,"url":"http://t.co/Cz1VPEc5Yy","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2013/NI-MUH_FV_18-2013-hidroxietil.htm","display_url":"aemps.gob.es/informa/notasI…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-18T15:27:19.000Z","possibly_sensitive":false,"text":"RT @AEMPSGOB: Infusion solutions containing hydroxyethyl starch: review of the benefit-risk balance http://t.co/Cz1VPEc5Yy","conversation_id":"347012657079009281","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"347012476258361345","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"hashtags":[{"start":84,"end":92,"tag":"Malaria"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-18T15:26:36.000Z","possibly_sensitive":false,"text":"RT @innovationunion: Resistance to combination drugs threatens efforts to eradicate #Malaria: With 300-500 million people falling ill... ht…","conversation_id":"347012476258361345","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"347009507748085760"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"347012393991294976","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":83,"end":105,"url":"http://t.co/QdisLxVoZv","expanded_url":"http://www.aemps.gob.es/medicamentosUsoHumano/informesPublicos/docs/criterios-anticoagulantes-orales.pdf","display_url":"aemps.gob.es/medicamentosUs…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-18T15:26:16.000Z","possibly_sensitive":false,"text":"RT @AEMPSGOB: Update of the therapeutic position report on new oral anticoagulants http://t.co/QdisLxVoZv","conversation_id":"347012393991294976","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"347012207663521792","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":81,"end":103,"url":"http://t.co/WeSOqXntqq","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/laAEMPS/2013/NI-AEMPS_08-2013-jornada-BPD.htm","display_url":"aemps.gob.es/informa/notasI…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-18T15:25:32.000Z","possibly_sensitive":false,"text":"RT @AEMPSGOB: New good distribution practice of medicinal products for human use http://t.co/WeSOqXntqq","conversation_id":"347012207663521792","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"346969014012096512","entities":{"mentions":[{"start":3,"end":19,"username":"EU_ScienceChief","id":"2743488442"}],"urls":[{"start":103,"end":125,"url":"http://t.co/d8t1bxPH7X","expanded_url":"http://www.leopoldina.org/en/publications/detailview/?publication%5bpublication%5d=475&cHash=1883f73140e3cc069425f3e234281083","display_url":"leopoldina.org/en/publication…"}],"hashtags":{},"annotations":[{"start":37,"end":52,"probability":0.5543,"type":"Organization","normalized_text":"German Academies"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-18T12:33:53.000Z","possibly_sensitive":false,"text":"RT @EU_ScienceChief: New report from German Academies on antibiotic resistance (in German and English) http://t.co/d8t1bxPH7X","conversation_id":"346969014012096512","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"346967604814049280"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"346965429668962305","entities":{"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/Lw4ork1lhR","expanded_url":"http://bit.ly/191Nun2","display_url":"bit.ly/191Nun2"}],"hashtags":[{"start":40,"end":58,"tag":"pharmacovigilance"},{"start":104,"end":110,"tag":"PSURs"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-18T12:19:39.000Z","possibly_sensitive":false,"text":"One week left to comment on our revised #pharmacovigilance guideline on periodic safety update reports (#PSURs): http://t.co/Lw4ork1lhR","conversation_id":"346965429668962305","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"fr","id":"346965044971573248","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":45,"end":67,"url":"http://t.co/5F4mzUUkez","expanded_url":"http://bit.ly/12Gytae","display_url":"bit.ly/12Gytae"}],"hashtags":[{"start":68,"end":75,"tag":"newjob"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-18T12:18:07.000Z","possibly_sensitive":false,"text":"RT @LV_MPA: Poison information centre doctor http://t.co/5F4mzUUkez #newjob","conversation_id":"346965044971573248","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"346963721203105792","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":87,"end":109,"url":"http://t.co/jclK5xozEa","expanded_url":"http://bit.ly/19eaz6k","display_url":"bit.ly/19eaz6k"}],"hashtags":[{"start":36,"end":45,"tag":"dementia"},{"start":65,"end":75,"tag":"Parkinson"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-18T12:12:52.000Z","possibly_sensitive":false,"text":"RT @euparkinsons: Neuropathology of #dementia in large cohort of #Parkinson's patients http://t.co/jclK5xozEa","conversation_id":"346963721203105792","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"346944556983545856"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"346936404783280132","entities":{"mentions":{},"urls":[{"start":76,"end":98,"url":"http://t.co/u5R9XaZkIW","expanded_url":"http://bit.ly/11t7fz0","display_url":"bit.ly/11t7fz0"}],"hashtags":{},"annotations":[{"start":45,"end":65,"probability":0.4483,"type":"Organization","normalized_text":"80th Management Board"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-18T10:24:19.000Z","possibly_sensitive":false,"text":"Yesterday we published the highlights of the 80th Management Board meeting: http://t.co/u5R9XaZkIW","conversation_id":"346936404783280132","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"346933436977651712","entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"urls":[{"start":116,"end":138,"url":"http://t.co/088NRwsYKW","expanded_url":"http://www.ages.at/ages/presse/pressemeldungen/information-zu-vogelschmuggel-mit-vogelgrippefall-h5n1-in-oesterreich/","display_url":"ages.at/ages/presse/pr…"}],"hashtags":[{"start":14,"end":19,"tag":"H5N1"}],"annotations":[{"start":37,"end":43,"probability":0.9941,"type":"Place","normalized_text":"Austria"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-18T10:12:31.000Z","possibly_sensitive":false,"text":"RT @agesnews: #H5N1 bird-flu case in Austria - Highly pathogenic form of the virus detected in a total of 6 animals http://t.co/088NRwsYKW","conversation_id":"346933436977651712","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"346932636998041600","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":115,"end":137,"url":"http://t.co/0MKDiVqg2b","expanded_url":"http://fb.me/UCPlGWNc","display_url":"fb.me/UCPlGWNc"}],"hashtags":{},"annotations":[{"start":35,"end":48,"probability":0.9224,"type":"Person","normalized_text":"Marta Gramazio"},{"start":84,"end":113,"probability":0.7788,"type":"Organization","normalized_text":"Counterfeiting Prevention Unit"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-18T10:09:21.000Z","possibly_sensitive":false,"text":"RT @Aifa_ufficiale: Interview with Marta Gramazio of the Italian medicines agency's Counterfeiting Prevention Unit http://t.co/0MKDiVqg2b","conversation_id":"346932636998041600","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"346932196654841856","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":90,"end":112,"url":"http://t.co/Q352Vog3Z9","expanded_url":"http://bit.ly/O15CaG","display_url":"bit.ly/O15CaG"}],"hashtags":[{"start":49,"end":59,"tag":"Parkinson"},{"start":62,"end":70,"tag":"Disease"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-18T10:07:36.000Z","possibly_sensitive":false,"text":"RT @euparkinsons: Stay up-2-date with the latest #Parkinson's #Disease research articles: http://t.co/Q352Vog3Z9","conversation_id":"346932196654841856","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"346921655601356802"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"346905846875312128","entities":{"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/Lw4ork1lhR","expanded_url":"http://bit.ly/191Nun2","display_url":"bit.ly/191Nun2"}],"hashtags":[{"start":40,"end":58,"tag":"pharmacovigilance"},{"start":104,"end":110,"tag":"PSURs"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-18T08:22:53.000Z","possibly_sensitive":false,"text":"One more week to comment on our revised #pharmacovigilance guideline on periodic safety update reports (#PSURs): http://t.co/Lw4ork1lhR","conversation_id":"346905846875312128","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"346905095096635392","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":47,"end":58,"username":"eupatients","id":"465674067"}],"urls":[{"start":111,"end":133,"url":"http://t.co/aM2TuAMCey","expanded_url":"http://bit.ly/19f6xKL","display_url":"bit.ly/19f6xKL"}],"hashtags":{},"annotations":[{"start":73,"end":76,"probability":0.9306,"type":"Place","normalized_text":"Rome"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-18T08:19:54.000Z","possibly_sensitive":false,"text":"RT @IMI_JU: Read the full report of the recent @eupatients conference in Rome on the project’s vision for 2020 http://t.co/aM2TuAMCey","conversation_id":"346905095096635392","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"346900962100781056"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"346662827345444865","entities":{"mentions":[{"start":3,"end":11,"username":"IlaeWeb","id":"611701745"}],"urls":[{"start":67,"end":89,"url":"http://t.co/jOKBeoDYgt","expanded_url":"http://www.ilae.org/Visitors/Centre/Guidelines.cfm","display_url":"ilae.org/Visitors/Centr…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T16:17:13.000Z","possibly_sensitive":false,"text":"RT @IlaeWeb: Guidelines for epilepsy treatment are available here: http://t.co/jOKBeoDYgt","conversation_id":"346662827345444865","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"346662054620442625"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"346659256709312512","entities":{"mentions":[{"start":0,"end":11,"username":"JorgeSegon","id":"3919565956"},{"start":12,"end":21,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":51,"end":73,"url":"http://t.co/5lYDPG0YrK","expanded_url":"http://bit.ly/12E1wLF","display_url":"bit.ly/12E1wLF"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T16:03:02.000Z","possibly_sensitive":false,"text":"@JorgeSegon @AEMPSGOB Apologies. Here is the link: http://t.co/5lYDPG0YrK","conversation_id":"346629040255414272","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"346652763641499648"}],"in_reply_to_user_id":"125443078","attachments":{"media_keys":{}}},{"lang":"en","id":"346658835555033088","entities":{"mentions":[{"start":3,"end":18,"username":"USPharmacopeia","id":"47953929"}],"urls":{},"hashtags":[{"start":24,"end":33,"tag":"research"},{"start":58,"end":66,"tag":"Vitamin"},{"start":84,"end":91,"tag":"asthma"},{"start":98,"end":106,"tag":"allergy"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T16:01:21.000Z","possibly_sensitive":false,"text":"RT @USPharmacopeia: New #research suggests a link between #Vitamin D deficiency and #asthma &amp; #allergy risk in obese teens: http://t.co/vpk…","conversation_id":"346658835555033088","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"346653767162269697"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"346658653304143872","entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":117,"end":139,"url":"http://t.co/kEGYgo4pZG","expanded_url":"http://ow.ly/m6A7n","display_url":"ow.ly/m6A7n"}],"hashtags":[{"start":61,"end":72,"tag":"Biomarkers"},{"start":109,"end":116,"tag":"Cancer"}],"annotations":[{"start":12,"end":32,"probability":0.4421,"type":"Other","normalized_text":"BioMarker IGF Project"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T16:00:38.000Z","possibly_sensitive":false,"text":"RT @myESMO: BioMarker IGF Project aims to identify, validate #Biomarkers for the IGF-1 Signalling Pathway in #Cancer http://t.co/kEGYgo4pZG","conversation_id":"346658653304143872","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"346639441210769408"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"346658413301882881","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":114,"end":136,"url":"http://t.co/bvud1ODLFq","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/medIlegales/2013/ICM_MI_01-2013.htm","display_url":"aemps.gob.es/informa/notasI…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T15:59:40.000Z","possibly_sensitive":false,"text":"RT @AEMPSGOB: Case of poisoning associated with the consumption of the product MVV (Mahavatvidhwansa Rasa 125 mg) http://t.co/bvud1ODLFq","conversation_id":"346658413301882881","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"346656677929562113","entities":{"mentions":{},"urls":[{"start":74,"end":96,"url":"http://t.co/u5R9XaZkIW","expanded_url":"http://bit.ly/11t7fz0","display_url":"bit.ly/11t7fz0"}],"hashtags":{},"annotations":[{"start":43,"end":63,"probability":0.431,"type":"Organization","normalized_text":"80th Management Board"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T15:52:47.000Z","possibly_sensitive":false,"text":"We've just published the highlights of the 80th Management Board meeting: http://t.co/u5R9XaZkIW","conversation_id":"346656677929562113","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"346629113785753601","entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"urls":[{"start":89,"end":111,"url":"http://t.co/ZZFGw5ThMD","expanded_url":"http://www.emcdda.europa.eu/publications/drugnet/82","display_url":"emcdda.europa.eu/publications/d…"}],"hashtags":{},"annotations":[{"start":73,"end":86,"probability":0.4199,"type":"Place","normalized_text":"Drugnet Europe"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T14:03:15.000Z","possibly_sensitive":false,"text":"RT @EMCDDA: Just published: the latest issue of the EMCDDA's newsletter, Drugnet Europe: http://t.co/ZZFGw5ThMD","conversation_id":"346629113785753601","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"346628794888626177"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"346629040255414272","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":76,"end":98,"url":"http://t.co/0heKf1XT7r","expanded_url":"http://aemps.gob.es/informa/inform","display_url":"aemps.gob.es/informa/inform"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T14:02:57.000Z","possibly_sensitive":false,"text":"RT @AEMPSGOB Monthly publication from the Spanish medicines agency May 2013\nhttp://t.co/0heKf1XT7r…","conversation_id":"346629040255414272","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"346627983978668032","entities":{"mentions":[{"start":3,"end":14,"username":"ECNPtweets","id":"347180217"}],"urls":{},"hashtags":{},"annotations":[{"start":16,"end":25,"probability":0.99,"type":"Person","normalized_text":"David Nutt"},{"start":101,"end":109,"probability":0.5553,"type":"Other","normalized_text":"Alzheimer"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T13:58:46.000Z","possibly_sensitive":false,"text":"RT @ECNPtweets: David Nutt tells Time magazine how the drug war is blocking potential treatments for Alzheimer’s and other diseases http://…","conversation_id":"346627983978668032","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"346613537646444544"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"346621435474739201","entities":{"mentions":[{"start":3,"end":17,"username":"FDADeviceInfo","id":"140427956"}],"urls":[{"start":105,"end":127,"url":"http://t.co/F1K0xiAAL1","expanded_url":"http://1.usa.gov/12QquZx","display_url":"1.usa.gov/12QquZx"}],"hashtags":[{"start":82,"end":91,"tag":"melanoma"},{"start":92,"end":103,"tag":"skincancer"},{"start":128,"end":132,"tag":"fda"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T13:32:44.000Z","possibly_sensitive":false,"text":"RT @FDADeviceInfo: THxID™ -BRAF Kit - assay 2 detect gene mutations that indicate #melanoma #skincancer. http://t.co/F1K0xiAAL1 #fda #medic…","conversation_id":"346621435474739201","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"346607728640286720"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"346621377341698050","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":27,"end":32,"tag":"ECDC"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T13:32:30.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: Read the 2012 #ECDC Director’s Annual Report; gives overview of the Centre’s accomplishments &amp; summary of operations http://t.…","conversation_id":"346621377341698050","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"346607346266554368"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"346621268965081088","entities":{"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"},{"start":51,"end":65,"username":"EU_Commission","id":"157981564"},{"start":105,"end":113,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":82,"end":104,"url":"http://t.co/1KT88MNLgL","expanded_url":"http://owl.li/m5KEC","display_url":"owl.li/m5KEC"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T13:32:05.000Z","possibly_sensitive":false,"text":"RT @EURLex: Find out which flavoring substance the @EU_Commission has prohibited: http://t.co/1KT88MNLgL @EFSA_EU","conversation_id":"346621268965081088","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"346604570132238336"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"346593288083603456","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":77,"end":99,"url":"http://t.co/u1bIlkbtDo","expanded_url":"http://bit.ly/11Ty1Uc","display_url":"bit.ly/11Ty1Uc"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T11:40:53.000Z","possibly_sensitive":false,"text":"RT @EFPIA: Find out more about Research &amp; Development on Efpia's website http://t.co/u1bIlkbtDo","conversation_id":"346593288083603456","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"346591727093706753"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"346592936928083968","entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"urls":[{"start":111,"end":133,"url":"http://t.co/fASGrdGEWF","expanded_url":"http://bit.ly/14cUieN","display_url":"bit.ly/14cUieN"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T11:39:30.000Z","possibly_sensitive":false,"text":"RT @Legemiddelinfo: You can subscribe to news alerts on our website and get emails when we post something new. http://t.co/fASGrdGEWF","conversation_id":"346592936928083968","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"346568817356439553","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":76,"end":98,"url":"http://t.co/Mu2uIhbdvW","expanded_url":"http://bbc.in/14qmI71","display_url":"bbc.in/14qmI71"}],"hashtags":[{"start":65,"end":75,"tag":"Alzheimer"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T10:03:39.000Z","possibly_sensitive":false,"text":"RT @EFPIA: Arc protein 'could be key to memory loss', says study #Alzheimer http://t.co/Mu2uIhbdvW","conversation_id":"346568817356439553","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"346553591856775170"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"346568642424602624","entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"urls":[{"start":118,"end":140,"url":"http://t.co/GmzYLoVLDs","expanded_url":"http://bit.ly/ZWQPkU","display_url":"bit.ly/ZWQPkU"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T10:02:57.000Z","possibly_sensitive":false,"text":"RT @Legemiddelinfo In the latest news about medicines you can read about new pan-European monitoring list and marking http://t.co/GmzYLoVLDs","conversation_id":"346568642424602624","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"346567608298004480","entities":{"mentions":{},"urls":[{"start":52,"end":74,"url":"http://t.co/Ko8NYa17H0","expanded_url":"http://bit.ly/10i97PV","display_url":"bit.ly/10i97PV"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T09:58:51.000Z","possibly_sensitive":false,"text":"We published the CVMP Meeting highlights on Friday: http://t.co/Ko8NYa17H0","conversation_id":"346567608298004480","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"346567364680228864","entities":{"mentions":{},"urls":[{"start":107,"end":129,"url":"http://t.co/1C4dAPuGrg","expanded_url":"http://bit.ly/10hNhfb","display_url":"bit.ly/10hNhfb"}],"hashtags":[{"start":86,"end":105,"tag":"hydroxyethylstarch"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T09:57:53.000Z","possibly_sensitive":false,"text":"PRAC recommends suspending marketing authorisations for infusion solutions containing #hydroxyethylstarch: http://t.co/1C4dAPuGrg","conversation_id":"346567364680228864","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"346567181116514304","entities":{"mentions":{},"urls":[{"start":73,"end":95,"url":"http://t.co/Zeux1aVCpW","expanded_url":"http://bit.ly/153dIl3","display_url":"bit.ly/153dIl3"}],"hashtags":[{"start":39,"end":50,"tag":"flupirtine"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T09:57:09.000Z","possibly_sensitive":false,"text":"PRAC recommends restricting the use of #flupirtine-containing medicines: http://t.co/Zeux1aVCpW","conversation_id":"346567181116514304","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"346566923825340416","entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/BN5Y9E2RBG","expanded_url":"http://bit.ly/153cYMW","display_url":"bit.ly/153cYMW"}],"hashtags":[{"start":39,"end":47,"tag":"codeine"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T09:56:08.000Z","possibly_sensitive":false,"text":"PRAC recommends restricting the use of #codeine when used for pain relief in children: http://t.co/BN5Y9E2RBG","conversation_id":"346566923825340416","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"346566728500789250","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/g9RgK87jfl","expanded_url":"http://bit.ly/ZOnpVU","display_url":"bit.ly/ZOnpVU"}],"hashtags":[{"start":56,"end":67,"tag":"diclofenac"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"created_at":"2013-06-17T09:55:21.000Z","possibly_sensitive":false,"text":"PRAC recommends the same cardiovascular precautions for #diclofenac as for selective COX-2 inhibitors: http://t.co/g9RgK87jfl","conversation_id":"346566728500789250","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"346566037992517632","entities":{"mentions":{},"urls":[{"start":52,"end":74,"url":"http://t.co/K7lRSRjQi6","expanded_url":"http://bit.ly/16m99p9","display_url":"bit.ly/16m99p9"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-17T09:52:37.000Z","possibly_sensitive":false,"text":"We published the PRAC meeting highlights on Friday: http://t.co/K7lRSRjQi6","conversation_id":"346566037992517632","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"346540079252123648","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/OUH41vlNtp","expanded_url":"http://bit.ly/11ANX9R","display_url":"bit.ly/11ANX9R"}],"hashtags":[{"start":95,"end":99,"tag":"HTA"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-17T08:09:27.000Z","possibly_sensitive":false,"text":"Register now for our workshop on parallel scientific advice with health-technology-assessment (#HTA) bodies: http://t.co/OUH41vlNtp","conversation_id":"346540079252123648","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345590191794298880","entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":{},"hashtags":{},"annotations":[{"start":13,"end":15,"probability":0.5782,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T17:14:57.000Z","possibly_sensitive":false,"text":"RT @FDACBER: FDA Releases Final Results of Mini-Sentinel Postlicensure Observational Study of Rotavirus Vaccines &amp; Intussusception http://t…","conversation_id":"345590191794298880","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345572702607777792"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345566775775211520","entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"urls":{},"hashtags":[{"start":94,"end":107,"tag":"womenshealth"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T15:41:54.000Z","possibly_sensitive":false,"text":"RT @FDAWomen: Be the first to know about drug &amp; device issues, warnings &amp; updates for #womenshealth. Sign up for our emails: http://t.co/yY…","conversation_id":"345566775775211520","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345566691771695106"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345556643574075392","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":117,"end":139,"url":"http://t.co/jQaqeEWWrW","expanded_url":"http://fb.me/EhRh6m5b","display_url":"fb.me/EhRh6m5b"}],"hashtags":{},"annotations":[{"start":20,"end":41,"probability":0.8523,"type":"Person","normalized_text":"Prof. Sergio Pecorelli"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T15:01:38.000Z","possibly_sensitive":false,"text":"RT @Aifa_ufficiale: Prof. Sergio Pecorelli, AIFA president: \"Focusing on innovation to meet the new needs of health\" http://t.co/jQaqeEWWrW","conversation_id":"345556643574075392","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345556070133014528","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":114,"end":136,"url":"http://t.co/RVkER7qsNE","expanded_url":"http://bit.ly/18Gv3rp","display_url":"bit.ly/18Gv3rp"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T14:59:21.000Z","possibly_sensitive":false,"text":"RT @LV_MPA: The same precautions to prevent serious cardiovascular side effects are recommended for diclofenac... http://t.co/RVkER7qsNE","conversation_id":"345556070133014528","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345551840139689984","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/OUH41vlNtp","expanded_url":"http://bit.ly/11ANX9R","display_url":"bit.ly/11ANX9R"}],"hashtags":[{"start":103,"end":107,"tag":"HTA"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T14:42:33.000Z","possibly_sensitive":false,"text":"Registration is open for our workshop on parallel scientific advice with health-technology-assessment (#HTA) bodies: http://t.co/OUH41vlNtp","conversation_id":"345551840139689984","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345550613406420992","entities":{"mentions":{},"urls":[{"start":50,"end":72,"url":"http://t.co/Ko8NYa17H0","expanded_url":"http://bit.ly/10i97PV","display_url":"bit.ly/10i97PV"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T14:37:40.000Z","possibly_sensitive":false,"text":"We've just published the CVMP Meeting highlights: http://t.co/Ko8NYa17H0","conversation_id":"345550613406420992","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345538526160486400","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"hashtags":[{"start":62,"end":69,"tag":"Cancer"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T13:49:39.000Z","possibly_sensitive":false,"text":"RT @innovationunion: New biomarker to help detect early stage #Cancer: The earlier cancer is detected, the more successful treatment... htt…","conversation_id":"345538526160486400","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345538312502665216"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345537674020519936","entities":{"mentions":[{"start":3,"end":16,"username":"HealthCanada","id":"928334374256472064"}],"urls":[{"start":94,"end":116,"url":"http://t.co/lsfVpY6wHa","expanded_url":"http://bit.ly/1ab01pO","display_url":"bit.ly/1ab01pO"}],"hashtags":[{"start":117,"end":124,"tag":"health"},{"start":125,"end":132,"tag":"safety"}],"annotations":[{"start":18,"end":34,"probability":0.6754,"type":"Organization","normalized_text":"Harper Government"}]},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T13:46:15.000Z","possibly_sensitive":false,"text":"RT @HealthCanada: Harper Government launches Plain Language Labelling to improve drug safety: http://t.co/lsfVpY6wHa #health #safety","conversation_id":"345537674020519936","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345535829998972928"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345526546926288897","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":92,"end":114,"url":"http://t.co/alb1dZVdMj","expanded_url":"http://urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-na-temat-produktu-leczniczego-numeta-g13-e","display_url":"urpl.gov.pl/aktualnosci/in…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T13:02:03.000Z","possibly_sensitive":false,"text":"RT @URPLWMiPB: Office of the President - information on the medicinal product Numeta G13% E http://t.co/alb1dZVdMj","conversation_id":"345526546926288897","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345522352815226880","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":113,"end":135,"url":"http://t.co/k6PNs58nNR","expanded_url":"http://fb.me/1tCIvNF3W","display_url":"fb.me/1tCIvNF3W"}],"hashtags":{},"annotations":[{"start":69,"end":110,"probability":0.5409,"type":"Organization","normalized_text":"European Medicines Agency Management Board"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-14T12:45:23.000Z","possibly_sensitive":false,"text":"RT @GCessak: Office communication concerning the 80th meeting of the European Medicines Agency Management Board. http://t.co/k6PNs58nNR","conversation_id":"345522352815226880","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345519150229229569","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":76,"end":98,"url":"http://t.co/Dz8GacQeP1","expanded_url":"http://mobile.reuters.com/article/idUSBRE95D0CY20130614?irpc=932","display_url":"mobile.reuters.com/article/idUSBR…"}],"hashtags":{},"annotations":[{"start":13,"end":19,"probability":0.4291,"type":"Organization","normalized_text":"Reuters"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T12:32:39.000Z","possibly_sensitive":false,"text":"RT @GCessak: Reuters: EU regulator advises caution on painkiller diclofenac http://t.co/Dz8GacQeP1","conversation_id":"345519150229229569","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345517017077518337"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345516549756567552","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":112,"end":134,"url":"http://t.co/jo7myFbAPr","expanded_url":"http://fb.me/28C499mgw","display_url":"fb.me/28C499mgw"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T12:22:19.000Z","possibly_sensitive":false,"text":"RT @Aifa_ufficiale: Communication on Numeta G13% E 300 ml The use of Numeta G13% E 300 ml in preterm infants... http://t.co/jo7myFbAPr","conversation_id":"345516549756567552","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345511231257448448","entities":{"mentions":{},"urls":[{"start":107,"end":129,"url":"http://t.co/1C4dAPuGrg","expanded_url":"http://bit.ly/10hNhfb","display_url":"bit.ly/10hNhfb"}],"hashtags":[{"start":86,"end":105,"tag":"hydroxyethylstarch"}],"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":1,"like_count":1,"quote_count":0},"created_at":"2013-06-14T12:01:11.000Z","possibly_sensitive":false,"text":"PRAC recommends suspending marketing authorisations for infusion solutions containing #hydroxyethylstarch: http://t.co/1C4dAPuGrg","conversation_id":"345511231257448448","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345510902944104449","entities":{"mentions":{},"urls":[{"start":73,"end":95,"url":"http://t.co/Zeux1aVCpW","expanded_url":"http://bit.ly/153dIl3","display_url":"bit.ly/153dIl3"}],"hashtags":[{"start":39,"end":50,"tag":"flupirtine"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T11:59:53.000Z","possibly_sensitive":false,"text":"PRAC recommends restricting the use of #flupirtine-containing medicines: http://t.co/Zeux1aVCpW","conversation_id":"345510902944104449","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345510439532261376","entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/BN5Y9E2RBG","expanded_url":"http://bit.ly/153cYMW","display_url":"bit.ly/153cYMW"}],"hashtags":[{"start":39,"end":47,"tag":"codeine"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":2,"like_count":2,"quote_count":0},"created_at":"2013-06-14T11:58:02.000Z","possibly_sensitive":false,"text":"PRAC recommends restricting the use of #codeine when used for pain relief in children: http://t.co/BN5Y9E2RBG","conversation_id":"345510439532261376","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345509336476418048","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/g9RgK87jfl","expanded_url":"http://bit.ly/ZOnpVU","display_url":"bit.ly/ZOnpVU"}],"hashtags":[{"start":56,"end":67,"tag":"diclofenac"}],"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":1,"like_count":4,"quote_count":0},"created_at":"2013-06-14T11:53:39.000Z","possibly_sensitive":false,"text":"PRAC recommends the same cardiovascular precautions for #diclofenac as for selective COX-2 inhibitors: http://t.co/g9RgK87jfl","conversation_id":"345509336476418048","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345503944493109250","entities":{"mentions":[{"start":29,"end":38,"username":"ICH_news","id":"305434870"}],"urls":[{"start":111,"end":133,"url":"http://t.co/Nh3n9fwpm9","expanded_url":"http://bit.ly/12KKk8z","display_url":"bit.ly/12KKk8z"}],"hashtags":[{"start":55,"end":65,"tag":"mutagenic"},{"start":91,"end":104,"tag":"carcinogenic"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-14T11:32:14.000Z","possibly_sensitive":false,"text":"Two weeks left to comment on @ICH_news guideline M7 on #mutagenic impurities and potential #carcinogenic risk: http://t.co/Nh3n9fwpm9","conversation_id":"345503944493109250","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345503851505401856","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/Go7t6OEvwh","expanded_url":"http://bit.ly/152U0G8","display_url":"bit.ly/152U0G8"}],"hashtags":[{"start":50,"end":64,"tag":"toxicological"},{"start":103,"end":115,"tag":"groundwater"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T11:31:52.000Z","possibly_sensitive":false,"text":"Two weeks left to comment on our concept paper on #toxicological risk of veterinary pharmaceuticals in #groundwater: http://t.co/Go7t6OEvwh","conversation_id":"345503851505401856","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345503312516378624","entities":{"mentions":{},"urls":[{"start":52,"end":74,"url":"http://t.co/K7lRSRjQi6","expanded_url":"http://bit.ly/16m99p9","display_url":"bit.ly/16m99p9"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T11:29:43.000Z","possibly_sensitive":false,"text":"We have just published the PRAC meeting highlights: http://t.co/K7lRSRjQi6","conversation_id":"345503312516378624","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345483555926855681","entities":{"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"}],"urls":[{"start":84,"end":106,"url":"http://t.co/2KFnLKR6v0","expanded_url":"http://www.ages.at/ages/presse/newsletter/kalenderjahr-2013/newsletter-0513-13062013/","display_url":"ages.at/ages/presse/ne…"},{"start":107,"end":129,"url":"http://t.co/gtQmGpmTHI","expanded_url":"https://twitter.com/agesnews/status/345480730635284480/photo/1","display_url":"pic.twitter.com/gtQmGpmTHI"}],"hashtags":[{"start":14,"end":19,"tag":"AGES"},{"start":34,"end":45,"tag":"glyphosate"},{"start":46,"end":54,"tag":"birdflu"},{"start":55,"end":65,"tag":"horsemeat"},{"start":66,"end":83,"tag":"wildlifediseases"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"created_at":"2013-06-14T10:11:13.000Z","possibly_sensitive":false,"text":"RT @agesnews: #AGES newsletter on #glyphosate #birdflu #horsemeat #wildlifediseases http://t.co/2KFnLKR6v0 http://t.co/gtQmGpmTHI","conversation_id":"345483555926855681","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":["3_345480730643673088"]}},{"lang":"en","id":"345476160118992896","entities":{"mentions":[{"start":33,"end":42,"username":"ICH_news","id":"305434870"}],"urls":[{"start":115,"end":137,"url":"http://t.co/Nh3n9fwpm9","expanded_url":"http://bit.ly/12KKk8z","display_url":"bit.ly/12KKk8z"}],"hashtags":[{"start":59,"end":69,"tag":"mutagenic"},{"start":95,"end":108,"tag":"carcinogenic"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T09:41:49.000Z","possibly_sensitive":false,"text":"Two more weeks to comment on the @ICH_news guideline M7 on #mutagenic impurities and potential #carcinogenic risk: http://t.co/Nh3n9fwpm9","conversation_id":"345476160118992896","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345475079406243840","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/Go7t6OEvwh","expanded_url":"http://bit.ly/152U0G8","display_url":"bit.ly/152U0G8"}],"hashtags":[{"start":50,"end":64,"tag":"toxicological"},{"start":103,"end":115,"tag":"groundwater"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T09:37:32.000Z","possibly_sensitive":false,"text":"Two more weeks to comment on our concept paper on #toxicological risk of veterinary pharmaceuticals in #groundwater: http://t.co/Go7t6OEvwh","conversation_id":"345475079406243840","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345454433875927041","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":63,"end":85,"url":"http://t.co/BSn72HFmG3","expanded_url":"http://goo.gl/uT5Xv","display_url":"goo.gl/uT5Xv"}],"hashtags":{},"annotations":[{"start":30,"end":61,"probability":0.6294,"type":"Other","normalized_text":"Middle East Respiratory Syndrome"}]},"public_metrics":{"retweet_count":58,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T08:15:29.000Z","possibly_sensitive":false,"text":"RT @WHO: Latest update on the Middle East Respiratory Syndrome http://t.co/BSn72HFmG3 (as of 14 June 2013)","conversation_id":"345454433875927041","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345454103960363008"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345454400082411520","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":45,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-14T08:15:21.000Z","possibly_sensitive":false,"text":"RT @WHO: Globally, from Sept. 2012 to date, WHO has been informed of 58 laboratory-confirmed Middle East Respiratory Syndrome cases, incl. …","conversation_id":"345454400082411520","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345452665150521344"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345215090049572864","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":47,"end":69,"url":"http://t.co/rROr06UKRM","expanded_url":"http://bit.ly/16iOVg4","display_url":"bit.ly/16iOVg4"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T16:24:25.000Z","possibly_sensitive":false,"text":"RT @LV_MPA New legislation for medicine safety http://t.co/rROr06UKRM","conversation_id":"345215090049572864","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345211520776552450","entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":69,"end":91,"url":"http://t.co/EV28EbrEPs","expanded_url":"http://1.usa.gov/150hcoj","display_url":"1.usa.gov/150hcoj"}],"hashtags":{},"annotations":[{"start":12,"end":14,"probability":0.8764,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T16:10:15.000Z","possibly_sensitive":false,"text":"RT @US_FDA: FDA approves Xgeva to treat giant cell tumor of the bone http://t.co/EV28EbrEPs","conversation_id":"345211520776552450","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345195042165649409"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345211289854935043","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"}],"urls":{},"hashtags":[{"start":31,"end":43,"tag":"bedaquiline"},{"start":105,"end":109,"tag":"HIV"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T16:09:19.000Z","possibly_sensitive":false,"text":"RT @ECDC_TB: Info on safety of #bedaquiline still limited:essential to collect safety data, includ among #HIV positives &amp;children http://t.…","conversation_id":"345211289854935043","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345188771186216961"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345211153934336000","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"},{"start":17,"end":21,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":42,"end":54,"tag":"bedaquiline"},{"start":96,"end":100,"tag":"MDR"},{"start":101,"end":104,"tag":"TB"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T16:08:47.000Z","possibly_sensitive":false,"text":"RT @ECDC_TB: New @WHO interim guidance on #bedaquiline: first TB drug in 40 yrs is new hope for #MDR #TB patients but need to develop more …","conversation_id":"345211153934336000","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345186337378426880"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345189219972558849","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"},{"start":110,"end":125,"username":"InPharmaTechno","id":"106444052"}],"urls":[{"start":83,"end":105,"url":"http://t.co/WELS3Y9mNM","expanded_url":"http://www.in-pharmatechnologist.com/Ingredients/EC-welcomes-list-of-Indian-API-suppliers-with-written-confirmation?utm_source=AddThis&utm_medium=Twitter&utm_campaign=SocialMedia/#.UbnLSpCcBMZ.twitter","display_url":"in-pharmatechnologist.com/Ingredients/EC…"}],"hashtags":{},"annotations":[{"start":13,"end":14,"probability":0.603,"type":"Organization","normalized_text":"EC"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T14:41:38.000Z","possibly_sensitive":false,"text":"RT @GCessak: EC welcomes list of Indian API suppliers with ‘written confirmation’  http://t.co/WELS3Y9mNM via @InPharmaTechno","conversation_id":"345189219972558849","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345173518146736128"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345156426169200640","entities":{"mentions":[{"start":3,"end":14,"username":"sanidadgob","id":"232124120"}],"urls":[{"start":110,"end":132,"url":"http://t.co/RNssZcAMEv","expanded_url":"http://msssi.es/gabinete/notas","display_url":"msssi.es/gabinete/notas"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-06-13T12:31:19.000Z","possibly_sensitive":false,"text":"RT @sanidadgob Reform of medicine laws will offer more safety to citizens &amp; eliminate falsified medicines http://t.co/RNssZcAMEv…","conversation_id":"345156426169200640","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345134287819005952","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/VMeReUppI9","expanded_url":"http://bit.ly/ZLkhdu","display_url":"bit.ly/ZLkhdu"}],"hashtags":[{"start":29,"end":38,"tag":"Stribild"},{"start":40,"end":53,"tag":"elvitegravir"},{"start":56,"end":67,"tag":"cobicistat"},{"start":70,"end":84,"tag":"emtricitabine"},{"start":87,"end":97,"tag":"tenofovir"},{"start":103,"end":107,"tag":"HIV"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T11:03:21.000Z","possibly_sensitive":false,"text":"We've published the EPAR for #Stribild (#elvitegravir / #cobicistat / #emtricitabine / #tenofovir) for #HIV: http://t.co/VMeReUppI9","conversation_id":"345134287819005952","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345132010999775232","entities":{"mentions":{},"urls":{},"hashtags":{},"annotations":[{"start":53,"end":56,"probability":0.4393,"type":"Organization","normalized_text":"ELPA"},{"start":99,"end":107,"probability":0.9121,"type":"Place","normalized_text":"Amsterdam"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T10:54:18.000Z","possibly_sensitive":false,"text":"RT @HepatitisEurope: Read the report and slides from ELPA's Symposium on Compassionate Use held at Amsterdam this April. Share and... http:…","conversation_id":"345132010999775232","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345130183537328128"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345131858796875776","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":{},"hashtags":[{"start":78,"end":86,"tag":"bigdata"}],"annotations":[{"start":12,"end":32,"probability":0.576,"type":"Organization","normalized_text":"Public Health England"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T10:53:42.000Z","possibly_sensitive":false,"text":"RT @EFPIA: 'Public Health England to launch largest cancer database' -- using #bigdata to further personalised meds development http://t.co…","conversation_id":"345131858796875776","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345128742324158464"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345131743092817920","entities":{"mentions":[{"start":61,"end":71,"username":"EU_Health","id":"606325697"}],"urls":[{"start":103,"end":125,"url":"http://t.co/k76RPlV4WM","expanded_url":"http://www.epruma.eu","display_url":"epruma.eu"}],"hashtags":[{"start":16,"end":23,"tag":"EPRUMA"},{"start":33,"end":48,"tag":"ResponsibleUse"},{"start":86,"end":102,"tag":"AnimalHealthLaw"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T10:53:14.000Z","possibly_sensitive":false,"text":"RT @IFAHEurope: #EPRUMA promotes #ResponsibleUse of vet meds @EU_Health Conference on #AnimalHealthLaw http://t.co/k76RPlV4WM http://t.co/W…","conversation_id":"345131743092817920","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345128139678171136"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345130754243698688","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"hashtags":[{"start":34,"end":40,"tag":"h2020"}],"annotations":{}},"public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T10:49:18.000Z","possibly_sensitive":false,"text":"RT @innovationunion: Horizon 2020 #h2020 calls on experts to join advisory groups: Published on: 13-June-2013 The EU’s program to... http:/…","conversation_id":"345130754243698688","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345124643650277376"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345130645674131456","entities":{"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"urls":[{"start":86,"end":108,"url":"http://t.co/cHW4TZG1s0","expanded_url":"http://www.bmj.com/content/346/bmj.f3692","display_url":"bmj.com/content/346/bm…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T10:48:52.000Z","possibly_sensitive":false,"text":"RT @EASDnews: Helping patients make sense of the risks of taking GLP-1 agonists | BMJ http://t.co/cHW4TZG1s0","conversation_id":"345130645674131456","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345124161947058177"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345130631845519361","entities":{"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"urls":[{"start":52,"end":74,"url":"http://t.co/K9jgwfSCNL","expanded_url":"http://www.bmj.com/content/346/bmj.f3750","display_url":"bmj.com/content/346/bm…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T10:48:49.000Z","possibly_sensitive":false,"text":"RT @EASDnews: Incretins and risk of neoplasia | BMJ http://t.co/K9jgwfSCNL","conversation_id":"345130631845519361","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345124014018150400"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345130599884918784","entities":{"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"urls":[{"start":89,"end":111,"url":"http://t.co/6WAL5gpNQJ","expanded_url":"http://www.bmj.com/content/346/bmj.f3617","display_url":"bmj.com/content/346/bm…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T10:48:41.000Z","possibly_sensitive":false,"text":"RT @EASDnews: Incretin therapy: should adverse consequences have been anticipated? | BMJ http://t.co/6WAL5gpNQJ","conversation_id":"345130599884918784","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345123861089640448"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345130580901511169","entities":{"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"urls":[{"start":101,"end":123,"url":"http://t.co/cdOkTDMZ3w","expanded_url":"http://www.bmj.com/content/346/bmj.f3680","display_url":"bmj.com/content/346/bm…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T10:48:37.000Z","possibly_sensitive":false,"text":"RT @EASDnews: Has pancreatic damage from glucagon suppressing diabetes drugs been underplayed? | BMJ http://t.co/cdOkTDMZ3w","conversation_id":"345130580901511169","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345123732190281728"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345129429640548352","entities":{"mentions":{},"urls":[{"start":41,"end":63,"url":"http://t.co/l9HITfjpxI","expanded_url":"http://bit.ly/17GQrvF","display_url":"bit.ly/17GQrvF"}],"hashtags":[{"start":16,"end":32,"tag":"AnimalHealthLaw"}],"annotations":[{"start":69,"end":74,"probability":0.938,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T10:44:02.000Z","possibly_sensitive":false,"text":"RT @IFAHEurope: #AnimalHealthLaw debate: http://t.co/l9HITfjpxI IFAH-Europe hopes new text will enhance collaboration between MS and EC on …","conversation_id":"345129429640548352","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345120846618193921"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345129314427215872","entities":{"mentions":{},"urls":[{"start":41,"end":63,"url":"http://t.co/l9HITfjpxI","expanded_url":"http://bit.ly/17GQrvF","display_url":"bit.ly/17GQrvF"}],"hashtags":[{"start":16,"end":32,"tag":"AnimalHealthLaw"}],"annotations":[{"start":69,"end":74,"probability":0.9707,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T10:43:35.000Z","possibly_sensitive":false,"text":"RT @IFAHEurope: #AnimalHealthLaw debate: http://t.co/l9HITfjpxI IFAH-Europe says efficacy of vet meds must be subject of surveillance http:…","conversation_id":"345129314427215872","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345119450309222400"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345117960941215744","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":113,"end":135,"url":"http://t.co/p7Op7Mf5fe","expanded_url":"http://goo.gl/es8It","display_url":"goo.gl/es8It"}],"hashtags":[{"start":16,"end":28,"tag":"bedaquiline"}],"annotations":{}},"public_metrics":{"retweet_count":42,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T09:58:28.000Z","possibly_sensitive":false,"text":"RT @WHO: Use of #bedaquiline in pregnant women and children with multidrug-resistant tuberculosis is not advised http://t.co/p7Op7Mf5fe #MD…","conversation_id":"345117960941215744","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345113619542974464"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345117930758995968","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T09:58:21.000Z","possibly_sensitive":false,"text":"RT @IMI_JU: IMI’s NEWMEDS project quoted in @NatureNews article on biomarkers in depression http://t.co/huSPfrbXbM","conversation_id":"345117930758995968","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345112768791314432"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345117889776467968","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":116,"end":138,"url":"http://t.co/p7Op7Mf5fe","expanded_url":"http://goo.gl/es8It","display_url":"goo.gl/es8It"}],"hashtags":[{"start":39,"end":51,"tag":"bedaquiline"}],"annotations":{}},"public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T09:58:11.000Z","possibly_sensitive":false,"text":"RT @WHO: Special caution required when #bedaquiline is used in people aged 65 and over, and in adults living w/ HIV http://t.co/p7Op7Mf5fe …","conversation_id":"345117889776467968","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345111451406585856"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345117825083523072","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":99,"end":121,"url":"http://t.co/p7Op7Mf5fe","expanded_url":"http://goo.gl/es8It","display_url":"goo.gl/es8It"}],"hashtags":[{"start":44,"end":56,"tag":"bedaquiline"},{"start":122,"end":128,"tag":"MDRTB"},{"start":129,"end":132,"tag":"TB"}],"annotations":{}},"public_metrics":{"retweet_count":34,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T09:57:56.000Z","possibly_sensitive":false,"text":"RT @WHO: WHO interim guidance on the use of #bedaquiline to treat multidrug-resistant tuberculosis http://t.co/p7Op7Mf5fe #MDRTB #TB","conversation_id":"345117825083523072","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345110202430914560"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345109760720371712","entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/VMeReUppI9","expanded_url":"http://bit.ly/ZLkhdu","display_url":"bit.ly/ZLkhdu"}],"hashtags":[{"start":22,"end":31,"tag":"Stribild"},{"start":33,"end":46,"tag":"elvitegravir"},{"start":49,"end":60,"tag":"cobicistat"},{"start":63,"end":77,"tag":"emtricitabine"},{"start":80,"end":90,"tag":"tenofovir"},{"start":96,"end":100,"tag":"HIV"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T09:25:53.000Z","possibly_sensitive":false,"text":"Assessment report for #Stribild (#elvitegravir / #cobicistat / #emtricitabine / #tenofovir) for #HIV now available: http://t.co/VMeReUppI9","conversation_id":"345109760720371712","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345103496837738497","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T09:01:00.000Z","possibly_sensitive":false,"text":"RT @EFPIA: \"Brain scan predicts best therapy for depression: Researchers find first potential biomarker for guiding treatment\" - http://t.c…","conversation_id":"345103496837738497","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345101614044049408"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345095827699675137","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":63,"end":85,"url":"http://t.co/YtHG6wnSAR","expanded_url":"http://sfy.co/bL6u","display_url":"sfy.co/bL6u"}],"hashtags":[{"start":86,"end":94,"tag":"storify"},{"start":95,"end":111,"tag":"IMIPatientFocus"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T08:30:31.000Z","possibly_sensitive":false,"text":"RT @IMI_JU: Read about IMI's Patient Focus meeting in tweets - http://t.co/YtHG6wnSAR #storify #IMIPatientFocus","conversation_id":"345095827699675137","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"345095764789321728"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"345089228398542848","entities":{"mentions":{},"urls":[{"start":108,"end":130,"url":"http://t.co/UzsajTUBh9","expanded_url":"http://bit.ly/14wQ7MT","display_url":"bit.ly/14wQ7MT"}],"hashtags":[{"start":6,"end":17,"tag":"recruiting"},{"start":66,"end":77,"tag":"veterinary"},{"start":131,"end":139,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T08:04:18.000Z","possibly_sensitive":false,"text":"We're #recruiting a scientific administrator to work on safety of #veterinary medicines. Apply by 12/07/13: http://t.co/UzsajTUBh9 #vacancy","conversation_id":"345089228398542848","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345089033917038592","entities":{"mentions":{},"urls":[{"start":108,"end":130,"url":"http://t.co/LjHMsWmR8d","expanded_url":"http://bit.ly/11HbdXE","display_url":"bit.ly/11HbdXE"}],"hashtags":[{"start":6,"end":17,"tag":"recruiting"},{"start":131,"end":139,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T08:03:31.000Z","possibly_sensitive":false,"text":"We're #recruiting a resourcing assistant to support our IT office. Deadline for applications: 12 July 2013: http://t.co/LjHMsWmR8d #vacancy","conversation_id":"345089033917038592","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"345088834062655488","entities":{"mentions":{},"urls":[{"start":108,"end":130,"url":"http://t.co/smbCJX2nuX","expanded_url":"http://bit.ly/16dSsfC","display_url":"bit.ly/16dSsfC"}],"hashtags":[{"start":6,"end":17,"tag":"recruiting"},{"start":20,"end":30,"tag":"scientist"},{"start":42,"end":50,"tag":"quality"},{"start":131,"end":139,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-13T08:02:44.000Z","possibly_sensitive":false,"text":"We're #recruiting a #scientist to work in #quality of medicines. Deadline for applications is 12 July 2013: http://t.co/smbCJX2nuX #vacancy","conversation_id":"345088834062655488","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"344845569577066497","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/UzsajTUBh9","expanded_url":"http://bit.ly/14wQ7MT","display_url":"bit.ly/14wQ7MT"}],"hashtags":[{"start":17,"end":25,"tag":"recruit"},{"start":64,"end":75,"tag":"veterinary"},{"start":132,"end":140,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-12T15:56:05.000Z","possibly_sensitive":false,"text":"We're looking to #recruit a scientific administrator to work on #veterinary-medicine safety. Apply by 12/07: http://t.co/UzsajTUBh9 #vacancy","conversation_id":"344845569577066497","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"344844599778492416","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"hashtags":{},"annotations":[{"start":84,"end":104,"probability":0.4576,"type":"Organization","normalized_text":"Glaxo Wellcome UK Ltd"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-12T15:52:14.000Z","possibly_sensitive":false,"text":"RT @MHRAmedicines: Class 2 Medicines recall: Ventolin Syrup sugar-free 2mg in 5ml - Glaxo Wellcome UK Ltd trading as Allen &amp; Hanb... http:/…","conversation_id":"344844599778492416","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344843850961002496"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344844560914059265","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":76,"end":98,"url":"http://t.co/0w5TyABv65","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/problemasSuministro/2013/NI-AEMPS_07-2013-epanutin.htm","display_url":"aemps.gob.es/informa/notasI…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-06-12T15:52:04.000Z","possibly_sensitive":false,"text":"RT @AEMPSGOB: Problems with the supply of the medicine Epanutin (phenytoin) http://t.co/0w5TyABv65","conversation_id":"344844560914059265","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"344843850994573312","entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/LjHMsWmR8d","expanded_url":"http://bit.ly/11HbdXE","display_url":"bit.ly/11HbdXE"}],"hashtags":[{"start":17,"end":25,"tag":"recruit"},{"start":121,"end":129,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-06-12T15:49:15.000Z","possibly_sensitive":false,"text":"We're looking to #recruit a resourcing assistant to support our IT office. Apply by 12 July 2013: http://t.co/LjHMsWmR8d #vacancy","conversation_id":"344843850994573312","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"344843319605600256","entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/smbCJX2nuX","expanded_url":"http://bit.ly/16dSsfC","display_url":"bit.ly/16dSsfC"}],"hashtags":[{"start":17,"end":25,"tag":"recruit"},{"start":28,"end":38,"tag":"scientist"},{"start":50,"end":58,"tag":"quality"},{"start":119,"end":127,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-06-12T15:47:08.000Z","possibly_sensitive":false,"text":"We're looking to #recruit a #scientist working in #quality of medicines. Apply by 12 July 2013: http://t.co/smbCJX2nuX #vacancy","conversation_id":"344843319605600256","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"344831685109628928","entities":{"mentions":[{"start":3,"end":16,"username":"HealthCanada","id":"928334374256472064"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-12T15:00:55.000Z","possibly_sensitive":false,"text":"RT @HealthCanada: Information for Health Care Professionals - Cannabis (marihuana, marijuana) and the cannabinoids available now: http://t.…","conversation_id":"344831685109628928","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344831531388370945"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344816315892117506","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"hashtags":[{"start":74,"end":81,"tag":"cancer"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-12T13:59:50.000Z","possibly_sensitive":false,"text":"RT @IMI_JU: IMI has 3 projects working to speed up the development of new #cancer treatments: OncoTrack, Quic-Concept, and PREDECT #IMIPati…","conversation_id":"344816315892117506","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344816264180555776"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344812611319250944","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":99,"end":121,"url":"http://t.co/JRNXoo0srJ","expanded_url":"http://bit.ly/11vqB5p","display_url":"bit.ly/11vqB5p"}],"hashtags":[{"start":18,"end":28,"tag":"Parkinson"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-12T13:45:07.000Z","possibly_sensitive":false,"text":"RT @euparkinsons: #Parkinson's and the Genetic Revolution presentation: From Genes to Treatments   http://t.co/JRNXoo0srJ","conversation_id":"344812611319250944","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344806413954084864"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344812153766809600","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":109,"end":131,"url":"http://t.co/edMrxXWrn1","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2012/06/event_detail_000585.jsp&mid=WC0b01ac058004d5c3","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"annotations":[{"start":56,"end":80,"probability":0.2859,"type":"Organization","normalized_text":"European Medicines Agency"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-12T13:43:18.000Z","possibly_sensitive":false,"text":"RT @GCessak: The next meeting of the Managment Board in European Medicines Agency (EMA) will start tomorrow. http://t.co/edMrxXWrn1","conversation_id":"344812153766809600","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344798816781864961"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344811921565954048","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":113,"end":135,"url":"http://t.co/VCGQOjNqg4","expanded_url":"http://tnij.org/v0p1","display_url":"tnij.org/v0p1"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-12T13:42:23.000Z","possibly_sensitive":false,"text":"RT @URPLWMiPB: Information from the Polish agency on marketing authorisations for products containing tetrazepam http://t.co/VCGQOjNqg4","conversation_id":"344811921565954048","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"344811555881353218","entities":{"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-12T13:40:55.000Z","possibly_sensitive":false,"text":"RT @EURLex: Updated: List of permitted health claims made on foods (except those reducing disease risk &amp; for children’s health): http://t.c…","conversation_id":"344811555881353218","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344788869587296256"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344811232332750849","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"hashtags":[{"start":58,"end":64,"tag":"Brain"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-12T13:39:38.000Z","possibly_sensitive":false,"text":"RT @innovationunion: Using gene therapy to tackle complex #Brain disease: Substantial progress has been made in the development of... http:…","conversation_id":"344811232332750849","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344772453182099456"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344810852576268289","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":96,"end":118,"url":"http://t.co/LDeERlXSUB","expanded_url":"http://www.newmeds-europe.com/","display_url":"newmeds-europe.com"}],"hashtags":[{"start":119,"end":135,"tag":"IMIPatientFocus"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-12T13:38:08.000Z","possibly_sensitive":false,"text":"RT @IMI_JU: IMI’s NEWMEDS project is improving drug development in schizophrenia and depression http://t.co/LDeERlXSUB #IMIPatientFocus","conversation_id":"344810852576268289","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344760041666146305"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344810782976000000","entities":{"mentions":[{"start":3,"end":12,"username":"EASDnews","id":"79702114"}],"urls":[{"start":107,"end":129,"url":"http://t.co/iSGnlWpvxQ","expanded_url":"http://link.springer.com/article/10.1007/s00125-013-2903-3","display_url":"link.springer.com/article/10.100…"}],"hashtags":[{"start":14,"end":23,"tag":"diabetes"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-12T13:37:51.000Z","possibly_sensitive":false,"text":"RT @EASDnews: #diabetes - Functional differences between aggregated and dispersed insulin-producing cells: http://t.co/iSGnlWpvxQ","conversation_id":"344810782976000000","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344758472983855104"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344807896485335042","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"hashtags":[{"start":12,"end":22,"tag":"Alzheimer"}],"annotations":[{"start":37,"end":42,"probability":0.9984,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-12T13:26:23.000Z","possibly_sensitive":false,"text":"RT @IMI_JU: #Alzheimer’s research in Europe is very fragmented. IMI’s PharmaCog and EMIF-AD projects are working to change that. #IMIPatien…","conversation_id":"344807896485335042","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344729292980224000"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344469813504114689","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":105,"end":127,"url":"http://t.co/2LNnqfJqAL","expanded_url":"http://bit.ly/17Ee6g9","display_url":"bit.ly/17Ee6g9"}],"hashtags":[{"start":92,"end":102,"tag":"Parkinson"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-11T15:02:58.000Z","possibly_sensitive":false,"text":"RT @euparkinsons: Network modeling to identify new mechanisms &amp; therapeutic targets for #Parkinson’s http://t.co/2LNnqfJqAL","conversation_id":"344469813504114689","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344465015224545280"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344446205352357889","entities":{"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"urls":[{"start":121,"end":143,"url":"http://t.co/wq5VaORkF4","expanded_url":"http://bit.ly/ZH82i2","display_url":"bit.ly/ZH82i2"}],"hashtags":{},"annotations":[{"start":23,"end":25,"probability":0.4835,"type":"Organization","normalized_text":"R&D"},{"start":47,"end":48,"probability":0.668,"type":"Organization","normalized_text":"EU"},{"start":54,"end":69,"probability":0.8588,"type":"Organization","normalized_text":"Gates Foundation"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-11T13:29:09.000Z","possibly_sensitive":false,"text":"RT @HAIEurope: News on R&amp;D and innovation: the EU and Gates Foundation have just signed a disease research agreement http://t.co/wq5VaORkF4","conversation_id":"344446205352357889","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344442204015702016"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344446045259972608","entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":[{"start":115,"end":137,"url":"http://t.co/aum5dtwguu","expanded_url":"http://1.usa.gov/15Tzie4","display_url":"1.usa.gov/15Tzie4"}],"hashtags":[{"start":13,"end":17,"tag":"FDA"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-11T13:28:31.000Z","possibly_sensitive":false,"text":"RT @FDACBER: #FDA Safety Communication: New boxed warning for thrombosis related to human immune globulin products http://t.co/aum5dtwguu","conversation_id":"344446045259972608","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344437779167576064"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344424070491807744","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":62,"end":66,"username":"WHO","id":"14499829"}],"urls":[{"start":70,"end":92,"url":"http://t.co/21t78O3xAl","expanded_url":"http://reut.rs/19YtJhC","display_url":"reut.rs/19YtJhC"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-11T12:01:12.000Z","possibly_sensitive":false,"text":"RT @EFPIA: 'MERS coronavirus has potential to cause pandemic: @WHO' - http://t.co/21t78O3xAl","conversation_id":"344424070491807744","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344424052410171392"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344412849747136512","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":108,"end":130,"url":"http://t.co/rPAeHqpE3K","expanded_url":"http://bit.ly/17EbC1d","display_url":"bit.ly/17EbC1d"}],"hashtags":[{"start":18,"end":30,"tag":"Genetherapy"},{"start":35,"end":45,"tag":"Parkinson"},{"start":81,"end":99,"tag":"neurodegenerative"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-11T11:16:36.000Z","possibly_sensitive":false,"text":"RT @euparkinsons: #Genetherapy for #Parkinson’s: state-of-the-art treatments for #neurodegenerative disease http://t.co/rPAeHqpE3K","conversation_id":"344412849747136512","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344412666988736512"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344410138926518272","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":86,"end":108,"url":"http://t.co/6PIAPwMFOh","expanded_url":"http://www.who.int/influenza/preparedness/pandemic/influenza_risk_management/en/","display_url":"who.int/influenza/prep…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":42,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-11T11:05:50.000Z","possibly_sensitive":false,"text":"RT @WHO: Edited tweet: new Interim Pandemic Influenza Risk Management Guidance posted http://t.co/6PIAPwMFOh","conversation_id":"344410138926518272","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344410045129314304"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344409356508487680","entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/Lw4ork1lhR","expanded_url":"http://bit.ly/191Nun2","display_url":"bit.ly/191Nun2"}],"hashtags":[{"start":41,"end":59,"tag":"pharmacovigilance"},{"start":105,"end":111,"tag":"PSURs"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-11T11:02:44.000Z","possibly_sensitive":false,"text":"Two weeks left to comment on our revised #pharmacovigilance guideline on periodic safety update reports (#PSURs): http://t.co/Lw4ork1lhR","conversation_id":"344409356508487680","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"344409245992771584","entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/H4zYBNPQyy","expanded_url":"http://bit.ly/ZlR31d","display_url":"bit.ly/ZlR31d"},{"start":115,"end":137,"url":"http://t.co/PGApjXG98G","expanded_url":"http://bit.ly/132jcyo","display_url":"bit.ly/132jcyo"}],"hashtags":[{"start":49,"end":57,"tag":"vaccine"},{"start":58,"end":76,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-11T11:02:17.000Z","possibly_sensitive":false,"text":"Just one more day to comment on our guideline on #vaccine #pharmacovigilance and its annex: http://t.co/H4zYBNPQyy http://t.co/PGApjXG98G","conversation_id":"344409245992771584","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"344390121732325377","entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"urls":[{"start":117,"end":139,"url":"http://t.co/pjVSwlcU01","expanded_url":"http://www.emcdda.europa.eu/topics/pods/controlling-new-psychoactive-substances","display_url":"emcdda.europa.eu/topics/pods/co…"}],"hashtags":{},"annotations":[{"start":32,"end":37,"probability":0.9967,"type":"Place","normalized_text":"Europe"},{"start":93,"end":103,"probability":0.9419,"type":"Place","normalized_text":"New Zealand"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-11T09:46:18.000Z","possibly_sensitive":false,"text":"RT @EMCDDA: Legal approaches in Europe to controlling new psychoactive substances, including New Zealand's approach: http://t.co/pjVSwlcU01","conversation_id":"344390121732325377","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344379223890333696"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344372253586247680","entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/Lw4ork1lhR","expanded_url":"http://bit.ly/191Nun2","display_url":"bit.ly/191Nun2"}],"hashtags":[{"start":41,"end":59,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-11T08:35:18.000Z","possibly_sensitive":false,"text":"Two more weeks to comment on our revised #pharmacovigilance guideline on periodic safety update reports: http://t.co/Lw4ork1lhR","conversation_id":"344372253586247680","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"344371546325925889","entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/S5hE2vM9F6","expanded_url":"http://bit.ly/18nIfBk","display_url":"bit.ly/18nIfBk"}],"hashtags":[{"start":69,"end":79,"tag":"transgene"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-11T08:32:29.000Z","possibly_sensitive":false,"text":"Our guideline on quality of biological active substances produced by #transgene expression in animals is available: http://t.co/S5hE2vM9F6","conversation_id":"344371546325925889","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"344371446719590400","entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/H4zYBNPQyy","expanded_url":"http://bit.ly/ZlR31d","display_url":"bit.ly/ZlR31d"},{"start":117,"end":139,"url":"http://t.co/PGApjXG98G","expanded_url":"http://bit.ly/132jcyo","display_url":"bit.ly/132jcyo"}],"hashtags":[{"start":44,"end":62,"tag":"pharmacovigilance"},{"start":67,"end":76,"tag":"vaccines"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-11T08:32:05.000Z","possibly_sensitive":false,"text":"One day left to comment on our guideline on #pharmacovigilance for #vaccines and its annex: http://t.co/H4zYBNPQyy   http://t.co/PGApjXG98G","conversation_id":"344371446719590400","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"344371069622288384","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":[{"start":77,"end":99,"url":"http://t.co/IRL33HGN6v","expanded_url":"http://www.euractiv.com/innovation-enterprise/eu-bill-gates-sign-disease-resea-news-528455","display_url":"euractiv.com/innovation-ent…"}],"hashtags":[{"start":100,"end":106,"tag":"h2020"}],"annotations":[{"start":21,"end":22,"probability":0.6747,"type":"Organization","normalized_text":"EU"},{"start":28,"end":43,"probability":0.5808,"type":"Organization","normalized_text":"Gates Foundation"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-11T08:30:35.000Z","possibly_sensitive":false,"text":"RT @innovationunion: EU and Gates Foundation sign disease research agreement http://t.co/IRL33HGN6v #h2020","conversation_id":"344371069622288384","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344370619581865984"}],"attachments":{"media_keys":{}}},{"lang":"de","id":"344370903750164480","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":99,"end":106,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":107,"end":129,"url":"http://t.co/I0PuTkTDDJ","expanded_url":"http://bit.ly/11spfIr","display_url":"bit.ly/11spfIr"}],"hashtags":[{"start":63,"end":72,"tag":"research"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-11T08:29:56.000Z","possibly_sensitive":false,"text":"RT @EFPIA: WATCH : EFPIA Director General Richard Bergström on #research in the pharma industry cc @IMI_JU http://t.co/I0PuTkTDDJ","conversation_id":"344370903750164480","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344367937773260800"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344370554335293440","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":113,"end":135,"url":"http://t.co/EuyZwKPGIs","expanded_url":"http://www.dzp.pl/konferencje/1490-konferencja-pharmacovigilance-i-planowane-zmiany-w-prawie-farmaceutycznym","display_url":"dzp.pl/konferencje/14…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-11T08:28:32.000Z","possibly_sensitive":false,"text":"RT @URPLWMiPB: Conference on pharmacovigilance and planned changes in pharmaceutical law, with the Polish agency http://t.co/EuyZwKPGIs","conversation_id":"344370554335293440","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"344111881876811777","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/S5hE2vM9F6","expanded_url":"http://bit.ly/18nIfBk","display_url":"bit.ly/18nIfBk"}],"hashtags":[{"start":83,"end":93,"tag":"transgene"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-10T15:20:40.000Z","possibly_sensitive":false,"text":"We've published a guideline on quality of biological active substances produced by #transgene expression in animals: http://t.co/S5hE2vM9F6","conversation_id":"344111881876811777","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"344108945142579200","entities":{"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"urls":{},"hashtags":[{"start":61,"end":76,"tag":"clinicaltrials"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T15:09:00.000Z","possibly_sensitive":false,"text":"RT @HAIEurope: our latest staff blog on the ENVI vote on the #clinicaltrials regulation has just gone live. Check it out here: http://t.co/…","conversation_id":"344108945142579200","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344106281428217856"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344108860807712768","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":67,"end":89,"url":"http://t.co/Gq1mkuBVIB","expanded_url":"http://bit.ly/17Ca6wN","display_url":"bit.ly/17Ca6wN"}],"hashtags":[{"start":18,"end":34,"tag":"GatesFoundation"}],"annotations":[{"start":11,"end":12,"probability":0.3508,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T15:08:40.000Z","possibly_sensitive":false,"text":"RT @EFPIA: EU and #GatesFoundation sign disease research agreement http://t.co/Gq1mkuBVIB","conversation_id":"344108860807712768","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344108737767821312"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344106396817698816","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":44,"end":66,"url":"http://t.co/B3UKetxcSj","expanded_url":"http://bit.ly/11pxJ44","display_url":"bit.ly/11pxJ44"}],"hashtags":[{"start":24,"end":43,"tag":"anticounterfeiting"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T14:58:52.000Z","possibly_sensitive":false,"text":"RT @EFPIA: Bad Medicine #anticounterfeiting http://t.co/B3UKetxcSj","conversation_id":"344106396817698816","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344106206278860800"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344084544019902464","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":12,"end":17,"tag":"MERS"}],"annotations":[{"start":88,"end":119,"probability":0.7359,"type":"Organization","normalized_text":"International Health Regulations"}]},"public_metrics":{"retweet_count":35,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T13:32:02.000Z","possibly_sensitive":false,"text":"RT @WHO: If #MERS cases are found they should be reported to WHO under the terms of the International Health Regulations http://t.co/z4Hk6x…","conversation_id":"344084544019902464","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344077674978877440"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344084419700731904","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":105,"end":127,"url":"http://t.co/z4Hk6xJEYh","expanded_url":"http://goo.gl/B1N6U","display_url":"goo.gl/B1N6U"}],"hashtags":[{"start":99,"end":104,"tag":"MERS"},{"start":128,"end":133,"tag":"nCoV"}],"annotations":[{"start":42,"end":73,"probability":0.5162,"type":"Other","normalized_text":"Middle East Respiratory Syndrome"}]},"public_metrics":{"retweet_count":44,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T13:31:33.000Z","possibly_sensitive":false,"text":"RT @WHO: The use of high-dose steroids in Middle East Respiratory Syndrome cases should be avoided #MERS http://t.co/z4Hk6xJEYh #nCoV","conversation_id":"344084419700731904","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344076383263285248"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344076301457559552","entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":[{"start":81,"end":103,"url":"http://t.co/uSHHko02rU","expanded_url":"http://1.usa.gov/17C9gzV","display_url":"1.usa.gov/17C9gzV"}],"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":39,"end":44,"tag":"REdI"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T12:59:17.000Z","possibly_sensitive":false,"text":"RT @FDA_Drug_Info: #FDA Small Business #REdI Conference – Registration now OPEN! http://t.co/uSHHko02rU","conversation_id":"344076301457559552","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344076174005264385"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344076277260632065","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":23,"end":28,"tag":"MERS"}],"annotations":{}},"public_metrics":{"retweet_count":41,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T12:59:11.000Z","possibly_sensitive":false,"text":"RT @WHO: Treatment for #MERS is primarily supportive, no convincing data that use of potent antivirals such as ribavirin or interferon are …","conversation_id":"344076277260632065","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344076019503857664"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344074454940397570","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":83,"end":105,"url":"http://t.co/z4Hk6xJEYh","expanded_url":"http://goo.gl/B1N6U","display_url":"goo.gl/B1N6U"}],"hashtags":[{"start":77,"end":82,"tag":"MERS"},{"start":106,"end":111,"tag":"nCoV"}],"annotations":{}},"public_metrics":{"retweet_count":41,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T12:51:57.000Z","possibly_sensitive":false,"text":"RT @WHO: We do not see evidence of widespread human-to-human transmission of #MERS http://t.co/z4Hk6xJEYh #nCoV","conversation_id":"344074454940397570","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344074166837850113"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344072742846464000","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":{},"annotations":[{"start":91,"end":96,"probability":0.9982,"type":"Place","normalized_text":"France"},{"start":99,"end":104,"probability":0.5157,"type":"Place","normalized_text":"Jordan"},{"start":107,"end":118,"probability":0.9222,"type":"Place","normalized_text":"Saudi Arabia"}]},"public_metrics":{"retweet_count":46,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T12:45:09.000Z","possibly_sensitive":false,"text":"RT @WHO: Middle East Respiratory Syndrome infections in health care facilities occurred in France, Jordan, Saudi Arabia http://t.co/z4Hk6xJ…","conversation_id":"344072742846464000","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344072488180912128"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344072722093060096","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":48,"end":53,"tag":"MERS"}],"annotations":{}},"public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T12:45:04.000Z","possibly_sensitive":false,"text":"RT @WHO: H2H transmission appears to be in most #MERS clusters, limited to people w/ close contact w/ a sick family member http://t.co/z4Hk…","conversation_id":"344072722093060096","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344072024685166594"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344071332427870208","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":18,"end":23,"tag":"MERS"}],"annotations":{}},"public_metrics":{"retweet_count":36,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T12:39:32.000Z","possibly_sensitive":false,"text":"RT @WHO: Sporadic #MERS cases are occurring in communities. At present we don’t know the source, how people became infected http://t.co/z4H…","conversation_id":"344071332427870208","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344070256643420160"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344071267512631296","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":117,"end":139,"url":"http://t.co/z4Hk6xJEYh","expanded_url":"http://goo.gl/B1N6U","display_url":"goo.gl/B1N6U"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":59,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T12:39:17.000Z","possibly_sensitive":false,"text":"RT @WHO: Total number of Middle East Respiratory Syndrome cases limited, virus causes death in about 60% of patients http://t.co/z4Hk6xJEYh…","conversation_id":"344071267512631296","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344069121023045632"}],"attachments":{"media_keys":{}}},{"lang":"ro","id":"344070341481603072","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":40,"end":62,"url":"http://t.co/NwqiN3CXBS","expanded_url":"http://bit.ly/13tb5JG","display_url":"bit.ly/13tb5JG"}],"hashtags":[{"start":63,"end":70,"tag":"newjob"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T12:35:36.000Z","possibly_sensitive":false,"text":"RT @LV_MPA: Oncologist or haematologist http://t.co/NwqiN3CXBS #newjob","conversation_id":"344070341481603072","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"344070141367169024","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":115,"end":137,"url":"http://t.co/q6kIyfNOeB","expanded_url":"http://bit.ly/LIn3v2","display_url":"bit.ly/LIn3v2"}],"hashtags":[{"start":32,"end":41,"tag":"westnile"}],"annotations":[{"start":112,"end":113,"probability":0.4979,"type":"Place","normalized_text":"EU"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T12:34:48.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: ECDC launches 2013 #westnile fever maps: first cases in neighbouring countries in May, no cases in EU http://t.co/q6kIyfNOeB #…","conversation_id":"344070141367169024","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344067613875400705"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344069953781108736","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":99,"end":104,"tag":"MERS"},{"start":116,"end":124,"tag":"measles"}],"annotations":[{"start":82,"end":90,"probability":0.5624,"type":"Place","normalized_text":"West Nile"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T12:34:04.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: Latest ECDC Communicable Disease Threats Report including updates on West Nile virus, #MERS-CoV  &amp; #measles http://t.co/AsEWMF…","conversation_id":"344069953781108736","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344065798094077954"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344069783655952384","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":118,"end":140,"url":"http://t.co/prCo3VJFd8","expanded_url":"http://bit.ly/13t5GCw","display_url":"bit.ly/13t5GCw"}],"hashtags":[{"start":29,"end":48,"tag":"AntiCounterfeiting"}],"annotations":[{"start":105,"end":116,"probability":0.9911,"type":"Person","normalized_text":"Stuart Hurst"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T12:33:23.000Z","possibly_sensitive":false,"text":"RT @EFPIA: WATCH : What does #AntiCounterfeiting Mean for the Pharmaceutical Industry? An interview with Stuart Hurst http://t.co/prCo3VJFd8","conversation_id":"344069783655952384","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344061532210073600"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344047989234466816","entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/q4niOGAnDE","expanded_url":"http://bit.ly/15PEmjK","display_url":"bit.ly/15PEmjK"}],"hashtags":[{"start":50,"end":62,"tag":"biosimilars"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T11:06:47.000Z","possibly_sensitive":false,"text":"Send us your comments on our revised guideline on #biosimilars containing biotechnology-derived proteins by 30 Nov: http://t.co/q4niOGAnDE","conversation_id":"344047989234466816","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"344044299010310144","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"hashtags":[{"start":45,"end":48,"tag":"EU"},{"start":86,"end":92,"tag":"h2020"}],"annotations":[{"start":21,"end":39,"probability":0.5709,"type":"Organization","normalized_text":"European Parliament"}]},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T10:52:07.000Z","possibly_sensitive":false,"text":"RT @innovationunion: European Parliament and #EU Council disagreement on Horizon 2020 #h2020 funding model threatens to delay the:... http:…","conversation_id":"344044299010310144","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344044157830037504"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344027796827426816","entities":{"mentions":{},"urls":[{"start":112,"end":134,"url":"http://t.co/q4niOGAnDE","expanded_url":"http://bit.ly/15PEmjK","display_url":"bit.ly/15PEmjK"}],"hashtags":[{"start":39,"end":51,"tag":"biosimilars"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":1,"like_count":3,"quote_count":0},"created_at":"2013-06-10T09:46:33.000Z","possibly_sensitive":false,"text":"We've published a revised guideline on #biosimilars containing biotechnology-derived proteins for consultation: http://t.co/q4niOGAnDE","conversation_id":"344027796827426816","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"344023907503837184","entities":{"mentions":[{"start":18,"end":32,"username":"EU_Commission","id":"157981564"},{"start":34,"end":50,"username":"gatesfoundation","id":"17899109"}],"urls":[{"start":111,"end":133,"url":"http://t.co/T4pPbRhVkX","expanded_url":"http://bit.ly/12ABOsI","display_url":"bit.ly/12ABOsI"}],"hashtags":{},"annotations":[{"start":93,"end":95,"probability":0.6262,"type":"Other","normalized_text":"HIV"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T09:31:05.000Z","possibly_sensitive":false,"text":"RT @EUlondonrep: .@EU_Commission, @GatesFoundation to fund late clinical trials for malaria, HIV, tuberculosis http://t.co/T4pPbRhVkX cc @i…","conversation_id":"344023907503837184","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344022215307689984"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344002693116854273","entities":{"mentions":[{"start":3,"end":19,"username":"Martinharvey100","id":"113148426"},{"start":21,"end":30,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":127,"end":132,"probability":0.9783,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T08:06:47.000Z","possibly_sensitive":false,"text":"RT @Martinharvey100: @EMA_News looking for digital consultancy for web design projects. Can you help us deliver health info to Europe? http…","conversation_id":"344002693116854273","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"344002513680363520"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"344001414621716480","entities":{"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/KefzFC1NIZ","expanded_url":"http://bit.ly/10VNnb4","display_url":"bit.ly/10VNnb4"}],"hashtags":[{"start":61,"end":72,"tag":"bluetongue"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-10T08:01:43.000Z","possibly_sensitive":false,"text":"Interim advice on fees for manufacturers of vaccines against #bluetongue disease is available on our website: http://t.co/KefzFC1NIZ","conversation_id":"344001414621716480","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"343032580267986945","entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/KefzFC1NIZ","expanded_url":"http://bit.ly/10VNnb4","display_url":"bit.ly/10VNnb4"}],"hashtags":[{"start":73,"end":84,"tag":"bluetongue"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-07T15:51:55.000Z","possibly_sensitive":false,"text":"We've published interim fee advice for manufacturers of vaccines against #bluetongue disease: http://t.co/KefzFC1NIZ","conversation_id":"343032580267986945","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"343023078416195584","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":88,"end":110,"url":"http://t.co/HzfmWi8BEU","expanded_url":"http://bit.ly/Zy93c9","display_url":"bit.ly/Zy93c9"}],"hashtags":[{"start":11,"end":15,"tag":"IMI"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-07T15:14:09.000Z","possibly_sensitive":false,"text":"RT @EFPIA: #IMI NEWMEDS project to find new treatments for schizophrenia and depression http://t.co/HzfmWi8BEU","conversation_id":"343023078416195584","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"343022893149589505"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"343002267152171008","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":62,"end":84,"url":"http://t.co/j6DMPwkovJ","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2013/NI-MUH_FV_15-2013-myolastan.htm","display_url":"aemps.gob.es/informa/notasI…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-06-07T13:51:27.000Z","possibly_sensitive":false,"text":"RT @AEMPSGOB: Tetrazepam (Myolastan): suspension of marketing http://t.co/j6DMPwkovJ","conversation_id":"343002267152171008","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342999812146348033","entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"},{"start":24,"end":40,"username":"worldbankhealth","id":"3140548064"}],"urls":{},"hashtags":{},"annotations":[{"start":78,"end":83,"probability":0.996,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-07T13:41:42.000Z","possibly_sensitive":false,"text":"RT @WHO_Europe: New WHO @worldbankhealth @LSHTMpress report: #HIV epidemic in Europe is growing, reached 1.5M cases in 2011 http://t.co/mqT…","conversation_id":"342999812146348033","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342999746740367361"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342996630246662144","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":78,"end":100,"url":"http://t.co/HxjJDnHBDz","expanded_url":"http://goo.gl/0LWWf","display_url":"goo.gl/0LWWf"}],"hashtags":[{"start":115,"end":120,"tag":"MERS"},{"start":121,"end":126,"tag":"nCoV"}],"annotations":[{"start":30,"end":61,"probability":0.5544,"type":"Other","normalized_text":"Middle East Respiratory Syndrome"}]},"public_metrics":{"retweet_count":35,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-07T13:29:03.000Z","possibly_sensitive":false,"text":"RT @WHO: Latest update on the Middle East Respiratory Syndrome available here http://t.co/HxjJDnHBDz (7 June 2013) #MERS #nCoV","conversation_id":"342996630246662144","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342996350952165376"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342993788391796737","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":63,"end":85,"url":"http://t.co/dY8XdrBRBr","expanded_url":"http://urpl.gov.pl/system/files/Downloads/20130607141410/Raport_Roczny_Prezesa_Urzedu_za_2012_rok.pdf?1370608487","display_url":"urpl.gov.pl/system/files/D…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-07T13:17:46.000Z","possibly_sensitive":false,"text":"RT @GCessak: Annual Report 2012 of the President of the Office http://t.co/dY8XdrBRBr","conversation_id":"342993788391796737","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342993123615596544"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342960509777235969","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/0rFfpOTVCc","expanded_url":"http://bit.ly/15RB1kE","display_url":"bit.ly/15RB1kE"}],"hashtags":[{"start":33,"end":51,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-07T11:05:32.000Z","possibly_sensitive":false,"text":"Send us your comments on our new #pharmacovigilance guidance module on risk-minimisation measures by 5 August: http://t.co/0rFfpOTVCc","conversation_id":"342960509777235969","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342960374003429376","entities":{"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/8F5aqktb4W","expanded_url":"http://bit.ly/113nUJo","display_url":"bit.ly/113nUJo"}],"hashtags":[{"start":71,"end":77,"tag":"names"},{"start":88,"end":98,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-07T11:04:59.000Z","possibly_sensitive":false,"text":"Send us your comments on our revised guideline on the acceptability of #names for human #medicines by 30 August: http://t.co/8F5aqktb4W","conversation_id":"342960374003429376","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342960133971771392","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/Ow504NGNbA","expanded_url":"http://bit.ly/17thPgD","display_url":"bit.ly/17thPgD"}],"hashtags":[{"start":26,"end":39,"tag":"Voriconazole"},{"start":50,"end":58,"tag":"generic"},{"start":62,"end":68,"tag":"Vfend"},{"start":73,"end":80,"tag":"fungal"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-07T11:04:02.000Z","possibly_sensitive":false,"text":"The assessment report for #Voriconazole Accord, a #generic of #Vfend for #fungal infections, is now available: http://t.co/Ow504NGNbA","conversation_id":"342960133971771392","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342960013926612992","entities":{"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/pH18a9HDwZ","expanded_url":"http://bit.ly/19OnY6h","display_url":"bit.ly/19OnY6h"}],"hashtags":[{"start":18,"end":36,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-07T11:03:33.000Z","possibly_sensitive":false,"text":"We've revised our #pharmacovigilance guidance on reporting of adverse reactions. Consultation open until 5 August: http://t.co/pH18a9HDwZ","conversation_id":"342960013926612992","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342959700217847808","entities":{"mentions":[{"start":32,"end":41,"username":"EUnetHTA","id":"56493220"}],"urls":[{"start":112,"end":134,"url":"http://t.co/Vmqe4IioAT","expanded_url":"http://bit.ly/11J4l7U","display_url":"bit.ly/11J4l7U"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-07T11:02:19.000Z","possibly_sensitive":false,"text":"See the latest on our work with @EUnetHTA: regulators and health-technology-assessment bodies working together: http://t.co/Vmqe4IioAT","conversation_id":"342959700217847808","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342953810433540098","entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/0rFfpOTVCc","expanded_url":"http://bit.ly/15RB1kE","display_url":"bit.ly/15RB1kE"}],"hashtags":[{"start":8,"end":26,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"created_at":"2013-06-07T10:38:54.000Z","possibly_sensitive":false,"text":"Our new #pharmacovigilance guidance module on risk-minimisation measures is now open for consultation until 05/08/13: http://t.co/0rFfpOTVCc","conversation_id":"342953810433540098","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342950576046346242","entities":{"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"urls":[{"start":107,"end":129,"url":"http://t.co/vq3l7lD3kJ","expanded_url":"http://owl.li/lLeDj","display_url":"owl.li/lLeDj"}],"hashtags":[{"start":23,"end":34,"tag":"researcheu"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-07T10:26:03.000Z","possibly_sensitive":false,"text":"RT @myCORDIS: Download #researcheu, issue 22, 'Rare diseases and genetic disorders under the microscope' \n http://t.co/vq3l7lD3kJ","conversation_id":"342950576046346242","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342950472837120000"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342949939355205632","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":90,"end":112,"url":"http://t.co/efMNVqoc9P","expanded_url":"http://www.polskieradio.pl/5/3/Artykul/861188,GIF-wycofuje-leki-zawierajace-tetrazepam","display_url":"polskieradio.pl/5/3/Artykul/86…"}],"hashtags":{},"annotations":[{"start":13,"end":41,"probability":0.484,"type":"Organization","normalized_text":"Main Pharmaceutical Inspector"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-07T10:23:31.000Z","possibly_sensitive":false,"text":"RT @GCessak: Main Pharmaceutical Inspector is withdrawing medicines containing tetrazepam http://t.co/efMNVqoc9P","conversation_id":"342949939355205632","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342947697038344192","entities":{"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/8F5aqktb4W","expanded_url":"http://bit.ly/113nUJo","display_url":"bit.ly/113nUJo"}],"hashtags":[{"start":67,"end":73,"tag":"names"},{"start":84,"end":94,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"created_at":"2013-06-07T10:14:37.000Z","possibly_sensitive":false,"text":"We've released a revision of our guideline on the acceptability of #names for human #medicines for consultation: http://t.co/8F5aqktb4W","conversation_id":"342947697038344192","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342946866733924353","entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":[{"start":97,"end":119,"url":"http://t.co/m6pTzPFAsW","expanded_url":"http://www.nice.org.uk/getinvolved/joinnwc/MemberDiabeticFootProblemsGDG.jsp","display_url":"nice.org.uk/getinvolved/jo…"}],"hashtags":[{"start":58,"end":63,"tag":"NICE"},{"start":73,"end":82,"tag":"diabetic"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-07T10:11:19.000Z","possibly_sensitive":false,"text":"RT @NICEcomms: Last chance to apply to be a member of the #NICE group on #diabetic foot problems http://t.co/m6pTzPFAsW","conversation_id":"342946866733924353","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342946394081988608"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342945082699296769","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":113,"end":135,"url":"http://t.co/N9E9bwLc7Z","expanded_url":"http://fb.me/2fEo5Gx0D","display_url":"fb.me/2fEo5Gx0D"}],"hashtags":{},"annotations":[{"start":31,"end":49,"probability":0.6128,"type":"Person","normalized_text":"President Pecorelli"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-07T10:04:13.000Z","possibly_sensitive":false,"text":"RT @Aifa_ufficiale: Lecture by President Pecorelli on new perspectives in the therapeutic treatment of cancer... http://t.co/N9E9bwLc7Z","conversation_id":"342945082699296769","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342944503356866562","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":110,"end":132,"url":"http://t.co/w5ehEMStXw","expanded_url":"http://www.agenziafarmaco.gov.it/sites/default/files/Pecorelli%20Perugia%206%20giugno%202013.pdf","display_url":"agenziafarmaco.gov.it/sites/default/…"}],"hashtags":[{"start":20,"end":25,"tag":"AIFA"},{"start":36,"end":46,"tag":"Pecorelli"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-07T10:01:55.000Z","possibly_sensitive":false,"text":"RT @Aifa_ufficiale: #AIFA president #Pecorelli on therapeutic perspectives in the treatment of ovarian cancer http://t.co/w5ehEMStXw","conversation_id":"342944503356866562","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342940448547028993","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/Ow504NGNbA","expanded_url":"http://bit.ly/17thPgD","display_url":"bit.ly/17thPgD"}],"hashtags":[{"start":42,"end":55,"tag":"Voriconazole"},{"start":66,"end":74,"tag":"generic"},{"start":78,"end":84,"tag":"Vfend"},{"start":89,"end":96,"tag":"fungal"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-07T09:45:49.000Z","possibly_sensitive":false,"text":"We've published the assessment report for #Voriconazole Accord, a #generic of #Vfend for #fungal infections: http://t.co/Ow504NGNbA","conversation_id":"342940448547028993","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342938889520025600","entities":{"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/pH18a9HDwZ","expanded_url":"http://bit.ly/19OnY6h","display_url":"bit.ly/19OnY6h"}],"hashtags":[{"start":33,"end":51,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-07T09:39:37.000Z","possibly_sensitive":false,"text":"We've released a revision of our #pharmacovigilance guidance on reporting of adverse reactions for consultation: http://t.co/pH18a9HDwZ","conversation_id":"342938889520025600","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342935076029485056","entities":{"mentions":[{"start":15,"end":24,"username":"EUnetHTA","id":"56493220"}],"urls":[{"start":110,"end":132,"url":"http://t.co/Vmqe4IioAT","expanded_url":"http://bit.ly/11J4l7U","display_url":"bit.ly/11J4l7U"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"created_at":"2013-06-07T09:24:28.000Z","possibly_sensitive":false,"text":"We’ve met with @EUnetHTA to discuss how regulators and health-technology-assessment bodies can work together: http://t.co/Vmqe4IioAT","conversation_id":"342935076029485056","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342914986236051457","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":{},"hashtags":[{"start":71,"end":78,"tag":"health"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-07T08:04:38.000Z","possibly_sensitive":false,"text":"RT @EFPIA: EU pharmaceutical industry leaders call for balance between #health care budget and economic growth objectives http://t.co/TspmQ…","conversation_id":"342914986236051457","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342913725034012672"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342679724184707073","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":{},"hashtags":[{"start":31,"end":37,"tag":"SANCO"},{"start":112,"end":121,"tag":"diabetes"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-06T16:29:47.000Z","possibly_sensitive":false,"text":"RT @EU_Health: Call for tender #SANCO/2013/C1/004: pilot project on successful prevention strategies for type 2 #diabetes http://t.co/DNzn4…","conversation_id":"342679724184707073","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342679570585096193"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342664087852953600","entities":{"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"}],"urls":[{"start":68,"end":90,"url":"http://t.co/rhV1lX3bAs","expanded_url":"http://www.europeanvoice.com/article/imported/call-for-greater-transparency-in-clinical-trials/77429.aspx","display_url":"europeanvoice.com/article/import…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-06T15:27:39.000Z","possibly_sensitive":false,"text":"RT @DrugInfoAssn: Call for greater transparency in clinical trials  http://t.co/rhV1lX3bAs","conversation_id":"342664087852953600","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342644688328749056"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342663948279091200","entities":{"mentions":[{"start":3,"end":15,"username":"Europarl_EN","id":"36329597"}],"urls":{},"hashtags":[{"start":39,"end":45,"tag":"virus"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-06T15:27:06.000Z","possibly_sensitive":false,"text":"RT @Europarl_EN: How likely is another #virus epidemic? How can international cooperation help? Read our blog for more information  http://…","conversation_id":"342663948279091200","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342643736410484737"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342600616083869696","entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/CUPDf8K3Wc","expanded_url":"http://bit.ly/121uZig","display_url":"bit.ly/121uZig"}],"hashtags":[{"start":57,"end":68,"tag":"paediatric"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-06T11:15:26.000Z","possibly_sensitive":false,"text":"Send us your comments on our priority list of off-patent #paediatric medicines for future funding by 5 July 2013: http://t.co/CUPDf8K3Wc","conversation_id":"342600616083869696","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342599677117607936","entities":{"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"urls":{},"hashtags":[{"start":83,"end":95,"tag":"patentpools"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-06T11:11:42.000Z","possibly_sensitive":false,"text":"RT @HAIEurope: More drug companies are partnering with non-for-profits and joining #patentpools to aid drug discoveries http://t.co/xB4Eid2…","conversation_id":"342599677117607936","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342578099587784706"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342598728479289344","entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"urls":[{"start":50,"end":72,"url":"http://t.co/rgSsr2c4eQ","expanded_url":"http://www.emcdda.europa.eu/topics/pods/preventing-overdose-deaths","display_url":"emcdda.europa.eu/topics/pods/pr…"}],"hashtags":{},"annotations":[{"start":42,"end":47,"probability":0.9966,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-06T11:07:56.000Z","possibly_sensitive":false,"text":"RT @EMCDDA: Preventing overdose deaths in Europe: http://t.co/rgSsr2c4eQ","conversation_id":"342598728479289344","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342568634029330434"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342558614055161856","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/CUPDf8K3Wc","expanded_url":"http://bit.ly/121uZig","display_url":"bit.ly/121uZig"}],"hashtags":[{"start":72,"end":83,"tag":"paediatric"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":2,"quote_count":0},"created_at":"2013-06-06T08:28:32.000Z","possibly_sensitive":false,"text":"We've launched a public consultation on the priority list of off-patent #paediatric medicines. Deadline 5 July 2013: http://t.co/CUPDf8K3Wc","conversation_id":"342558614055161856","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342557249912311808","entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/r6RbmSEiik","expanded_url":"http://bit.ly/14w9Qc2","display_url":"bit.ly/14w9Qc2"}],"hashtags":[{"start":14,"end":32,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":1,"like_count":1,"quote_count":0},"created_at":"2013-06-06T08:23:07.000Z","possibly_sensitive":false,"text":"Amendments to #pharmacovigilance legislation apply for centrally authorised medicines: new notification requirements: http://t.co/r6RbmSEiik","conversation_id":"342557249912311808","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342556780011847680","entities":{"mentions":[{"start":3,"end":17,"username":"EUAuditorsECA","id":"803430727844888576"},{"start":104,"end":113,"username":"EbS_News","id":"2833417317"}],"urls":{},"hashtags":[{"start":23,"end":29,"tag":"audit"},{"start":36,"end":39,"tag":"EU"},{"start":52,"end":61,"tag":"research"},{"start":63,"end":75,"tag":"Horizon2020"},{"start":76,"end":82,"tag":"h2020"},{"start":83,"end":87,"tag":"FP7"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-06T08:21:15.000Z","possibly_sensitive":false,"text":"RT @EUAuditorsECA: Our #audit about #EU support for #research, #Horizon2020 #h2020 #FP7 will be LIVE on @EbS_News TOMORROW at 10:30! http:/…","conversation_id":"342556780011847680","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342555275947036672"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342556241689714689","entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-06T08:19:07.000Z","possibly_sensitive":false,"text":"RT @Legemiddelinfo: 'Adverse event' now also applies to medication errors, abuse, misuse, overdose, occupational exposure and off-label use","conversation_id":"342556241689714689","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342309315731927040","entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":111,"end":133,"url":"http://t.co/1IPVLOXbYJ","expanded_url":"http://1.usa.gov/1b0NnYb","display_url":"1.usa.gov/1b0NnYb"}],"hashtags":[{"start":84,"end":91,"tag":"Animal"},{"start":92,"end":97,"tag":"Drug"}],"annotations":[{"start":21,"end":34,"probability":0.2672,"type":"Other","normalized_text":"The Green Book"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-05T15:57:55.000Z","possibly_sensitive":false,"text":"RT @FDAanimalhealth: The Green Book has been updated. Did you know these are latest #Animal #Drug   Approvals? http://t.co/1IPVLOXbYJ","conversation_id":"342309315731927040","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342309176531353601"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342303913128632320","entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/r6RbmSEiik","expanded_url":"http://bit.ly/14w9Qc2","display_url":"bit.ly/14w9Qc2"}],"hashtags":[{"start":82,"end":100,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-06-05T15:36:27.000Z","possibly_sensitive":false,"text":"New notification requirements for companies now apply following amendments to the #pharmacovigilance legislation: http://t.co/r6RbmSEiik","conversation_id":"342303913128632320","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342286211467051008","entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":42,"end":51,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":113,"end":125,"tag":"raredisease"}],"annotations":[{"start":25,"end":37,"probability":0.978,"type":"Person","normalized_text":"Jordi Linares"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-05T14:26:06.000Z","possibly_sensitive":false,"text":"RT @eurordis: Video from Jordi Linares of @EMA_News \"Key concepts of orphan designation and latest developments\" #raredisease http://t.co/o…","conversation_id":"342286211467051008","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342283466928447488"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342278031471149056","entities":{"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"created_at":"2013-06-05T13:53:36.000Z","possibly_sensitive":false,"text":"@trinevillemann We cannot see any emails from you in our press inbox. Please send your request to us again at press@ema.europa.eu.","conversation_id":"342270891427782656","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"342273297259569153"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"lang":"en","id":"342274945046421504","entities":{"mentions":[{"start":3,"end":7,"username":"WDD","id":"15179874"}],"urls":[{"start":62,"end":84,"url":"http://t.co/6dNEPSMraS","expanded_url":"http://bit.ly/12pkQgU","display_url":"bit.ly/12pkQgU"}],"hashtags":[{"start":32,"end":40,"tag":"complex"},{"start":51,"end":60,"tag":"diabetes"},{"start":85,"end":93,"tag":"WDC2013"},{"start":94,"end":108,"tag":"diabetesvoice"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-05T13:41:20.000Z","possibly_sensitive":false,"text":"RT @WDD: Want to understand the #complex nature of #diabetes? http://t.co/6dNEPSMraS #WDC2013 #diabetesvoice","conversation_id":"342274945046421504","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342271508980318208"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342271235020955648","entities":{"mentions":[{"start":3,"end":18,"username":"USPharmacopeia","id":"47953929"}],"urls":{},"hashtags":[{"start":20,"end":24,"tag":"USP"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-05T13:26:36.000Z","possibly_sensitive":false,"text":"RT @USPharmacopeia: #USP is hiring a Senior GMP Specialist. If you have manufacturing &amp; tablets &amp; injectables experience check it out http:…","conversation_id":"342271235020955648","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342270438229024768"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342271133053235200","entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":105,"end":127,"url":"http://t.co/5i9JfMs66J","expanded_url":"http://ow.ly/lJgI2","display_url":"ow.ly/lJgI2"}],"hashtags":[{"start":95,"end":104,"tag":"Melanoma"}],"annotations":[{"start":12,"end":14,"probability":0.6524,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-05T13:26:11.000Z","possibly_sensitive":false,"text":"RT @myESMO: FDA approves Trametinib and Dabrafenib for Unresectable or Metastatic BRAF-Mutated #Melanoma http://t.co/5i9JfMs66J","conversation_id":"342271133053235200","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342264533596897282"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342270981643051009","entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"urls":{},"hashtags":[{"start":67,"end":71,"tag":"HIV"}],"annotations":[{"start":14,"end":16,"probability":0.7376,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-05T13:25:35.000Z","possibly_sensitive":false,"text":"RT @FDAWomen: FDA public meeting (6/14) to gather patient input on #HIV therapies+research. In-person reg. ends today http://t.co/Lw4AgubCv…","conversation_id":"342270981643051009","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"342263657280974848"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"342270891427782656","entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"urls":[{"start":98,"end":120,"url":"http://t.co/NX3vO5qUir","expanded_url":"http://bit.ly/X9GBaY","display_url":"bit.ly/X9GBaY"}],"hashtags":[{"start":121,"end":130,"tag":"PasSem13"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"created_at":"2013-06-05T13:25:14.000Z","possibly_sensitive":false,"text":"RT @Legemiddelinfo: Patients can report side effects through pharmacies, via doctor or even here: http://t.co/NX3vO5qUir #PasSem13","conversation_id":"342270891427782656","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342235082649632769","entities":{"mentions":{},"urls":[{"start":89,"end":111,"url":"http://t.co/H4zYBNPQyy","expanded_url":"http://bit.ly/ZlR31d","display_url":"bit.ly/ZlR31d"},{"start":114,"end":136,"url":"http://t.co/PGApjXG98G","expanded_url":"http://bit.ly/132jcyo","display_url":"bit.ly/132jcyo"}],"hashtags":[{"start":42,"end":50,"tag":"vaccine"},{"start":51,"end":69,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-05T11:02:56.000Z","possibly_sensitive":false,"text":"Send us your comments on our guideline on #vaccine #pharmacovigilance by next Wednesday: http://t.co/H4zYBNPQyy   http://t.co/PGApjXG98G","conversation_id":"342235082649632769","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"342199337754951680","entities":{"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/H4zYBNPQyy","expanded_url":"http://bit.ly/ZlR31d","display_url":"bit.ly/ZlR31d"},{"start":117,"end":139,"url":"http://t.co/PGApjXG98G","expanded_url":"http://bit.ly/132jcyo","display_url":"bit.ly/132jcyo"}],"hashtags":[{"start":45,"end":63,"tag":"pharmacovigilance"},{"start":68,"end":77,"tag":"vaccines"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-05T08:40:54.000Z","possibly_sensitive":false,"text":"One more week to comment on our guideline on #pharmacovigilance for #vaccines and its annex: http://t.co/H4zYBNPQyy  http://t.co/PGApjXG98G","conversation_id":"342199337754951680","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"341952205366108160","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":100,"end":122,"url":"http://t.co/QMfTWsrHPw","expanded_url":"http://tnij.org/vxe0","display_url":"tnij.org/vxe0"}],"hashtags":{},"annotations":[{"start":74,"end":81,"probability":0.4049,"type":"Person","normalized_text":"Diane 35"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-04T16:18:53.000Z","possibly_sensitive":false,"text":"RT @URPLWMiPB: Information from the Polish medicines agency on the use of Diane 35 and its generics http://t.co/QMfTWsrHPw","conversation_id":"341952205366108160","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"341910616879005696","entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":131,"end":140,"username":"EMA_News","id":"116716199"}],"urls":[{"start":104,"end":126,"url":"http://t.co/h6cU0HwCcs","expanded_url":"http://ow.ly/lGUV3","display_url":"ow.ly/lGUV3"}],"hashtags":{},"annotations":[{"start":12,"end":14,"probability":0.4475,"type":"Organization","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-04T13:33:38.000Z","possibly_sensitive":false,"text":"RT @myESMO: EMA recommends approval of pomalidomide: mgmt of relapsed &amp; refractory multiple myeloma http://t.co/h6cU0HwCcs via @EMA_News","conversation_id":"341910616879005696","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"341909097135890432"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"341892572500873216","entities":{"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/bR86hsq6PB","expanded_url":"http://bit.ly/11oxOIj","display_url":"bit.ly/11oxOIj"}],"hashtags":[{"start":28,"end":35,"tag":"bovine"},{"start":36,"end":42,"tag":"serum"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-06-04T12:21:56.000Z","possibly_sensitive":false,"text":"Our guideline on the use of #bovine #serum in the manufacture of human biological medicines is now available: http://t.co/bR86hsq6PB","conversation_id":"341892572500873216","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"ro","id":"341892124817620992","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"hashtags":[{"start":21,"end":39,"tag":"ResearchHeadlines"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-04T12:20:09.000Z","possibly_sensitive":false,"text":"RT @innovationunion: #ResearchHeadlines - Finding a cure for a rare and debilitating genetic disease: DevelopAKUre is a European Union... h…","conversation_id":"341892124817620992","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"341884043266244608"}],"attachments":{"media_keys":{}}},{"lang":"ca","id":"341891471944847360","entities":{"mentions":[{"start":3,"end":13,"username":"UNLibrary","id":"109720244"}],"urls":[{"start":80,"end":102,"url":"http://t.co/lpr0qkRNu5","expanded_url":"http://ow.ly/lGvUO","display_url":"ow.ly/lGvUO"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-04T12:17:33.000Z","possibly_sensitive":false,"text":"RT @UNLibrary: UNAIDS to establish international scientific expert panel on HIV http://t.co/lpr0qkRNu5","conversation_id":"341891471944847360","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"341852169764483075"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"341891353891975169","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":82,"end":104,"url":"http://t.co/uMVHN2V4Sa","expanded_url":"http://urpl.gov.pl/pl-komunikaty-bezp/nowe-dane-dotyczace-bezpieczenstwa-stosowania-roztworow-zawierajacych-hydroksyetyloskrobie","display_url":"urpl.gov.pl/pl-komunikaty-…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-04T12:17:05.000Z","possibly_sensitive":false,"text":"RT @URPLWMiPB: New data on the safety of solutions containing hydroxyethyl starch http://t.co/uMVHN2V4Sa","conversation_id":"341891353891975169","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"341891125495345152","entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"urls":[{"start":60,"end":82,"url":"http://t.co/sxUKz2KPQH","expanded_url":"http://www.emcdda.europa.eu/topics/pods/hepatitis-c-treatment","display_url":"emcdda.europa.eu/topics/pods/he…"}],"hashtags":{},"annotations":[{"start":12,"end":22,"probability":0.3569,"type":"Organization","normalized_text":"Hepatitis C"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-04T12:16:11.000Z","possibly_sensitive":false,"text":"RT @EMCDDA: Hepatitis C treatment for injecting drug users: http://t.co/sxUKz2KPQH","conversation_id":"341891125495345152","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"341847868354740226"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"341834425287471104","entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/bR86hsq6PB","expanded_url":"http://bit.ly/11oxOIj","display_url":"bit.ly/11oxOIj"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-04T08:30:52.000Z","possibly_sensitive":false,"text":"We just published the guideline on the use of bovine serum in the manufacture of human biological medicinal products: http://t.co/bR86hsq6PB","conversation_id":"341834425287471104","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"341833500254666752","entities":{"mentions":{},"urls":[{"start":115,"end":137,"url":"http://t.co/ZNvZhqxGxI","expanded_url":"http://bit.ly/11gR2wx","display_url":"bit.ly/11gR2wx"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-04T08:27:12.000Z","possibly_sensitive":false,"text":"Companies: we advise you to use the new version of the application form for initial evaluation of human medicines: http://t.co/ZNvZhqxGxI","conversation_id":"341833500254666752","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"341833373720932354","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/cn53zZiomf","expanded_url":"http://bit.ly/14aSIMe","display_url":"bit.ly/14aSIMe"}],"hashtags":[{"start":49,"end":56,"tag":"HyQvia"},{"start":71,"end":86,"tag":"immunoglobulin"},{"start":92,"end":109,"tag":"immunodeficiency"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-04T08:26:41.000Z","possibly_sensitive":false,"text":"Yesterday we published the assessment report for #HyQvia (human normal #immunoglobulin) for #immunodeficiency: http://t.co/cn53zZiomf","conversation_id":"341833373720932354","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"341833277369352192","entities":{"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/6mZIJI1xz1","expanded_url":"http://bit.ly/11QCCrK","display_url":"bit.ly/11QCCrK"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-04T08:26:18.000Z","possibly_sensitive":false,"text":"Send us your comments on our concept paper on the revision of our guideline on venous thromboembolic disease: http://t.co/6mZIJI1xz1","conversation_id":"341833277369352192","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"341590044013891584","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":121,"end":143,"url":"http://t.co/BVJ4uah3QB","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2013/NI-MUH_FV_13-2013-retigabina.htm","display_url":"aemps.gob.es/informa/notasI…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-03T16:19:47.000Z","possibly_sensitive":false,"text":"RT @AEMPSGOB: Retigabine (Trobalt): restriction of indication after notification of cases of eye &amp; skin pigmentation http://t.co/BVJ4uah3QB","conversation_id":"341590044013891584","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"341589496988577793","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":74,"end":86,"tag":"coronavirus"},{"start":88,"end":93,"tag":"MERS"}],"annotations":{}},"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-03T16:17:37.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: Nine new confirmed cases of Middle East respiratory syndrome #coronavirus (#MERS-CoV) infection have been reported. http://t.c…","conversation_id":"341589496988577793","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"341587377686446080"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"341588854924509184","entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/ZNvZhqxGxI","expanded_url":"http://bit.ly/11gR2wx","display_url":"bit.ly/11gR2wx"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"created_at":"2013-06-03T16:15:04.000Z","possibly_sensitive":false,"text":"A new version of the application form for initial evaluation of human medicines is available for use: http://t.co/ZNvZhqxGxI","conversation_id":"341588854924509184","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"341581163799904257","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":101,"end":123,"url":"http://t.co/4ES8yniiMf","expanded_url":"http://tnij.org/vwwo","display_url":"tnij.org/vwwo"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-03T15:44:30.000Z","possibly_sensitive":false,"text":"RT @URPLWMiPB: Information on the restriction of the use of medicinal products containing retigabine http://t.co/4ES8yniiMf","conversation_id":"341581163799904257","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"341580356786466816","entities":{"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"urls":[{"start":108,"end":131,"url":"https://t.co/eEsAvGur81","expanded_url":"https://medicinesevents.nice.org.uk/npc/frontend/reg/thome.csp?pageID=47371&eventID=183&eventID=183","display_url":"medicinesevents.nice.org.uk/npc/frontend/r…"}],"hashtags":[{"start":44,"end":49,"tag":"NICE"},{"start":65,"end":72,"tag":"pharma"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-03T15:41:17.000Z","possibly_sensitive":false,"text":"RT @NICEcomms: Scientific advice seminar: a #NICE perspective on #pharma product development - register now https://t.co/eEsAvGur81","conversation_id":"341580356786466816","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"341579956805046272"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"341580097653981185","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":107,"end":129,"url":"http://t.co/bJnWZDH5to","expanded_url":"http://tnij.org/vwwd","display_url":"tnij.org/vwwd"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-06-03T15:40:16.000Z","possibly_sensitive":false,"text":"RT @URPLWMiPB: Information on the revocation of marketing authorisations for products containing almitrine http://t.co/bJnWZDH5to","conversation_id":"341580097653981185","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"341579308730552320","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-03T15:37:08.000Z","possibly_sensitive":false,"text":"RT @MHRAmedicines: Class 2 Drug Alert (Action Within 48 Hours): Questran 4g sachet Powder for Oral Suspension, Colestyramine Powd... http:/…","conversation_id":"341579308730552320","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"341551205803241472"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"341579202534965249","entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"urls":{},"hashtags":{},"annotations":[{"start":24,"end":26,"probability":0.9195,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-03T15:36:42.000Z","possibly_sensitive":false,"text":"RT @FDAWomen: Listen as FDA committees discuss the reanalysis of RECORD trial results on type 2 diabetes treatment AVANDIA. Details http://…","conversation_id":"341579202534965249","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"341550152462524416"}],"attachments":{"media_keys":{}}},{"lang":"fr","id":"341579130720100352","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":23,"end":45,"url":"http://t.co/Qgje8xkc38","expanded_url":"http://bit.ly/15xQuX9","display_url":"bit.ly/15xQuX9"}],"hashtags":[{"start":46,"end":53,"tag":"newjob"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-03T15:36:25.000Z","possibly_sensitive":false,"text":"RT @LV_MPA: Oncologist http://t.co/Qgje8xkc38 #newjob","conversation_id":"341579130720100352","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"ro","id":"341579060184485888","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":40,"end":62,"url":"http://t.co/B2kOOt1xbf","expanded_url":"http://bit.ly/15xQwOA","display_url":"bit.ly/15xQwOA"}],"hashtags":[{"start":63,"end":70,"tag":"newjob"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-03T15:36:08.000Z","possibly_sensitive":false,"text":"RT @LV_MPA: Doctor of internal medicine http://t.co/B2kOOt1xbf #newjob","conversation_id":"341579060184485888","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"341578535456088064","entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":[{"start":117,"end":139,"url":"http://t.co/oqNfbQoias","expanded_url":"http://bit.ly/16Dc6VX","display_url":"bit.ly/16Dc6VX"}],"hashtags":[{"start":35,"end":39,"tag":"flu"}],"annotations":[{"start":74,"end":81,"probability":0.55,"type":"Person","normalized_text":"ERLI-Net"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-03T15:34:03.000Z","possibly_sensitive":false,"text":"RT @ECDC_Flu: The monthly European #flu virus characterisation reports by ERLI-Net (former CNRL) are available here: http://t.co/oqNfbQoias","conversation_id":"341578535456088064","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"341536161526865920"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"341578521145114624","entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":{},"hashtags":[{"start":34,"end":38,"tag":"flu"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-03T15:34:00.000Z","possibly_sensitive":false,"text":"RT @ECDC_Flu: Network of European #flu reference labs, former CNRL, has a new name, European Reference Laboratory Network for Human Influen…","conversation_id":"341578521145114624","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"341535849982337024"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"341521701747687424","entities":{"mentions":{},"urls":[{"start":78,"end":100,"url":"http://t.co/0oLNKjuskD","expanded_url":"http://bit.ly/18C7qPJ","display_url":"bit.ly/18C7qPJ"}],"hashtags":[{"start":25,"end":38,"tag":"pomalidomide"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-06-03T11:48:13.000Z","possibly_sensitive":false,"text":"We recommend approval of #pomalidomide for the treatment of multiple myeloma: http://t.co/0oLNKjuskD","conversation_id":"341521701747687424","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"341521657732689920","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/cn53zZiomf","expanded_url":"http://bit.ly/14aSIMe","display_url":"bit.ly/14aSIMe"}],"hashtags":[{"start":47,"end":54,"tag":"HyQvia"},{"start":69,"end":84,"tag":"immunoglobulin"},{"start":90,"end":107,"tag":"immunodeficiency"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-03T11:48:03.000Z","possibly_sensitive":false,"text":"We've just published the assessment report for #HyQvia (human normal #immunoglobulin) for #immunodeficiency: http://t.co/cn53zZiomf","conversation_id":"341521657732689920","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"341521311459315712","entities":{"mentions":{},"urls":[{"start":54,"end":76,"url":"http://t.co/Yu6pi8QPg2","expanded_url":"http://bit.ly/11GmTvu","display_url":"bit.ly/11GmTvu"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-03T11:46:40.000Z","possibly_sensitive":false,"text":"We published the CHMP meeting highlights last Friday: http://t.co/Yu6pi8QPg2","conversation_id":"341521311459315712","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"341520246617817089","entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/6mZIJI1xz1","expanded_url":"http://bit.ly/11QCCrK","display_url":"bit.ly/11QCCrK"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-03T11:42:26.000Z","possibly_sensitive":false,"text":"We've published a concept paper on the revision of our guideline on venous thromboembolic disease for consultation: http://t.co/6mZIJI1xz1","conversation_id":"341520246617817089","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"341498137875214336","entities":{"mentions":[{"start":0,"end":6,"username":"Fiouw","id":"1367162942"}],"urls":[{"start":65,"end":87,"url":"http://t.co/rMxJXKOpHn","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-03T10:14:35.000Z","possibly_sensitive":false,"text":"@Fiouw •Thanks for your message. Please send your query to us at http://t.co/rMxJXKOpHn so that we can reply to you directly.","conversation_id":"333531395681054720","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"341301570757083136"}],"in_reply_to_user_id":"1367162942","attachments":{"media_keys":{}}},{"lang":"en","id":"341497151026761728","entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"urls":[{"start":46,"end":68,"url":"http://t.co/fLGOW029NY","expanded_url":"http://www.emcdda.europa.eu/topics/pods/synthetic-cannabinoids","display_url":"emcdda.europa.eu/topics/pods/sy…"}],"hashtags":{},"annotations":[{"start":38,"end":43,"probability":0.9923,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-03T10:10:40.000Z","possibly_sensitive":false,"text":"RT @EMCDDA: Synthetic cannabinoids in Europe: http://t.co/fLGOW029NY","conversation_id":"341497151026761728","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"341479097291141120"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"341496953114337280","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":101,"end":123,"url":"http://t.co/oAtENSWHyE","expanded_url":"http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2813%2960900-9/fulltext#article_upsell","display_url":"thelancet.com/journals/lance…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-06-03T10:09:52.000Z","possibly_sensitive":false,"text":"RT @GCessak: Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: \n http://t.co/oAtENSWHyE","conversation_id":"341496953114337280","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"341473105849487360"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"340494198119747585","entities":{"mentions":{},"urls":[{"start":79,"end":101,"url":"http://t.co/84xRwXelW7","expanded_url":"http://bit.ly/10DYHIw","display_url":"bit.ly/10DYHIw"}],"hashtags":[{"start":21,"end":31,"tag":"almitrine"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-05-31T15:45:17.000Z","possibly_sensitive":false,"text":"Oral formulations of #almitrine are to be withdrawn across the European Union: http://t.co/84xRwXelW7","conversation_id":"340494198119747585","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"340493953482756097","entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/dzJ09I01fn","expanded_url":"http://bit.ly/15o09Pd","display_url":"bit.ly/15o09Pd"}],"hashtags":[{"start":30,"end":38,"tag":"Trobalt"},{"start":40,"end":51,"tag":"retigabine"},{"start":77,"end":86,"tag":"epilepsy"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-05-31T15:44:19.000Z","possibly_sensitive":false,"text":"We've recommended restricting #Trobalt (#retigabine) to last-line therapy in #epilepsy: http://t.co/dzJ09I01fn","conversation_id":"340493953482756097","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"340475505172156417","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":107,"end":129,"url":"http://t.co/nKZ1kPDfbw","expanded_url":"http://bit.ly/1aHSRXG","display_url":"bit.ly/1aHSRXG"}],"hashtags":[{"start":47,"end":56,"tag":"outbrake"},{"start":68,"end":76,"tag":"measles"},{"start":78,"end":88,"tag":"hepatitis"},{"start":95,"end":100,"tag":"MERS"},{"start":101,"end":106,"tag":"nCOV"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-31T14:31:00.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: ECDC weekly threat report is out: #outbrake updates on #measles, #hepatitis A and #MERS #nCOV http://t.co/nKZ1kPDfbw","conversation_id":"340475505172156417","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"340450856149331968"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"340429409662164992","entities":{"mentions":{},"urls":[{"start":78,"end":100,"url":"http://t.co/0oLNKjuskD","expanded_url":"http://bit.ly/18C7qPJ","display_url":"bit.ly/18C7qPJ"}],"hashtags":[{"start":25,"end":38,"tag":"pomalidomide"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":2,"quote_count":0},"created_at":"2013-05-31T11:27:50.000Z","possibly_sensitive":false,"text":"We recommend approval of #pomalidomide for the treatment of multiple myeloma: http://t.co/0oLNKjuskD","conversation_id":"340429409662164992","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"340428847772233728","entities":{"mentions":{},"urls":[{"start":52,"end":74,"url":"http://t.co/Yu6pi8QPg2","expanded_url":"http://bit.ly/11GmTvu","display_url":"bit.ly/11GmTvu"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-05-31T11:25:36.000Z","possibly_sensitive":false,"text":"We have just published the CHMP meeting highlights: http://t.co/Yu6pi8QPg2","conversation_id":"340428847772233728","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"340408123133132800","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":90,"end":112,"url":"http://t.co/o4pDSU14mU","expanded_url":"http://bit.ly/13hFxFu","display_url":"bit.ly/13hFxFu"}],"hashtags":{},"annotations":[{"start":36,"end":41,"probability":0.3528,"type":"Person","normalized_text":"Hamlet"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-31T10:03:15.000Z","possibly_sensitive":false,"text":"RT @EFPIA: Read how breast milk and Hamlet play a role in reversing antibiotic resistance http://t.co/o4pDSU14mU","conversation_id":"340408123133132800","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"340407919281569792"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"340404578073837568","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":[{"start":86,"end":108,"url":"http://t.co/yqypzeCNoG","expanded_url":"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/index.htm","display_url":"mhra.gov.uk/Safetyinformat…"}],"hashtags":{},"annotations":[{"start":39,"end":56,"probability":0.5834,"type":"Other","normalized_text":"Drug Safety Update"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-31T09:49:10.000Z","possibly_sensitive":false,"text":"RT @MHRAmedicines: The latest issue of Drug Safety Update (May 2013) is now available http://t.co/yqypzeCNoG","conversation_id":"340404578073837568","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"340404531563225088"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"340399355552993280","entities":{"mentions":{},"urls":[{"start":53,"end":75,"url":"http://t.co/84xRwXelW7","expanded_url":"http://bit.ly/10DYHIw","display_url":"bit.ly/10DYHIw"}],"hashtags":[{"start":5,"end":15,"tag":"almitrine"}],"annotations":[{"start":35,"end":50,"probability":0.7768,"type":"Organization","normalized_text":"EU Member States"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-31T09:28:25.000Z","possibly_sensitive":false,"text":"Oral #almitrine to be withdrawn by EU Member States: http://t.co/84xRwXelW7","conversation_id":"340399355552993280","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"340398401160093696","entities":{"mentions":{},"urls":[{"start":77,"end":99,"url":"http://t.co/dzJ09I01fn","expanded_url":"http://bit.ly/15o09Pd","display_url":"bit.ly/15o09Pd"}],"hashtags":{},"annotations":[{"start":0,"end":2,"probability":0.4589,"type":"Organization","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-31T09:24:37.000Z","possibly_sensitive":false,"text":"EMA recommends restricting Trobalt to last-line therapy in partial epilepsy: http://t.co/dzJ09I01fn","conversation_id":"340398401160093696","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"340391136151613441","entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":122,"end":136,"username":"yann_eurordis","id":"966574250"}],"urls":{},"hashtags":[{"start":27,"end":40,"tag":"rarediseases"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-31T08:55:45.000Z","possibly_sensitive":false,"text":"RT @eurordis: \"Maintaining #rarediseases as a sustainable EU health policy through 2020 and beyond is a leading priority\" @yann_eurordis #E…","conversation_id":"340391136151613441","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"340390385736089600"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"340391079062958080","entities":{"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"urls":[{"start":100,"end":122,"url":"http://t.co/TUEXXaABEB","expanded_url":"http://bit.ly/11bvX6p","display_url":"bit.ly/11bvX6p"}],"hashtags":{},"annotations":[{"start":90,"end":97,"probability":0.245,"type":"Organization","normalized_text":"Selincro"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-31T08:55:32.000Z","possibly_sensitive":false,"text":"RT @Legemiddelinfo: In the latest news about medicines you will find a clinical review of Selincro: http://t.co/TUEXXaABEB","conversation_id":"340391079062958080","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"340382556639858688","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":57,"end":79,"url":"http://t.co/84JOywBtCj","expanded_url":"http://bit.ly/17CcTGL","display_url":"bit.ly/17CcTGL"}],"hashtags":[{"start":27,"end":34,"tag":"cancer"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-31T08:21:40.000Z","possibly_sensitive":false,"text":"RT @EFPIA: Professor seeks #cancer signals in the blood  http://t.co/84JOywBtCj","conversation_id":"340382556639858688","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"340382028069474306"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"340378207041748992","entities":{"mentions":{},"urls":[{"start":108,"end":130,"url":"http://t.co/CzlGpQPCXt","expanded_url":"http://bit.ly/11dBoVR","display_url":"bit.ly/11dBoVR"}],"hashtags":[{"start":79,"end":84,"tag":"pain"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-31T08:04:23.000Z","possibly_sensitive":false,"text":"Send us your comments on our new guideline on the development of medicines for #pain. Deadline is 30/11/13: http://t.co/CzlGpQPCXt","conversation_id":"340378207041748992","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"340377992679268352","entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/3gilln9RIt","expanded_url":"http://bit.ly/140u5ln","display_url":"bit.ly/140u5ln"}],"hashtags":[{"start":51,"end":59,"tag":"Diane35"}],"annotations":[{"start":4,"end":7,"probability":0.2418,"type":"Organization","normalized_text":"CMDh"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-05-31T08:03:32.000Z","possibly_sensitive":false,"text":"The CMDh has endorsed the PRAC's recommendation on #Diane35 and generics: benefits outweigh risks in some patients: http://t.co/3gilln9RIt","conversation_id":"340377992679268352","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"340377656774238208","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/9EPf33c4rR","expanded_url":"http://bit.ly/17xDftn","display_url":"bit.ly/17xDftn"}],"hashtags":[{"start":90,"end":101,"tag":"depression"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-31T08:02:11.000Z","possibly_sensitive":false,"text":"Yesterday we published a revised guideline on the clinical investigation of medicines for #depression: http://t.co/9EPf33c4rR","conversation_id":"340377656774238208","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"340377589921243137","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/jkZ7fak3tO","expanded_url":"http://bit.ly/114kgO4","display_url":"bit.ly/114kgO4"}],"hashtags":[{"start":75,"end":91,"tag":"thromboembolism"},{"start":93,"end":97,"tag":"VTE"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-31T08:01:56.000Z","possibly_sensitive":false,"text":"Yesterday we published an updated guideline on medicines to prevent venous #thromboembolism (#VTE) in surgery: http://t.co/jkZ7fak3tO","conversation_id":"340377589921243137","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"fr","id":"340137918632955904","entities":{"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"urls":[{"start":77,"end":99,"url":"http://t.co/Cw4tn0iVIr","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON282763","display_url":"mhra.gov.uk/NewsCentre/Pre…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-30T16:09:33.000Z","possibly_sensitive":false,"text":"RT @MHRApress: MHRA responds to European Medicines Agency review on Dianette http://t.co/Cw4tn0iVIr","conversation_id":"340137918632955904","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"340124913618800640"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"340137814433861633","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"hashtags":[{"start":46,"end":54,"tag":"Medical"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-30T16:09:09.000Z","possibly_sensitive":false,"text":"RT @innovationunion: Shortening the time from #Medical research to treatment: Chronic diseases such as cancer and Alzheimer's have... http:…","conversation_id":"340137814433861633","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"340124458301939712"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"340120367869870082","entities":{"mentions":[{"start":3,"end":15,"username":"Europarl_EN","id":"36329597"}],"urls":[{"start":85,"end":107,"url":"http://t.co/joxYW3kath","expanded_url":"http://ow.ly/lxJ4t","display_url":"ow.ly/lxJ4t"}],"hashtags":[{"start":55,"end":70,"tag":"clinicaltrials"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-30T14:59:49.000Z","possibly_sensitive":false,"text":"RT @Europarl_EN: New rules set to inject new life into #clinicaltrials. Find out how http://t.co/joxYW3kath","conversation_id":"340120367869870082","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"340109401790763008"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"340120246344093696","entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"urls":{},"hashtags":[{"start":99,"end":105,"tag":"ESPID"}],"annotations":[{"start":126,"end":130,"probability":0.7983,"type":"Place","normalized_text":"Milan"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-30T14:59:20.000Z","possibly_sensitive":false,"text":"RT @WHO_Europe_VPI: 31st Annual Meeting of the European Society for Paediatric Infectious Diseases #ESPID underway this wk in Milan http://…","conversation_id":"340120246344093696","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"340105004981567490"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"340100102377066496","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/CzlGpQPCXt","expanded_url":"http://bit.ly/11dBoVR","display_url":"bit.ly/11dBoVR"}],"hashtags":[{"start":67,"end":72,"tag":"pain"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"created_at":"2013-05-30T13:39:17.000Z","possibly_sensitive":false,"text":"We've released a new guideline on the development of medicines for #pain for public consultation. Deadline 30/11/13: http://t.co/CzlGpQPCXt","conversation_id":"340100102377066496","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"340096674909270016","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-30T13:25:40.000Z","possibly_sensitive":false,"text":"RT @MHRAmedicines: Safety warnings and messages for medicines: Information sent to healthcare professionals in May about the safe... http:/…","conversation_id":"340096674909270016","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"340085698948386816"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"340082610548113409","entities":{"mentions":{},"urls":[{"start":51,"end":73,"url":"http://t.co/3gilln9RIt","expanded_url":"http://bit.ly/140u5ln","display_url":"bit.ly/140u5ln"}],"hashtags":[{"start":23,"end":29,"tag":"Diane"}],"annotations":[{"start":45,"end":48,"probability":0.4671,"type":"Person","normalized_text":"CMDh"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-05-30T12:29:47.000Z","possibly_sensitive":false,"text":"PRAC recommendation on #Diane 35 endorsed by CMDh: http://t.co/3gilln9RIt","conversation_id":"340082610548113409","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"340076424142680064","entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/9EPf33c4rR","expanded_url":"http://bit.ly/17xDftn","display_url":"bit.ly/17xDftn"}],"hashtags":[{"start":83,"end":94,"tag":"depression"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"created_at":"2013-05-30T12:05:12.000Z","possibly_sensitive":false,"text":"We've published a revised guideline on the clinical investigation of medicines for #depression: http://t.co/9EPf33c4rR","conversation_id":"340076424142680064","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"340066287034179584","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":79,"end":101,"url":"http://t.co/RTRlP8K2rv","expanded_url":"http://bit.ly/13lbHBm","display_url":"bit.ly/13lbHBm"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-30T11:24:55.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: ECDC is looking for an Expert in Sexually Transmitted Infections. http://t.co/RTRlP8K2rv","conversation_id":"340066287034179584","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"340066242771709952"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"340065754407915521","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/jkZ7fak3tO","expanded_url":"http://bit.ly/114kgO4","display_url":"bit.ly/114kgO4"}],"hashtags":[{"start":73,"end":89,"tag":"thromboembolism"},{"start":91,"end":95,"tag":"VTE"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-30T11:22:48.000Z","possibly_sensitive":false,"text":"We've just published an updated guideline on medicines to prevent venous #thromboembolism (#VTE) in\nsurgery: http://t.co/jkZ7fak3tO","conversation_id":"340065754407915521","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"340056830791270400","entities":{"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"urls":{},"hashtags":[{"start":31,"end":36,"tag":"ENVI"}],"annotations":[{"start":102,"end":103,"probability":0.7081,"type":"Place","normalized_text":"CT"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-30T10:47:21.000Z","possibly_sensitive":false,"text":"RT @HAIEurope: Clinical trials #ENVI clarifies in Recital: there's no commercial confidential data in CT related to authorized meds. Some p…","conversation_id":"340056830791270400","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"340056535478697985"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"340053644860850177","entities":{"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"urls":[{"start":115,"end":137,"url":"http://t.co/43EIo5H3t6","expanded_url":"http://www.mhra.gov.uk/NewsCentre/Whatsnew/CON282755","display_url":"mhra.gov.uk/NewsCentre/Wha…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-30T10:34:41.000Z","possibly_sensitive":false,"text":"RT @MHRApress: MHRA response to published research paper concerning non-steroidal anti-inflammatory drugs (NSAIDs) http://t.co/43EIo5H3t6","conversation_id":"340053644860850177","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"340045836421582848"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"340053173312028672","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":{},"hashtags":[{"start":44,"end":58,"tag":"antimicrobial"},{"start":59,"end":70,"tag":"resistance"},{"start":71,"end":89,"tag":"pharmacovigilance"},{"start":90,"end":98,"tag":"frailty"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-30T10:32:49.000Z","possibly_sensitive":false,"text":"RT @IMI_JU: Indicative IMI 9th Call topics: #antimicrobial #resistance #pharmacovigilance #frailty drug-drug combinations http://t.co/iAWN6…","conversation_id":"340053173312028672","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"340037563312111616"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"340052290763362305","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":121,"end":143,"url":"http://t.co/qbYuzzL5aB","expanded_url":"http://bit.ly/1409g9B","display_url":"bit.ly/1409g9B"}],"hashtags":[{"start":28,"end":31,"tag":"EC"},{"start":32,"end":47,"tag":"ClinicalTrials"},{"start":106,"end":120,"tag":"patientsafety"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-30T10:29:18.000Z","possibly_sensitive":false,"text":"RT @EU_Health: MEPs support #EC #ClinicalTrials Directive: simpler &amp; uniform rules for research &amp; #patientsafety http://t.co/qbYuzzL5aB @EP…","conversation_id":"340052290763362305","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"340018056061399040"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339782327926398976","entities":{"mentions":[{"start":3,"end":19,"username":"IlariaPassarani","id":"1106659014"},{"start":67,"end":76,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":34,"end":49,"tag":"clinicaltrials"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-29T16:36:34.000Z","possibly_sensitive":false,"text":"RT @IlariaPassarani: ENVI vote on #clinicaltrials: MEPs agree that @EMA_News transparency policy should be upheld and reinforced. Well done…","conversation_id":"339782327926398976","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339777324998340609"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339765902377615360","entities":{"mentions":[{"start":3,"end":18,"username":"EP_Environment","id":"951333319"},{"start":103,"end":118,"username":"GlenisWillmott","id":"106110469"}],"urls":[{"start":70,"end":92,"url":"http://t.co/NqpSIwSmcP","expanded_url":"http://bit.ly/15iKvEQ","display_url":"bit.ly/15iKvEQ","status":200,"unwound_url":"https://www.europarl.europa.eu/news/en/press-room/20130527IPR10525/clinical-trials-clearer-rules-better-protection?quizBaseUrl=https%3A%2F%2Fquizweb.europarl.europa.eu"}],"hashtags":[{"start":20,"end":35,"tag":"Clinicaltrials"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-29T15:31:18.000Z","possibly_sensitive":false,"text":"RT @EP_Environment: #Clinicaltrials: clearer rules, better protection http://t.co/NqpSIwSmcP report by @GlenisWillmott adopted unanimously.…","conversation_id":"339765902377615360","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339765744306892800"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339747608446779393","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":32,"end":54,"url":"http://t.co/VxqKMsSXgq","expanded_url":"http://goo.gl/BxN8G","display_url":"goo.gl/BxN8G","unwound_url":"https://www.who.int/csr/don/2013_05_29/en/index.html"}],"hashtags":[{"start":26,"end":31,"tag":"H7N9"}],"annotations":{}},"public_metrics":{"retweet_count":34,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-29T14:18:36.000Z","possibly_sensitive":false,"text":"RT @WHO: Latest update on #H7N9 http://t.co/VxqKMsSXgq","conversation_id":"339747608446779393","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339745438506827776"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339747593921896449","entities":{"mentions":[{"start":3,"end":18,"username":"USPharmacopeia","id":"47953929"}],"urls":[{"start":99,"end":121,"url":"http://t.co/qgMBNWOO1X","expanded_url":"http://bit.ly/18sigYH","display_url":"bit.ly/18sigYH"}],"hashtags":{},"annotations":[{"start":49,"end":54,"probability":0.9971,"type":"Place","normalized_text":"Africa"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-29T14:18:33.000Z","possibly_sensitive":false,"text":"RT @USPharmacopeia: How counterfeit medicines in Africa are undermining the fight against malaria: http://t.co/qgMBNWOO1X","conversation_id":"339747593921896449","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339745282780721153"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339731974296047616","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":50,"end":55,"tag":"H7N9"}],"annotations":[{"start":9,"end":13,"probability":0.9563,"type":"Place","normalized_text":"China"}]},"public_metrics":{"retweet_count":35,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-29T13:16:29.000Z","possibly_sensitive":false,"text":"RT @WHO: China has notified WHO of one additional #H7N9 laboratory-confirmed case and a new death","conversation_id":"339731974296047616","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339731568639766528"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339725035067543552","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":52,"end":74,"url":"http://t.co/JfQ08S9L4r","expanded_url":"http://bit.ly/17rOQu3","display_url":"bit.ly/17rOQu3"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-29T12:48:54.000Z","possibly_sensitive":false,"text":"RT @LV_MPA: Monthly report from the PRAC (May 2013) http://t.co/JfQ08S9L4r","conversation_id":"339725035067543552","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"339720807624355841","entities":{"mentions":{},"urls":[{"start":107,"end":129,"url":"http://t.co/06HsjEajNf","expanded_url":"http://bit.ly/111YtX6","display_url":"bit.ly/111YtX6"}],"hashtags":[{"start":33,"end":44,"tag":"veterinary"},{"start":45,"end":60,"tag":"antimicrobials"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-29T12:32:06.000Z","possibly_sensitive":false,"text":"Our guideline on the efficacy of #veterinary #antimicrobials is open for comments. Deadline is 30/11/2013: http://t.co/06HsjEajNf","conversation_id":"339720807624355841","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"339720700879331328","entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/H4zYBNPQyy","expanded_url":"http://bit.ly/ZlR31d","display_url":"bit.ly/ZlR31d"},{"start":118,"end":140,"url":"http://t.co/PGApjXG98G","expanded_url":"http://bit.ly/132jcyo","display_url":"bit.ly/132jcyo"}],"hashtags":[{"start":46,"end":64,"tag":"pharmacovigilance"},{"start":69,"end":78,"tag":"vaccines"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-29T12:31:41.000Z","possibly_sensitive":false,"text":"Two weeks left to comment on our guideline on #pharmacovigilance for #vaccines and its annex: http://t.co/H4zYBNPQyy  http://t.co/PGApjXG98G","conversation_id":"339720700879331328","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"339688321477390336","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":123,"end":130,"username":"UNAIDS","id":"19177501"}],"urls":[{"start":97,"end":119,"url":"http://t.co/1Jx0kDQFX9","expanded_url":"http://bit.ly/1ay52WU","display_url":"bit.ly/1ay52WU"}],"hashtags":[{"start":40,"end":43,"tag":"EU"},{"start":44,"end":51,"tag":"Health"},{"start":73,"end":77,"tag":"HIV"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-29T10:23:01.000Z","possibly_sensitive":false,"text":"RT @EU_Health: Have you seen our latest #EU #Health newsletter? Focus on #HIV &amp; human rights http://t.co/1Jx0kDQFX9 cc @UNAIDS","conversation_id":"339688321477390336","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339687859080544256"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339667250107805696","entities":{"mentions":{},"urls":[{"start":113,"end":135,"url":"http://t.co/06HsjEajNf","expanded_url":"http://bit.ly/111YtX6","display_url":"bit.ly/111YtX6"}],"hashtags":[{"start":60,"end":71,"tag":"veterinary"},{"start":72,"end":87,"tag":"antimicrobials"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"created_at":"2013-05-29T08:59:17.000Z","possibly_sensitive":false,"text":"We're inviting comments on our guideline on the efficacy of #veterinary #antimicrobials. Deadline is 30/11/2013: http://t.co/06HsjEajNf","conversation_id":"339667250107805696","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"339658692687454208","entities":{"mentions":{},"urls":[{"start":94,"end":116,"url":"http://t.co/H4zYBNPQyy","expanded_url":"http://bit.ly/ZlR31d","display_url":"bit.ly/ZlR31d"},{"start":117,"end":139,"url":"http://t.co/PGApjXG98G","expanded_url":"http://bit.ly/132jcyo","display_url":"bit.ly/132jcyo"}],"hashtags":[{"start":46,"end":64,"tag":"pharmacovigilance"},{"start":69,"end":78,"tag":"vaccines"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":1,"like_count":2,"quote_count":0},"created_at":"2013-05-29T08:25:17.000Z","possibly_sensitive":false,"text":"Two more weeks to comment on our guideline on #pharmacovigilance for #vaccines and its annex: http://t.co/H4zYBNPQyy http://t.co/PGApjXG98G","conversation_id":"339658692687454208","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"339391225352302593","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":41,"end":63,"url":"http://t.co/AJGB2mfgjS","expanded_url":"http://goo.gl/Sul4f","display_url":"goo.gl/Sul4f"}],"hashtags":[{"start":64,"end":69,"tag":"nCoV"},{"start":70,"end":75,"tag":"MERS"}],"annotations":{}},"public_metrics":{"retweet_count":62,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-28T14:42:28.000Z","possibly_sensitive":false,"text":"RT @WHO: Naming of the Novel Coronavirus http://t.co/AJGB2mfgjS #nCoV #MERS","conversation_id":"339391225352302593","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339385116398870529"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339376066449784832","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"},{"start":93,"end":101,"username":"ECDC_EU","id":"204752573"},{"start":103,"end":117,"username":"WHO_Europe_TB","id":"920721606"},{"start":119,"end":127,"username":"kncvtbc","id":"222452977"}],"urls":{},"hashtags":[{"start":41,"end":54,"tag":"Tuberculosis"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-28T13:42:14.000Z","possibly_sensitive":false,"text":"RT @ECDC_TB: Annual Meetings of European #Tuberculosis Networks: follow discussion live with @ECDC_EU, @WHO_Europe_TB, @kncvtbc http://t.co…","conversation_id":"339376066449784832","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339375787457249283"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339376049148276737","entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"urls":[{"start":103,"end":125,"url":"http://t.co/8YvG0ElwaF","expanded_url":"http://bit.ly/1725LTe","display_url":"bit.ly/1725LTe"}],"hashtags":[{"start":26,"end":29,"tag":"TB"},{"start":55,"end":64,"tag":"Wolfheze"},{"start":126,"end":133,"tag":"TBchat"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-28T13:42:10.000Z","possibly_sensitive":false,"text":"RT @WHO_Europe: This week #TB and M/XDR-TB in focus at #Wolfheze workshops 2013 follow live webstream: http://t.co/8YvG0ElwaF #TBchat","conversation_id":"339376049148276737","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339375676341751810"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339368334627844097","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":52,"end":74,"url":"http://t.co/Evf0wM4mZ0","expanded_url":"http://m.bbc.co.uk/news/health-22689601","display_url":"m.bbc.co.uk/news/health-22…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-28T13:11:30.000Z","possibly_sensitive":false,"text":"RT @GCessak: H7N9 Bird flu drug resistance 'concern http://t.co/Evf0wM4mZ0","conversation_id":"339368334627844097","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339365832654192642"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339364838570606593","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":85,"end":96,"username":"WHO_Europe","id":"125403342"}],"urls":[{"start":109,"end":131,"url":"http://t.co/rMdJA3Ehaf","expanded_url":"http://bit.ly/130a4u1","display_url":"bit.ly/130a4u1"}],"hashtags":[{"start":56,"end":67,"tag":"depression"},{"start":97,"end":108,"tag":"brainmonth"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-28T12:57:37.000Z","possibly_sensitive":false,"text":"RT @EU_Health: Each year, 25% of population suffer from #depression/anxiety. Info by @WHO_Europe #brainmonth http://t.co/rMdJA3Ehaf via @in…","conversation_id":"339364838570606593","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339334297284640769"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339364604020920321","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-28T12:56:41.000Z","possibly_sensitive":false,"text":"RT @EU_ECHA: We have a new five-year strategic plan for the Agency. You are invited to provide comments until 15 July. http://t.co/evnFKy92…","conversation_id":"339364604020920321","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339333901673705472"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339364279469875200","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":109,"end":131,"url":"http://t.co/5INIQJogHV","expanded_url":"http://bit.ly/11mq5WT","display_url":"bit.ly/11mq5WT"}],"hashtags":[{"start":67,"end":81,"tag":"schizophrenia"},{"start":86,"end":97,"tag":"depression"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-28T12:55:23.000Z","possibly_sensitive":false,"text":"RT @IMI_JU: IMI press release: NEWMEDS makes progress in quest for #schizophrenia and #depression treatments http://t.co/5INIQJogHV #brainm…","conversation_id":"339364279469875200","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339326208477106178"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339363711615647744","entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"urls":{},"hashtags":[{"start":52,"end":59,"tag":"EUPATI"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-28T12:53:08.000Z","possibly_sensitive":false,"text":"RT @eurordis: EURORDIS contributes expertise to the #EUPATI patient training programme in medicine development and regulation. http://t.co/…","conversation_id":"339363711615647744","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339318384690884608"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339363499459358720","entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"urls":[{"start":45,"end":68,"url":"https://t.co/Mr309kuzX7","expanded_url":"https://www.youtube.com/watch?v=mGbduEIHqm4","display_url":"youtube.com/watch?v=mGbduE…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-28T12:52:18.000Z","possibly_sensitive":false,"text":"RT @EMCDDA: 2013 European Drug Report video: https://t.co/Mr309kuzX7","conversation_id":"339363499459358720","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339314450739916801"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339363203039506434","entities":{"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"},{"start":103,"end":110,"username":"EMCDDA","id":"50638521"}],"urls":[{"start":111,"end":133,"url":"http://t.co/smEOGo9b3I","expanded_url":"http://ow.ly/lsag7","display_url":"ow.ly/lsag7"}],"hashtags":[{"start":32,"end":37,"tag":"Drug"}],"annotations":[{"start":57,"end":62,"probability":0.9551,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-28T12:51:07.000Z","possibly_sensitive":false,"text":"RT @EU_Commission: New European #Drug Report out today - Europe’s drugs problem in ‘state of flux’ via @EMCDDA http://t.co/smEOGo9b3I","conversation_id":"339363203039506434","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339307882627616768"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339363013838635010","entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"urls":[{"start":59,"end":81,"url":"http://t.co/qMeiABCxK3","expanded_url":"http://www.emcdda.europa.eu/edr2013","display_url":"emcdda.europa.eu/edr2013"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":44,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-28T12:50:22.000Z","possibly_sensitive":false,"text":"RT @EMCDDA: Just published: the European Drug Report 2013: http://t.co/qMeiABCxK3","conversation_id":"339363013838635010","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339305952887054336"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339362780740202498","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_TB","id":"1282878908"},{"start":53,"end":61,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":30,"end":33,"tag":"TB"}],"annotations":[{"start":116,"end":121,"probability":0.9875,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-28T12:49:26.000Z","possibly_sensitive":false,"text":"RT @ECDC_TB: Week of European #TB Networks meetings: @ECDC_EU &amp; partners come together to discuss TB elimination in Europe. Starting today …","conversation_id":"339362780740202498","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339302287551897600"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"339023701452398593","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":107,"end":129,"url":"http://t.co/iLlR9kUyNG","expanded_url":"http://bit.ly/13cvyCO","display_url":"bit.ly/13cvyCO"}],"hashtags":[{"start":80,"end":87,"tag":"Europe"},{"start":102,"end":106,"tag":"HIV"}],"annotations":[{"start":62,"end":65,"probability":0.3752,"type":"Organization","normalized_text":"ECDC"}]},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-27T14:22:03.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: Strong leadership, late diagnoses: new series of ECDC reports show #Europe’s response to #HIV http://t.co/iLlR9kUyNG","conversation_id":"339023701452398593","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"339021730829979648"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"338992695362064385","entities":{"mentions":[{"start":3,"end":8,"username":"Eu2P","id":"420241833"}],"urls":{},"hashtags":[{"start":47,"end":65,"tag":"Pharmacovigilance"},{"start":70,"end":91,"tag":"Pharmacoepidemiology"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-27T12:18:51.000Z","possibly_sensitive":false,"text":"RT @Eu2P: Application to Eu2P online Master in #Pharmacovigilance and #Pharmacoepidemiology open till June 23 for next year http://t.co/AmL…","conversation_id":"338992695362064385","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337555279782760448"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"338945803953508355","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":72,"end":94,"url":"http://t.co/ACYdcHA4wo","expanded_url":"http://bbc.in/11k9pzt","display_url":"bbc.in/11k9pzt"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-27T09:12:31.000Z","possibly_sensitive":false,"text":"RT @EFPIA: 'Stroke patients see signs of recovery in stem-cell trial' - http://t.co/ACYdcHA4wo","conversation_id":"338945803953508355","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"338944324958048256"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"338939015287930881","entities":{"mentions":[{"start":3,"end":15,"username":"EUombudsman","id":"873777758"},{"start":119,"end":128,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-27T08:45:33.000Z","possibly_sensitive":false,"text":"RT @EUombudsman: Diamandouros: Can't name single case but 3 large areas where I am proud: transparency is one and here @EMA_News has made g…","conversation_id":"338939015287930881","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"338938105937661954"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"338937472492908544","entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":[{"start":104,"end":126,"url":"http://t.co/kmMMjcOWN3","expanded_url":"http://bit.ly/124c9s4","display_url":"bit.ly/124c9s4"}],"hashtags":[{"start":99,"end":103,"tag":"flu"}],"annotations":[{"start":52,"end":57,"probability":0.993,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-27T08:39:25.000Z","possibly_sensitive":false,"text":"RT @ECDC_Flu: Influenza season 2012-2013 is over in Europe, concludes ECDC monitoring for seasonal #flu http://t.co/kmMMjcOWN3","conversation_id":"338937472492908544","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337950444561264641"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"338936711260282880","entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":[{"start":82,"end":104,"url":"http://t.co/XmGKoR0Lcy","expanded_url":"http://1.usa.gov/170vkok","display_url":"1.usa.gov/170vkok"}],"hashtags":[{"start":77,"end":81,"tag":"FDA"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-27T08:36:23.000Z","possibly_sensitive":false,"text":"RT @FDACBER: Potential “universal” influenza vaccine developed and tested at #FDA http://t.co/XmGKoR0Lcy","conversation_id":"338936711260282880","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337943247672463362"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"338936576140783616","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":{},"hashtags":[{"start":15,"end":18,"tag":"EU"},{"start":42,"end":49,"tag":"health"},{"start":95,"end":102,"tag":"Health"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-27T08:35:51.000Z","possibly_sensitive":false,"text":"RT @EU_Health: #EU support for key public #health initiatives - joint actions funded under the #Health Programme 2008-2011 http://t.co/nB5S…","conversation_id":"338936576140783616","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337938482792128513"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"338936289854369794","entities":{"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"urls":[{"start":102,"end":124,"url":"http://t.co/ZE1YCvD49L","expanded_url":"http://bit.ly/Z58dmT","display_url":"bit.ly/Z58dmT"}],"hashtags":[{"start":95,"end":101,"tag":"wha66"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-27T08:34:43.000Z","possibly_sensitive":false,"text":"RT @IAPOtweets: Today, IAPO called for WHO Member State action on counterfeit medical products #wha66 http://t.co/ZE1YCvD49L","conversation_id":"338936289854369794","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337936035268947968"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337590488137867266","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":111,"end":133,"url":"http://t.co/cfO8fDR3Pb","expanded_url":"http://bit.ly/16bGMx6","display_url":"bit.ly/16bGMx6"}],"hashtags":[{"start":105,"end":110,"tag":"ATMP"}],"annotations":[{"start":69,"end":103,"probability":0.3181,"type":"Product","normalized_text":"Advanced Therapy Medicinal Products"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-23T15:26:59.000Z","possibly_sensitive":false,"text":"RT @EU_Health: Responses to public consultation on the regulation on Advanced Therapy Medicinal Products #ATMP http://t.co/cfO8fDR3Pb cc @E…","conversation_id":"337590488137867266","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337590367107047424"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337588620598837248","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"hashtags":[{"start":102,"end":112,"tag":"Parkinson"},{"start":124,"end":135,"tag":"brainmonth"}],"annotations":[{"start":21,"end":34,"probability":0.3619,"type":"Person","normalized_text":"EU-Marie Curie"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-23T15:19:33.000Z","possibly_sensitive":false,"text":"RT @innovationunion: EU-Marie Curie Fellow's innovative genetic research targets better prognosis for #Parkinson's patients #brainmonth htt…","conversation_id":"337588620598837248","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337586587032510465"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337588581906382850","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":102,"end":114,"tag":"coronavirus"},{"start":116,"end":121,"tag":"MERS"},{"start":122,"end":127,"tag":"nCov"}],"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-23T15:19:24.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: Epidemiological update: new cases of Middle East respiratory syndrome coronavirus (novel #coronavirus) #MERS #nCov http://t.co…","conversation_id":"337588581906382850","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337585734116589569"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337569555226427392","entities":{"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"urls":[{"start":100,"end":122,"url":"http://t.co/IDB3kFR1DH","expanded_url":"http://owl.li/ljmn1","display_url":"owl.li/ljmn1"}],"hashtags":[{"start":48,"end":58,"tag":"additives"},{"start":81,"end":88,"tag":"animal"},{"start":89,"end":99,"tag":"nutrition"},{"start":124,"end":129,"tag":"food"},{"start":130,"end":133,"tag":"EU"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-23T14:03:48.000Z","possibly_sensitive":false,"text":"RT @EU_Health: Update to authorized nutritional #additives &amp; amino acids for #animal #nutrition http://t.co/IDB3kFR1DH  #food #EU via @EURL…","conversation_id":"337569555226427392","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337569356915544064"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337551580045930497","entities":{"mentions":[{"start":0,"end":15,"username":"maxwellmedtech","id":"1576183399"}],"urls":[{"start":73,"end":95,"url":"http://t.co/rMxJXKOpHn","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-23T12:52:22.000Z","possibly_sensitive":false,"text":"@maxwellmedtech Thanks for your message. Please send your query to us at http://t.co/rMxJXKOpHn so that we can reply to you directly.","conversation_id":"337524821703397377","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"337532998318702593"}],"in_reply_to_user_id":"183177433","attachments":{"media_keys":{}}},{"lang":"en","id":"337551086116290560","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":58,"end":80,"url":"http://t.co/QUYwplmX1c","expanded_url":"http://goo.gl/BcH4p","display_url":"goo.gl/BcH4p"}],"hashtags":[{"start":81,"end":86,"tag":"MERS"}],"annotations":{}},"public_metrics":{"retweet_count":59,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-23T12:50:24.000Z","possibly_sensitive":false,"text":"RT @WHO: Latest update on the novel coronavirus situation http://t.co/QUYwplmX1c #MERS","conversation_id":"337551086116290560","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337543542610202626"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337550814400888832","entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"urls":[{"start":90,"end":112,"url":"http://t.co/21QDedRyJy","expanded_url":"http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(13)70059-8/fulltext?elsca1=ETOC-TLID&elsca2=email&elsca3=HTDJ35F","display_url":"thelancet.com/journals/lanin…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-23T12:49:20.000Z","possibly_sensitive":false,"text":"RT @Hep_Alliance: Immediate treatment preferable to delayed for patients with acute hep C http://t.co/21QDedRyJy","conversation_id":"337550814400888832","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337533763628199936"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337524821703397377","entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/vTmcvhNZMb","expanded_url":"http://bit.ly/16Q91kA","display_url":"bit.ly/16Q91kA"}],"hashtags":[{"start":37,"end":54,"tag":"medicationerrors"}],"annotations":[{"start":62,"end":63,"probability":0.344,"type":"Place","normalized_text":"EU"}]},"public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"created_at":"2013-05-23T11:06:03.000Z","possibly_sensitive":false,"text":"To help deal with the harm caused by #medicationerrors in the EU, we've issued six key recommendations: http://t.co/vTmcvhNZMb","conversation_id":"337524821703397377","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"337515119741386752","entities":{"mentions":[{"start":3,"end":18,"username":"cochranecollab","id":"20429156"}],"urls":{},"hashtags":[{"start":71,"end":80,"tag":"Cochrane"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-23T10:27:29.000Z","possibly_sensitive":false,"text":"RT @cochranecollab: Three senior management positions available at The #Cochrane Collaboration | Closing date 16 June 2013 | http://t.co/Ph…","conversation_id":"337515119741386752","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337513998092210176"}],"attachments":{"media_keys":{}}},{"lang":"ca","id":"337514556823838721","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":33,"end":55,"url":"http://t.co/H4erDMwUGn","expanded_url":"http://bit.ly/14Bha8O","display_url":"bit.ly/14Bha8O"}],"hashtags":[{"start":56,"end":63,"tag":"newjob"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-23T10:25:15.000Z","possibly_sensitive":false,"text":"RT @LV_MPA: Signal investigators http://t.co/H4erDMwUGn #newjob","conversation_id":"337514556823838721","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"337509379408531457","entities":{"mentions":{},"urls":[{"start":79,"end":101,"url":"http://t.co/vTmcvhNZMb","expanded_url":"http://bit.ly/16Q91kA","display_url":"bit.ly/16Q91kA"}],"hashtags":[{"start":60,"end":77,"tag":"medicationerrors"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"created_at":"2013-05-23T10:04:41.000Z","possibly_sensitive":false,"text":"We've issued six key recommendations to tackle the issue of #medicationerrors: http://t.co/vTmcvhNZMb","conversation_id":"337509379408531457","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"337493592618700801","entities":{"mentions":{},"urls":[{"start":116,"end":138,"url":"http://t.co/YRzeY7uEBq","expanded_url":"http://bit.ly/10LXhHt","display_url":"bit.ly/10LXhHt"}],"hashtags":[{"start":80,"end":92,"tag":"eSubmission"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-05-23T09:01:57.000Z","possibly_sensitive":false,"text":"From March next year, all applications for human medicines will need to use the #eSubmission Gateway or web client: http://t.co/YRzeY7uEBq","conversation_id":"337493592618700801","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"337493509365968896","entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/YeD2aNPLiV","expanded_url":"http://bit.ly/13HX9dT","display_url":"bit.ly/13HX9dT"}],"hashtags":[{"start":26,"end":33,"tag":"Maruxa"},{"start":35,"end":45,"tag":"memantine"},{"start":72,"end":78,"tag":"Ebixa"},{"start":83,"end":93,"tag":"Alzheimer"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-23T09:01:37.000Z","possibly_sensitive":false,"text":"The assessment report for #Maruxa (#memantine) is available; generic of #Ebixa for #Alzheimer's disease: http://t.co/YeD2aNPLiV","conversation_id":"337493509365968896","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"337491907909410816","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":77,"end":99,"url":"http://t.co/uGSQAmLYny","expanded_url":"http://bit.ly/14AT661","display_url":"bit.ly/14AT661"}],"hashtags":{},"annotations":[{"start":26,"end":56,"probability":0.4039,"type":"Organization","normalized_text":"Swedish Medical Products Agency"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-23T08:55:15.000Z","possibly_sensitive":false,"text":"RT @LV_MPA: Plans for the Swedish Medical Products Agency monitoring in 2013 http://t.co/uGSQAmLYny","conversation_id":"337491907909410816","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"337240356494127104","entities":{"mentions":[{"start":3,"end":18,"username":"EP_Environment","id":"951333319"},{"start":71,"end":84,"username":"CHedegaardEU","id":"2558819556"},{"start":108,"end":122,"username":"DRothBehrendt","id":"20757050"},{"start":130,"end":141,"username":"peterliese","id":"42590805"}],"urls":{},"hashtags":[{"start":53,"end":67,"tag":"climateaction"},{"start":89,"end":104,"tag":"medicaldevices"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-22T16:15:41.000Z","possibly_sensitive":false,"text":"RT @EP_Environment: 2/2 Next Week in ENVI: debate on #climateaction w. @CHedegaardEU; on #medicaldevices w. @DRothBehrendt  &amp; @peterliese; …","conversation_id":"337240356494127104","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337239751679680513"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337240274998804481","entities":{"mentions":[{"start":3,"end":18,"username":"EP_Environment","id":"951333319"},{"start":61,"end":76,"username":"GlenisWillmott","id":"106110469"},{"start":95,"end":110,"username":"Frederiqueries","id":"191779603"}],"urls":{},"hashtags":[{"start":44,"end":59,"tag":"clinicaltrials"},{"start":118,"end":129,"tag":"bioeconomy"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-22T16:15:21.000Z","possibly_sensitive":false,"text":"RT @EP_Environment: 1/2 Next Week: votes on #clinicaltrials (@GlenisWillmott); baby milk/food (@Frederiqueries); on a #bioeconomy for #Euro…","conversation_id":"337240274998804481","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337238263389634561"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337230023750737920","entities":{"mentions":{},"urls":[{"start":105,"end":127,"url":"http://t.co/YRzeY7uEBq","expanded_url":"http://bit.ly/10LXhHt","display_url":"bit.ly/10LXhHt"}],"hashtags":[{"start":69,"end":81,"tag":"eSubmission"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"created_at":"2013-05-22T15:34:37.000Z","possibly_sensitive":false,"text":"From March all applications for human medicines will need to use the #eSubmission Gateway or web client: http://t.co/YRzeY7uEBq","conversation_id":"337230023750737920","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"337219190815592448","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":87,"end":109,"url":"http://t.co/FtYkmmaHr9","expanded_url":"http://bit.ly/13L7cSV","display_url":"bit.ly/13L7cSV"}],"hashtags":[{"start":37,"end":52,"tag":"counterfeiting"}],"annotations":[{"start":56,"end":61,"probability":0.9765,"type":"Place","normalized_text":"Africa"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-22T14:51:34.000Z","possibly_sensitive":false,"text":"RT @EFPIA: 'Chinese drugmaker fights #counterfeiting in Africa with SMS technology'  - http://t.co/FtYkmmaHr9","conversation_id":"337219190815592448","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337217376200306689"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337203124190199808","entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":{},"hashtags":[{"start":13,"end":17,"tag":"FDA"}],"annotations":[{"start":41,"end":75,"probability":0.4892,"type":"Other","normalized_text":"Japanese Encephalitis Virus vaccine"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-22T13:47:44.000Z","possibly_sensitive":false,"text":"RT @FDACBER: #FDA approves extension of  Japanese Encephalitis Virus vaccine (IXIARO) use to individuals 2 months and older http://t.co/ZR4…","conversation_id":"337203124190199808","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337202973157507073"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337194819229188096","entities":{"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/YeD2aNPLiV","expanded_url":"http://bit.ly/13HX9dT","display_url":"bit.ly/13HX9dT"}],"hashtags":[{"start":42,"end":49,"tag":"Maruxa"},{"start":51,"end":61,"tag":"memantine"},{"start":77,"end":83,"tag":"Ebixa"},{"start":88,"end":98,"tag":"Alzheimer"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-22T13:14:44.000Z","possibly_sensitive":false,"text":"We've published the assessment report for #Maruxa (#memantine), a generic of #Ebixa for #Alzheimer's disease: http://t.co/YeD2aNPLiV","conversation_id":"337194819229188096","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"337193728492056576","entities":{"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"urls":{},"hashtags":{},"annotations":[{"start":34,"end":49,"probability":0.7458,"type":"Place","normalized_text":"Cochrane Library"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-22T13:10:24.000Z","possibly_sensitive":false,"text":"RT @EMCDDA: Just published in the Cochrane Library: Slow-release oral morphine as maintenance therapy for opioid dependence: http://t.co/z4…","conversation_id":"337193728492056576","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337193666609311744"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337184873393557505","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":73,"end":95,"url":"http://t.co/8QAIiCRKlV","expanded_url":"http://goo.gl/sI02p","display_url":"goo.gl/sI02p"}],"hashtags":[{"start":38,"end":44,"tag":"polio"}],"annotations":[{"start":58,"end":71,"probability":0.535,"type":"Place","normalized_text":"Horn of Africa"}]},"public_metrics":{"retweet_count":38,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-22T12:35:13.000Z","possibly_sensitive":false,"text":"RT @WHO: More information on the wild #polio virus in the Horn of Africa http://t.co/8QAIiCRKlV","conversation_id":"337184873393557505","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337179240678174721"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337184721924665344","entities":{"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"}],"urls":{},"hashtags":[{"start":49,"end":58,"tag":"vaccines"}],"annotations":[{"start":20,"end":28,"probability":0.9972,"type":"Person","normalized_text":"Adam Finn"},{"start":31,"end":32,"probability":0.7956,"type":"Place","normalized_text":"UK"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-22T12:34:36.000Z","possibly_sensitive":false,"text":"RT @WHO_Europe_VPI: Adam Finn (UK) describes how #vaccines work and why we all have a role in ensuring that they are effective. http://t.co…","conversation_id":"337184721924665344","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337176853712355329"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337168303573307392","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":80,"end":102,"url":"http://t.co/6ymmatjGch","expanded_url":"http://bit.ly/12ouMlB","display_url":"bit.ly/12ouMlB"}],"hashtags":[{"start":18,"end":23,"tag":"SNCA"},{"start":67,"end":77,"tag":"Parkinson"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-22T11:29:22.000Z","possibly_sensitive":false,"text":"RT @euparkinsons: #SNCA: Major genetic modifier of age at onset of #Parkinson's http://t.co/6ymmatjGch","conversation_id":"337168303573307392","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337164687420571649"}],"attachments":{"media_keys":{}}},{"lang":"in","id":"337167851116953600","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":50,"end":72,"url":"http://t.co/xivipGSU5w","expanded_url":"http://bbc.in/13Ht4el","display_url":"bbc.in/13Ht4el"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-22T11:27:34.000Z","possibly_sensitive":false,"text":"RT @GCessak: Vitamin C can kill drug-resistant TB http://t.co/xivipGSU5w","conversation_id":"337167851116953600","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337147187932831744"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337167601329389569","entities":{"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"urls":[{"start":72,"end":94,"url":"http://t.co/CSNKPjc4yj","expanded_url":"http://tinyurl.com/orswy3d","display_url":"tinyurl.com/orswy3d"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-22T11:26:35.000Z","possibly_sensitive":false,"text":"RT @myCORDIS: ANGIOSTOP project and the role of SMEs in cancer research http://t.co/CSNKPjc4yj","conversation_id":"337167601329389569","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337136207354015745"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337123954063966208","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":76,"end":98,"url":"http://t.co/Jkd8cQRZFT","expanded_url":"http://goo.gl/FgDZd","display_url":"goo.gl/FgDZd","status":500,"unwound_url":"https://www.who.int/csr/don/2013_05_22_ncov/en/"}],"hashtags":[{"start":99,"end":104,"tag":"nCoV"}],"annotations":[{"start":67,"end":73,"probability":0.923,"type":"Place","normalized_text":"Tunisia"}]},"public_metrics":{"retweet_count":50,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-22T08:33:08.000Z","possibly_sensitive":false,"text":"RT @WHO: Latest update on novel coronavirus (new cases reported by Tunisia) http://t.co/Jkd8cQRZFT #nCoV","conversation_id":"337123954063966208","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337123073016856576"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337123931712520192","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"hashtags":[{"start":21,"end":39,"tag":"ResearchHeadlines"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-22T08:33:03.000Z","possibly_sensitive":false,"text":"RT @innovationunion: #ResearchHeadlines - Preparing the way for the understanding of a rare neurological disease: ENRAH-SME was a... http:/…","conversation_id":"337123931712520192","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337122290795954176"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"337116609170780161","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"hashtags":[{"start":32,"end":41,"tag":"Develage"},{"start":110,"end":120,"tag":"Alzheimer"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-22T08:03:57.000Z","possibly_sensitive":false,"text":"RT @innovationunion: EU project #Develage is exploring the kind of genetic structure that can protect against #Alzheimer’s http://t.co/51Ft…","conversation_id":"337116609170780161","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"337115624583090176"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"336877022259322882","entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":117,"end":139,"url":"http://t.co/OTnzJsw4w4","expanded_url":"http://1.usa.gov/rLC1E9","display_url":"1.usa.gov/rLC1E9"}],"hashtags":[{"start":49,"end":56,"tag":"animal"},{"start":57,"end":62,"tag":"drug"},{"start":63,"end":70,"tag":"safety"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-21T16:11:55.000Z","possibly_sensitive":false,"text":"RT @FDAanimalhealth: If you have questions about #animal #drug #safety, you might be able to find your answers here. http://t.co/OTnzJsw4w4","conversation_id":"336877022259322882","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"336876882584801280"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"336840658868379648","entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":[{"start":121,"end":143,"url":"http://t.co/EQy5jJeCpc","expanded_url":"http://ow.ly/lf42i","display_url":"ow.ly/lf42i"}],"hashtags":{},"annotations":[{"start":27,"end":33,"probability":0.9727,"type":"Person","normalized_text":"D.Juric"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-21T13:47:26.000Z","possibly_sensitive":false,"text":"RT @myESMO: Interview with D.Juric: horizon of PI3K &amp; other inhibitors present in range of common &amp; rare cancers http://t.co/EQy5jJeCpc","conversation_id":"336840658868379648","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"336839269127700480"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"336838464559525888","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":90,"end":112,"url":"http://t.co/3RM5SCs400","expanded_url":"http://bit.ly/O15CaH","display_url":"bit.ly/O15CaH"}],"hashtags":[{"start":49,"end":59,"tag":"Parkinson"},{"start":62,"end":70,"tag":"Disease"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-21T13:38:42.000Z","possibly_sensitive":false,"text":"RT @euparkinsons: Stay up-2-date with the latest #Parkinson's #Disease research articles: http://t.co/3RM5SCs400","conversation_id":"336838464559525888","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"336834603052572673"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"336838401368145920","entities":{"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"urls":[{"start":102,"end":124,"url":"http://t.co/BaT32Zu945","expanded_url":"http://www.mhra.gov.uk/Howweregulate/Medicines/Licensingofmedicines/SubmittinganapplicationtotheMHRA/CentralEuropeanSubmissionsPlatformCESP/index.htm","display_url":"mhra.gov.uk/Howweregulate/…"}],"hashtags":{},"annotations":[{"start":57,"end":92,"probability":0.7563,"type":"Other","normalized_text":"Common European Submissions Platform"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-21T13:38:27.000Z","possibly_sensitive":false,"text":"RT @MHRAgovuk: MHRA is participating in the pilot of the Common European Submissions Platform (CESP). http://t.co/BaT32Zu945","conversation_id":"336838401368145920","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"336833013029675008"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"336838070718574592","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":111,"end":133,"url":"http://t.co/scfv2KprOP","expanded_url":"http://bit.ly/10LMnFH","display_url":"bit.ly/10LMnFH"}],"hashtags":{},"annotations":[{"start":13,"end":16,"probability":0.3037,"type":"Person","normalized_text":"ECHA"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-21T13:37:08.000Z","possibly_sensitive":false,"text":"RT @EU_ECHA: ECHA calls for a new round of comments on etridiazole's reproductive toxicity and carcinogenicity http://t.co/scfv2KprOP","conversation_id":"336838070718574592","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"336826829128228864"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"336837359784034304","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":83,"end":105,"url":"http://t.co/a98zoWxyu4","expanded_url":"http://bit.ly/Z77kg3","display_url":"bit.ly/Z77kg3"}],"hashtags":[{"start":13,"end":21,"tag":"ESCAIDE"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-21T13:34:19.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: #ESCAIDE 2013: Call for abstracts will open between 27 May and 5 July http://t.co/a98zoWxyu4","conversation_id":"336837359784034304","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"336820365084995584"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"336817244447313920","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":113,"end":135,"url":"http://t.co/1Cz3AEpyzV","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2013/NI-MUH_FV_12-2013-ciproterona.htm","display_url":"aemps.gob.es/informa/notasI…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-21T12:14:23.000Z","possibly_sensitive":false,"text":"RT @AEMPSGOB: Medicines containing cyproterone acetate in combination with ethinyl estradiol. Information update http://t.co/1Cz3AEpyzV","conversation_id":"336817244447313920","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"336801041406369792","entities":{"mentions":{},"urls":[{"start":102,"end":124,"url":"http://t.co/BRRNLVoTHo","expanded_url":"http://bit.ly/10SJ0ZN","display_url":"bit.ly/10SJ0ZN"}],"hashtags":[{"start":21,"end":29,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-21T11:10:00.000Z","possibly_sensitive":false,"text":"Applications for the #vacancy for Head of our IT Development Sector close tomorrow, Wednesday 22 May: http://t.co/BRRNLVoTHo","conversation_id":"336801041406369792","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"336800867757981696","entities":{"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"},{"start":82,"end":92,"username":"EAHPtweet","id":"203357203"},{"start":93,"end":98,"username":"PGEU","id":"459292439"},{"start":106,"end":113,"username":"EIPGeu","id":"424089030"}],"urls":{},"hashtags":[{"start":38,"end":48,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-21T11:09:19.000Z","possibly_sensitive":false,"text":"RT @EAHPtweet: Its time for action on #medicines shortages! See the joint call by @EAHPtweet @PGEU &amp; \n@EIPGeu on this urgent topic\n http://…","conversation_id":"336800867757981696","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"336800118508498944"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"336800469970206720","entities":{"mentions":[{"start":3,"end":15,"username":"FDAMedWatch","id":"205847300"}],"urls":[{"start":110,"end":132,"url":"http://t.co/vsfG16Kczh","expanded_url":"http://go.usa.gov/b3b4","display_url":"go.usa.gov/b3b4"}],"hashtags":[{"start":133,"end":137,"tag":"FDA"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-21T11:07:44.000Z","possibly_sensitive":false,"text":"RT @FDAMedWatch: Methotrexate Sodium, USP Injectable Vials by Sandoz US: Recall - Particulate Matter In Vials http://t.co/vsfG16Kczh #FDA","conversation_id":"336800469970206720","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"336789412568514560"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"336798769528049664","entities":{"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"urls":[{"start":110,"end":132,"url":"http://t.co/j7X53z9ADW","expanded_url":"http://www.worldhepatitisalliance.org/mediacentre/press_releases/13-05-21/d14e8bcd-76fe-4b46-a6a8-1b57ca3dd1ff.aspx","display_url":"worldhepatitisalliance.org/mediacentre/pr…"}],"hashtags":[{"start":59,"end":69,"tag":"hepatitis"},{"start":73,"end":79,"tag":"WHA66"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-21T11:00:58.000Z","possibly_sensitive":false,"text":"RT @Hep_Alliance: Global health community meets to discuss #hepatitis at #WHA66 - read the press release here http://t.co/j7X53z9ADW","conversation_id":"336798769528049664","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"336767472264966144"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"336757203421773824","entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/BRRNLVoTHo","expanded_url":"http://bit.ly/10SJ0ZN","display_url":"bit.ly/10SJ0ZN"}],"hashtags":[{"start":30,"end":38,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-21T08:15:48.000Z","possibly_sensitive":false,"text":"One day left to apply for our #vacancy for Head of our IT Development Sector. Deadline is tomorrow, Wednesday 22 May: http://t.co/BRRNLVoTHo","conversation_id":"336757203421773824","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"336756932687839232","entities":{"mentions":{},"urls":[{"start":96,"end":118,"url":"http://t.co/6yLDCWGyAb","expanded_url":"http://bit.ly/Z1MGOc","display_url":"bit.ly/Z1MGOc"}],"hashtags":[{"start":69,"end":77,"tag":"Diane35"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-05-21T08:14:44.000Z","possibly_sensitive":false,"text":"On Friday evening we reiterated the PRAC's earlier recommendation on #Diane35 and its generics: http://t.co/6yLDCWGyAb","conversation_id":"336756932687839232","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"336756822646067201","entities":{"mentions":{},"urls":[{"start":73,"end":95,"url":"http://t.co/2GhdC2vNa1","expanded_url":"http://bit.ly/10KaUYE","display_url":"bit.ly/10KaUYE"}],"hashtags":[{"start":27,"end":42,"tag":"ClinicalTrials"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-21T08:14:17.000Z","possibly_sensitive":false,"text":"We supported International #ClinicalTrials Day yesterday, Monday 20 May: http://t.co/2GhdC2vNa1","conversation_id":"336756822646067201","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"336756653926006784","entities":{"mentions":{},"urls":[{"start":77,"end":99,"url":"http://t.co/Wi6JaWySES","expanded_url":"http://bit.ly/Z17TrC","display_url":"bit.ly/Z17TrC"}],"hashtags":[{"start":42,"end":53,"tag":"veterinary"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-21T08:13:37.000Z","possibly_sensitive":false,"text":"We published the full highlights from our #veterinary committee last Friday: http://t.co/Wi6JaWySES","conversation_id":"336756653926006784","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"336756522304561152","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/4O6hKdO0Af","expanded_url":"http://bit.ly/13AYSVL","display_url":"bit.ly/13AYSVL"}],"hashtags":[{"start":4,"end":15,"tag":"veterinary"},{"start":60,"end":73,"tag":"footandmouth"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-05-21T08:13:06.000Z","possibly_sensitive":false,"text":"Our #veterinary committee recommended the first vaccine for #footandmouth disease for authorisation last week: http://t.co/4O6hKdO0Af","conversation_id":"336756522304561152","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"336756326862577664","entities":{"mentions":{},"urls":[{"start":84,"end":106,"url":"http://t.co/oJ4Nmm5nhY","expanded_url":"http://bit.ly/16pwHMT","display_url":"bit.ly/16pwHMT"}],"hashtags":[{"start":42,"end":60,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-05-21T08:12:19.000Z","possibly_sensitive":false,"text":"We published the full highlights from our #pharmacovigilance committee last Friday: http://t.co/oJ4Nmm5nhY","conversation_id":"336756326862577664","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"336756167223164928","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/nm2IYqoZNI","expanded_url":"http://bit.ly/10CxqBy","display_url":"bit.ly/10CxqBy"}],"hashtags":[{"start":14,"end":32,"tag":"pharmacovigilance"},{"start":88,"end":96,"tag":"Diane35"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-21T08:11:41.000Z","possibly_sensitive":false,"text":"Last week our #pharmacovigilance committee recommended positive benefit/risk balance of #Diane35 and generics: http://t.co/nm2IYqoZNI","conversation_id":"336756167223164928","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"335488046277484544","entities":{"mentions":{},"urls":[{"start":81,"end":103,"url":"http://t.co/6yLDCWGyAb","expanded_url":"http://bit.ly/Z1MGOc","display_url":"bit.ly/Z1MGOc"}],"hashtags":[{"start":54,"end":62,"tag":"Diane35"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":2,"like_count":0,"quote_count":0},"created_at":"2013-05-17T20:12:37.000Z","possibly_sensitive":false,"text":"We've reiterated the PRAC's earlier recommendation on #Diane35 and its generics: http://t.co/6yLDCWGyAb","conversation_id":"335488046277484544","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"335432567857758208","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"hashtags":[{"start":13,"end":18,"tag":"EFSA"}],"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T16:32:10.000Z","possibly_sensitive":false,"text":"RT @EFSA_EU: #EFSA: Flavouring substance 3-acetyl-2,5-dimethylthiophene is genotoxic and a safety concern for human health. http://t.co/sPR…","conversation_id":"335432567857758208","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"335432180706734080"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"335432413335416832","entities":{"mentions":{},"urls":[{"start":62,"end":84,"url":"http://t.co/2GhdC2vNa1","expanded_url":"http://bit.ly/10KaUYE","display_url":"bit.ly/10KaUYE"}],"hashtags":[{"start":31,"end":46,"tag":"ClinicalTrials"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":1,"like_count":1,"quote_count":0},"created_at":"2013-05-17T16:31:34.000Z","possibly_sensitive":false,"text":"We're supporting International #ClinicalTrials Day on Monday: http://t.co/2GhdC2vNa1","conversation_id":"335432413335416832","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"335425712074928128","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":46,"end":68,"url":"http://t.co/DSCa7TT0Dv","expanded_url":"http://goo.gl/WicSW","display_url":"goo.gl/WicSW"}],"hashtags":[{"start":30,"end":35,"tag":"H7N9"}],"annotations":{}},"public_metrics":{"retweet_count":41,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T16:04:56.000Z","possibly_sensitive":false,"text":"RT @WHO: Latest update on the #H7N9 situation http://t.co/DSCa7TT0Dv","conversation_id":"335425712074928128","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"335425649571409920"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"335423854509953024","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":115,"end":137,"url":"http://t.co/bsC0wt0D4W","expanded_url":"http://www.urpl.gov.pl/aktualnosci/informacja-prezesa-urzedu-z-dnia-17-maja-2013-r-w-sprawie-rekomendacji-komitetu-ds-oceny-ryzyka-w-ramach-nadzoru-nad-bezpieczenstwem-farmakoterapii-do","display_url":"urpl.gov.pl/aktualnosci/in…"}],"hashtags":{},"annotations":[{"start":106,"end":110,"probability":0.8609,"type":"Person","normalized_text":"Diane"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"created_at":"2013-05-17T15:57:33.000Z","possibly_sensitive":false,"text":"RT @GCessak: Information Office (17/05/13) EMA recommendation on the evaluation of the benefits of taking Diane 35 http://t.co/bsC0wt0D4W","conversation_id":"335423854509953024","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"335422385895391233","entities":{"mentions":[{"start":3,"end":16,"username":"HealthCanada","id":"928334374256472064"}],"urls":[{"start":89,"end":111,"url":"http://t.co/KJS8zINlL5","expanded_url":"http://bit.ly/10VQqke","display_url":"bit.ly/10VQqke"}],"hashtags":[{"start":112,"end":119,"tag":"health"},{"start":120,"end":127,"tag":"safety"}],"annotations":[{"start":25,"end":30,"probability":0.6174,"type":"Place","normalized_text":"Canada"},{"start":44,"end":48,"probability":0.6891,"type":"Person","normalized_text":"Diane"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T15:51:43.000Z","possibly_sensitive":false,"text":"RT @HealthCanada: Health Canada's review of Diane-35 supports current labelling and use: http://t.co/KJS8zINlL5 #health #safety","conversation_id":"335422385895391233","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"335421707668033538"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"335411803620253696","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":59,"end":81,"url":"http://t.co/zrJWWgsbe3","expanded_url":"http://goo.gl/m8WEg","display_url":"goo.gl/m8WEg"}],"hashtags":[{"start":82,"end":87,"tag":"nCoV"}],"annotations":{}},"public_metrics":{"retweet_count":53,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T15:09:40.000Z","possibly_sensitive":false,"text":"RT @WHO: Summary update on the novel coronavirus situation http://t.co/zrJWWgsbe3 #nCoV","conversation_id":"335411803620253696","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"335411758023991296"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"335411024347930624","entities":{"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"urls":{},"hashtags":[{"start":21,"end":24,"tag":"EU"},{"start":25,"end":34,"tag":"research"},{"start":103,"end":113,"tag":"Alzheimer"},{"start":116,"end":127,"tag":"brainmonth"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T15:06:34.000Z","possibly_sensitive":false,"text":"RT @innovationunion: #EU #research project LANIR is developing a nanoscope to screen patient cells for #Alzheimer’s #brainmonth http://t.co…","conversation_id":"335411024347930624","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"335410716259540992"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"335409039364202496","entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"urls":[{"start":98,"end":120,"url":"http://t.co/0DWqqlmwdH","expanded_url":"http://bit.ly/15TgzU5","display_url":"bit.ly/15TgzU5"}],"hashtags":[{"start":92,"end":97,"tag":"H7N9"}],"annotations":[{"start":86,"end":90,"probability":0.9934,"type":"Place","normalized_text":"China"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T14:58:41.000Z","possibly_sensitive":false,"text":"RT @WHO_Europe: Latest update for European Region on avian influenza A(H7N9) virus in China #H7N9 http://t.co/0DWqqlmwdH","conversation_id":"335409039364202496","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"335408822485143552"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"335408893150756864","entities":{"mentions":[{"start":3,"end":15,"username":"Europarl_EN","id":"36329597"}],"urls":{},"hashtags":{},"annotations":[{"start":17,"end":18,"probability":0.5439,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T14:58:06.000Z","possibly_sensitive":false,"text":"RT @Europarl_EN: EU laws made easy: new interactive app explains step by step how majority of legislation gets created http://t.co/DvRvTWqE…","conversation_id":"335408893150756864","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"335406548304138240"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"335407598855655424","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":108,"end":130,"url":"http://t.co/XLCNrrUE15","expanded_url":"http://bit.ly/10VtIJh","display_url":"bit.ly/10VtIJh"}],"hashtags":{},"annotations":[{"start":28,"end":32,"probability":0.7633,"type":"Person","normalized_text":"Diane"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T14:52:57.000Z","possibly_sensitive":false,"text":"RT @LV_MPA: The benefits of Diane 35 and its generics outweigh their risks in a specific patient population http://t.co/XLCNrrUE15","conversation_id":"335407598855655424","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"335407260874452994","entities":{"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"urls":{},"hashtags":{},"annotations":[{"start":53,"end":73,"probability":0.4588,"type":"Organization","normalized_text":"Black Triangle Scheme"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T14:51:37.000Z","possibly_sensitive":false,"text":"RT @MHRApress: .@CompliMed Latest information on the Black Triangle Scheme available here  http://t.co/mocA2eHrVa","conversation_id":"335407260874452994","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"335385344583299072"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"335406629870772224","entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T14:49:06.000Z","possibly_sensitive":false,"text":"RT @WHO_Europe: Yellow fever ‘booster’ jab given 10 yrs after initial vaccination not necessary concludes advisory group http://t.co/CJFlWU…","conversation_id":"335406629870772224","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"335373042018574336"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"335406221853065216","entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"urls":[{"start":71,"end":93,"url":"http://t.co/4y1nOziPQM","expanded_url":"http://bit.ly/12A3VEB","display_url":"bit.ly/12A3VEB"}],"hashtags":[{"start":36,"end":48,"tag":"coronavirus"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T14:47:29.000Z","possibly_sensitive":false,"text":"RT @WHO_Europe: New update on novel #coronavirus , now called MERS-CoV http://t.co/4y1nOziPQM","conversation_id":"335406221853065216","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"335367426495614977"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"335406000616112128","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":95,"end":117,"url":"http://t.co/9mAH563HhG","expanded_url":"http://bit.ly/10CAiyi","display_url":"bit.ly/10CAiyi"}],"hashtags":[{"start":55,"end":60,"tag":"MERS"},{"start":81,"end":93,"tag":"coronavirus"}],"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T14:46:36.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: ECDC updates its rapid risk assessment of #MERS-CoV, formerly novel #coronavirus: http://t.co/9mAH563HhG","conversation_id":"335406000616112128","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"335365845733740544"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"335405852649463808","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":94,"end":116,"url":"http://t.co/RrJDXBmdHR","expanded_url":"http://goo.gl/1wVuF","display_url":"goo.gl/1wVuF"}],"hashtags":[{"start":64,"end":76,"tag":"yellowfever"}],"annotations":{}},"public_metrics":{"retweet_count":32,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T14:46:01.000Z","possibly_sensitive":false,"text":"RT @WHO: Full article on WHO’s Weekly Epidemiological Record on #yellowfever vaccination here http://t.co/RrJDXBmdHR","conversation_id":"335405852649463808","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"335355524793131009"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"335395605172088833","entities":{"mentions":{},"urls":[{"start":47,"end":69,"url":"http://t.co/Wi6JaWySES","expanded_url":"http://bit.ly/Z17TrC","display_url":"bit.ly/Z17TrC"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-05-17T14:05:18.000Z","possibly_sensitive":false,"text":"We have published the CVMP meeting highlights: http://t.co/Wi6JaWySES","conversation_id":"335395605172088833","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"335392584480468992","entities":{"mentions":{},"urls":[{"start":87,"end":109,"url":"http://t.co/4O6hKdO0Af","expanded_url":"http://bit.ly/13AYSVL","display_url":"bit.ly/13AYSVL"}],"hashtags":{},"annotations":[{"start":0,"end":2,"probability":0.363,"type":"Organization","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-05-17T13:53:18.000Z","possibly_sensitive":false,"text":"EMA recommends first vaccine for foot-and-mouth disease for authorisation at EU level: http://t.co/4O6hKdO0Af","conversation_id":"335392584480468992","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"335358648299687938","entities":{"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"urls":{},"hashtags":[{"start":62,"end":67,"tag":"nCoV"},{"start":117,"end":122,"tag":"MERS"}],"annotations":[{"start":14,"end":36,"probability":0.52,"type":"Organization","normalized_text":"Coronavirus Study Group"}]},"public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T11:38:27.000Z","possibly_sensitive":false,"text":"RT @ECDC_Flu: Coronavirus Study Group decides on new name for #nCoV, Middle East respiratory syndrome coronavirus or #MERS-CoV: http://t.co…","conversation_id":"335358648299687938","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"335350374976331776"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"335358491126542336","entities":{"mentions":{},"urls":[{"start":44,"end":66,"url":"http://t.co/oJ4Nmm5nhY","expanded_url":"http://bit.ly/16pwHMT","display_url":"bit.ly/16pwHMT"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T11:37:49.000Z","possibly_sensitive":false,"text":"We have just published the PRAC highlights: http://t.co/oJ4Nmm5nhY","conversation_id":"335358491126542336","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"335357753885331457","entities":{"mentions":{},"urls":[{"start":98,"end":120,"url":"http://t.co/nm2IYqoZNI","expanded_url":"http://bit.ly/10CxqBy","display_url":"bit.ly/10CxqBy"}],"hashtags":[{"start":49,"end":55,"tag":"Diane"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-05-17T11:34:53.000Z","possibly_sensitive":false,"text":"PRAC recommends positive benefit/risk balance of #Diane 35 and generics in specific patient group http://t.co/nm2IYqoZNI","conversation_id":"335357753885331457","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"335336979900268544","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":96,"end":118,"url":"http://t.co/l58khM7EkO","expanded_url":"http://bit.ly/16pbzqf","display_url":"bit.ly/16pbzqf"}],"hashtags":[{"start":80,"end":95,"tag":"counterfeiting"}],"annotations":[{"start":12,"end":16,"probability":0.9837,"type":"Place","normalized_text":"China"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T10:12:20.000Z","possibly_sensitive":false,"text":"RT @EFPIA: 'China arrests dozens, seizes tens of millions of counterfeit drugs' #counterfeiting http://t.co/l58khM7EkO","conversation_id":"335336979900268544","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"335336656158736386"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"335333329584930816","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":115,"end":137,"url":"http://t.co/WNEW9gwJNN","expanded_url":"http://bit.ly/13rEjY8","display_url":"bit.ly/13rEjY8"}],"hashtags":[{"start":70,"end":81,"tag":"Salmonella"},{"start":86,"end":100,"tag":"Campylobacter"},{"start":102,"end":114,"tag":"infographic"}],"annotations":[{"start":13,"end":18,"probability":0.9738,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T09:57:50.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: Europe's fight against antimicrobial resistance found in #Salmonella and #Campylobacter: #infographic http://t.co/WNEW9gwJNN #…","conversation_id":"335333329584930816","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"335332512786169857"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"335326984039174144","entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/mO192V7xJb","expanded_url":"http://bit.ly/10ZvMdc","display_url":"bit.ly/10ZvMdc"}],"hashtags":[{"start":29,"end":33,"tag":"CTD"},{"start":86,"end":93,"tag":"herbal"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-17T09:32:37.000Z","possibly_sensitive":false,"text":"A new guideline on using the #CTD format in registration applications for traditional #herbal medicines is available: http://t.co/mO192V7xJb","conversation_id":"335326984039174144","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"335032197889277954","entities":{"mentions":[{"start":3,"end":8,"username":"PGEU","id":"459292439"}],"urls":[{"start":94,"end":116,"url":"http://t.co/w3bOj4b0Vi","expanded_url":"http://www.pgeu.eu/en/press/1-press-releases/100-european-pharmacist-organisations-make-joint-call-for-action-on-medicines-shortages.html","display_url":"pgeu.eu/en/press/1-pre…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-16T14:01:15.000Z","possibly_sensitive":false,"text":"RT @PGEU: European pharmacist organisations make joint call for action on medicines shortages\nhttp://t.co/w3bOj4b0Vi","conversation_id":"335032197889277954","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"335029529540173825"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"335006574395408385","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/fuK3LUMNsS","expanded_url":"http://bit.ly/10ZvMdc","display_url":"bit.ly/10ZvMdc"}],"hashtags":[{"start":41,"end":45,"tag":"CTD"},{"start":98,"end":105,"tag":"herbal"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"created_at":"2013-05-16T12:19:26.000Z","possibly_sensitive":false,"text":"We've published a guideline on using the #CTD format in registration applications for traditional #herbal medicines: http://t.co/fuK3LUMNsS","conversation_id":"335006574395408385","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"334988028617584640","entities":{"mentions":{},"urls":[{"start":122,"end":144,"url":"http://t.co/wbLqZTvHSl","expanded_url":"http://bit.ly/12DkBdd","display_url":"bit.ly/12DkBdd"}],"hashtags":[{"start":74,"end":85,"tag":"infectious"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-05-16T11:05:44.000Z","possibly_sensitive":false,"text":"Send us comments on our inventory of research &amp; development needs for #infectious diseases in children by 15/07/2013: http://t.co/wbLqZTvHSl","conversation_id":"334988028617584640","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"334987659413954560","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/bbT3WVlnHY","expanded_url":"http://bit.ly/10HMoHs","display_url":"bit.ly/10HMoHs"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-16T11:04:16.000Z","possibly_sensitive":false,"text":"Our office is closed on Monday 20th. We have an emergency out-of-hours telephone number for problems with medicines: http://t.co/bbT3WVlnHY","conversation_id":"334987659413954560","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"334987503910150144","entities":{"mentions":{},"urls":[{"start":85,"end":107,"url":"http://t.co/pRdOU9V7Ph","expanded_url":"http://bit.ly/13nZwCl","display_url":"bit.ly/13nZwCl"}],"hashtags":[{"start":11,"end":32,"tag":"WorldHypertensionDay"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-05-16T11:03:39.000Z","possibly_sensitive":false,"text":"We support #WorldHypertensionDay tomorrow, 17 May. Find out what we do in this area: http://t.co/pRdOU9V7Ph","conversation_id":"334987503910150144","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"334986819919814658","entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/K6ysIkZOeb","expanded_url":"http://bit.ly/18MZTw3","display_url":"bit.ly/18MZTw3"}],"hashtags":[{"start":25,"end":32,"tag":"herbal"},{"start":62,"end":72,"tag":"Phaseolus"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-16T11:00:56.000Z","possibly_sensitive":false,"text":"Public consultation on a #herbal monograph on green bean pod (#Phaseolus vulgaris) open until 15/07/13: http://t.co/K6ysIkZOeb","conversation_id":"334986819919814658","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"334986251218337792","entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/7ccsTEWmWB","expanded_url":"http://bit.ly/12DkBdd","display_url":"bit.ly/12DkBdd"}],"hashtags":[{"start":32,"end":43,"tag":"paediatric"},{"start":62,"end":73,"tag":"infectious"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-16T10:58:40.000Z","possibly_sensitive":false,"text":"We've published an inventory of #paediatric medicine needs in #infectious diseases for consultation until 15/07/2013  http://t.co/7ccsTEWmWB","conversation_id":"334986251218337792","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"334983382742212609","entities":{"mentions":[{"start":3,"end":12,"username":"esno_web","id":"1185837546"}],"urls":[{"start":103,"end":125,"url":"http://t.co/gARXggBxY2","expanded_url":"http://ish-world.com/events/e/World-Hypertension-Day-WHD/","display_url":"ish-world.com/events/e/World…"}],"hashtags":[{"start":51,"end":72,"tag":"WorldHypertensionDay"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-16T10:47:16.000Z","possibly_sensitive":false,"text":"RT @esno_web: Raising awareness of Hypertension at #WorldHypertensionDay 17 May 2013 and visit website http://t.co/gARXggBxY2","conversation_id":"334983382742212609","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"334983283148460034"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334980048941629441","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":116,"end":138,"url":"http://t.co/zd8x6G1F7E","expanded_url":"http://bit.ly/10Adz6b","display_url":"bit.ly/10Adz6b"}],"hashtags":[{"start":66,"end":78,"tag":"infographic"},{"start":97,"end":101,"tag":"AMR"},{"start":102,"end":114,"tag":"antibiotics"}],"annotations":[{"start":13,"end":18,"probability":0.9821,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-16T10:34:01.000Z","possibly_sensitive":false,"text":"RT @EFSA_EU: Europe's fight against antimicrobial resistance. New #infographic with latest data. #AMR #antibiotics: http://t.co/zd8x6G1F7E","conversation_id":"334980048941629441","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"334979906645667842"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334980029719130112","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":110,"end":132,"url":"http://t.co/HnHewmdaAO","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/05/news_detail_001788.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"annotations":[{"start":40,"end":61,"probability":0.8042,"type":"Other","normalized_text":"World Hypertension Day"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-16T10:33:57.000Z","possibly_sensitive":false,"text":"RT @URPLWMiPB: The Office also supports World Hypertension Day, which is taking place on Friday 17 May 2013. \nhttp://t.co/HnHewmdaAO","conversation_id":"334980029719130112","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"334979783962284032"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334971154966142976","entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/bbT3WVlnHY","expanded_url":"http://bit.ly/10HMoHs","display_url":"bit.ly/10HMoHs"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-16T09:58:41.000Z","possibly_sensitive":false,"text":"We're closed on Monday. We have an emergency out-of-hours telephone number for problems with medicines: http://t.co/bbT3WVlnHY","conversation_id":"334971154966142976","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"334963631936651264","entities":{"mentions":{},"urls":[{"start":49,"end":71,"url":"http://t.co/pRdOU9V7Ph","expanded_url":"http://bit.ly/13nZwCl","display_url":"bit.ly/13nZwCl"}],"hashtags":[{"start":17,"end":38,"tag":"WorldHypertensionDay"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-16T09:28:47.000Z","possibly_sensitive":false,"text":"We're supporting #WorldHypertensionDay tomorrow: http://t.co/pRdOU9V7Ph","conversation_id":"334963631936651264","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"334958024038944769","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"hashtags":[{"start":100,"end":105,"tag":"EFSA"},{"start":110,"end":115,"tag":"ECDC"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-16T09:06:30.000Z","possibly_sensitive":false,"text":"RT @EFSA_EU: Antimicrobial resistance in zoonotic bacteria affecting humans, animals and foods: new #EFSA and #ECDC report: http://t.co/fYA…","conversation_id":"334958024038944769","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"334957344142286848"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334957988395745281","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":13,"end":27,"tag":"Antimicrobial"},{"start":64,"end":75,"tag":"Salmonella"},{"start":80,"end":94,"tag":"Campylobacter"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-16T09:06:22.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: #Antimicrobial resistance continues to be found in #Salmonella and #Campylobacter. Read the joint ECDC/EFSA report: http://t.c…","conversation_id":"334957988395745281","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"334957917054832640"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334954064574042112","entities":{"mentions":{},"urls":[{"start":118,"end":140,"url":"http://t.co/K6ysIkZOeb","expanded_url":"http://bit.ly/18MZTw3","display_url":"bit.ly/18MZTw3"}],"hashtags":[{"start":41,"end":48,"tag":"herbal"},{"start":78,"end":88,"tag":"Phaseolus"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-16T08:50:46.000Z","possibly_sensitive":false,"text":"We've started a public consultation on a #herbal monograph on green bean pod (#Phaseolus vulgaris). Deadline 15/07/13 http://t.co/K6ysIkZOeb","conversation_id":"334954064574042112","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"334943140853198848","entities":{"mentions":[{"start":0,"end":6,"username":"Fiouw","id":"1367162942"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-05-16T08:07:22.000Z","possibly_sensitive":false,"text":"@Fiouw We're afraid we can't release more details while the evaluation is ongoing. We will publish the outcome as soon as it's complete.","conversation_id":"333531395681054720","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"334766728758308864"}],"in_reply_to_user_id":"1367162942","attachments":{"media_keys":{}}},{"lang":"en","id":"334693968233234434","entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":44,"end":66,"url":"http://t.co/Fs4fNLjZAS","expanded_url":"http://bit.ly/cynKxg","display_url":"bit.ly/cynKxg"}],"hashtags":[{"start":25,"end":29,"tag":"FDA"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-15T15:37:15.000Z","possibly_sensitive":false,"text":"RT @FDAanimalhealth: Get #FDA email updates http://t.co/Fs4fNLjZAS","conversation_id":"334693968233234434","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"334693912725831681"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334686347715547136","entities":{"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"urls":[{"start":63,"end":85,"url":"http://t.co/rTTJCynWzu","expanded_url":"http://1.usa.gov/16fuQdG","display_url":"1.usa.gov/16fuQdG"}],"hashtags":{},"annotations":[{"start":12,"end":14,"probability":0.8773,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-15T15:06:58.000Z","possibly_sensitive":false,"text":"RT @US_FDA: FDA approves new drug for advanced prostate cancer http://t.co/rTTJCynWzu","conversation_id":"334686347715547136","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"334686305323720704"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334675083475943424","entities":{"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"},{"start":17,"end":25,"username":"EFSA_EU","id":"84582815"}],"urls":[{"start":75,"end":97,"url":"http://t.co/GE5aRGmoWF","expanded_url":"http://bit.ly/19sO0Jk","display_url":"bit.ly/19sO0Jk"}],"hashtags":[{"start":38,"end":48,"tag":"aspartame"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-15T14:22:12.000Z","possibly_sensitive":false,"text":"RT @EU_Consumer: @EFSA_EU reschedules #aspartame opinion for November 2013 http://t.co/GE5aRGmoWF","conversation_id":"334675083475943424","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"334670736855797760"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334665048746246146","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"urls":[{"start":73,"end":95,"url":"http://t.co/9YxeBOJoRT","expanded_url":"http://bit.ly/12bqTAT","display_url":"bit.ly/12bqTAT"}],"hashtags":[{"start":96,"end":107,"tag":"brainmonth"},{"start":108,"end":115,"tag":"SF2013"}],"annotations":[{"start":31,"end":53,"probability":0.3694,"type":"Organization","normalized_text":"IMI’s Stakeholder Forum"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-15T13:42:20.000Z","possibly_sensitive":false,"text":"RT @IMI_JU: Presentations from IMI’s Stakeholder Forum are now online at http://t.co/9YxeBOJoRT #brainmonth #SF2013","conversation_id":"334665048746246146","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"334654623015116800"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334624300780900352","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/BRRNLVoTHo","expanded_url":"http://bit.ly/10SJ0ZN","display_url":"bit.ly/10SJ0ZN"}],"hashtags":[{"start":41,"end":49,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-15T11:00:24.000Z","possibly_sensitive":false,"text":"Just one more week left to apply for our #vacancy for Head of our IT Development Sector. Deadline is 22 May: http://t.co/BRRNLVoTHo","conversation_id":"334624300780900352","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"334623043517304832","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":87,"end":109,"url":"http://t.co/4nHzMdqxC8","expanded_url":"http://urpl.gov.pl/pl-komunikaty-bezp/przypadki-martwiczego-zapalenia-powiezi-w-zwiazku-z-zastosowaniem-produktu-avastin-bewacyzumab","display_url":"urpl.gov.pl/pl-komunikaty-…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":0},"created_at":"2013-05-15T10:55:25.000Z","possibly_sensitive":false,"text":"RT @URPLWMiPB: Cases of necrotising fasciitis due to the use of Avastin (bevacizumab): http://t.co/4nHzMdqxC8 …","conversation_id":"334623043517304832","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"334619001755930624","entities":{"mentions":[{"start":0,"end":10,"username":"URPLWMiPB","id":"556679074"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-15T10:39:21.000Z","possibly_sensitive":false,"text":"@URPLWMiPB The link isn't working!","conversation_id":"334607280630808577","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"334607280630808577"}],"in_reply_to_user_id":"556679074","attachments":{"media_keys":{}}},{"lang":"en","id":"334588964721786880","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":115,"end":137,"url":"http://t.co/Szx6Hnq7l0","expanded_url":"http://goo.gl/jIvAM","display_url":"goo.gl/jIvAM"}],"hashtags":[{"start":77,"end":82,"tag":"data"},{"start":92,"end":99,"tag":"health"}],"annotations":[{"start":25,"end":47,"probability":0.6501,"type":"Other","normalized_text":"World Health Statistics"}]},"public_metrics":{"retweet_count":227,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-15T08:40:00.000Z","possibly_sensitive":false,"text":"RT @WHO: 2013 edition of World Health Statistics, WHO’s definitive source of #data on world #health, now available http://t.co/Szx6Hnq7l0 #…","conversation_id":"334588964721786880","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"334587875834359808"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334579494243418112","entities":{"mentions":{},"urls":[{"start":99,"end":121,"url":"http://t.co/BRRNLVoTHo","expanded_url":"http://bit.ly/10SJ0ZN","display_url":"bit.ly/10SJ0ZN"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-15T08:02:22.000Z","possibly_sensitive":false,"text":"One week left to apply for our #vacancy for Head of our IT Development Sector. Deadline is 22 May: http://t.co/BRRNLVoTHo","conversation_id":"334579494243418112","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"334313307383140352","entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":104,"end":126,"url":"http://t.co/Uc9mCW2vSW","expanded_url":"http://1.usa.gov/pOpSme","display_url":"1.usa.gov/pOpSme"}],"hashtags":{},"annotations":[{"start":69,"end":71,"probability":0.7922,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-14T14:24:38.000Z","possibly_sensitive":false,"text":"RT @FDAanimalhealth: Do you know what happens when a problem with an FDA regulated product is reported? http://t.co/Uc9mCW2vSW","conversation_id":"334313307383140352","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"334313240639197185"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334311326866341888","entities":{"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-14T14:16:46.000Z","possibly_sensitive":false,"text":"RT @FDAWomen: Research shows sex may affect the safety &amp; efficacy of some drugs &amp; devices. We support research to understand how: http://t.…","conversation_id":"334311326866341888","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"334311270750748672"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334310284460167168","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":61,"end":70,"username":"EURACTIV","id":"14808226"}],"urls":[{"start":108,"end":130,"url":"http://t.co/uIRPCa0c1H","expanded_url":"http://bit.ly/10LpuDM","display_url":"bit.ly/10LpuDM"}],"hashtags":{},"annotations":[{"start":13,"end":14,"probability":0.6979,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-14T14:12:37.000Z","possibly_sensitive":false,"text":"RT @IMI_JU: 'EU calls for more research into ‘complex brain’ @EurActiv article from IMI's Stakeholder Forum http://t.co/uIRPCa0c1H #brainmo…","conversation_id":"334310284460167168","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"334310230823419905"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334310251014782976","entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":{},"hashtags":[{"start":67,"end":71,"tag":"FDA"},{"start":119,"end":124,"tag":"CBER"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-14T14:12:29.000Z","possibly_sensitive":false,"text":"RT @FDACBER: Learn more about Innovation and Regulatory Science at #FDA. Find recently published research conducted by #CBER at http://t.co…","conversation_id":"334310251014782976","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"334310177337647106"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334309581750673412","entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-14T14:09:50.000Z","possibly_sensitive":false,"text":"RT @FDA_Drug_Info: Drug Safety: Label changes for zolpidem products&amp;new dosing recommendation for the day after Ambien CR use http://t.co/7…","conversation_id":"334309581750673412","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"334309502058893314"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334282502313242625","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":54,"end":76,"url":"http://t.co/tOaH4pVSzI","expanded_url":"http://bit.ly/10L61Dm","display_url":"bit.ly/10L61Dm"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-14T12:22:13.000Z","possibly_sensitive":false,"text":"RT @LV_MPA: Monthly report from the CHMP (April 2013) http://t.co/tOaH4pVSzI","conversation_id":"334282502313242625","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"334257550834941952","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":74,"end":96,"url":"http://t.co/ayLhQQsXaR","expanded_url":"http://www.urpl.gov.pl/pl-komunikaty-bezp/protelos-osseor-dhcp-pdf","display_url":"urpl.gov.pl/pl-komunikaty-…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-05-14T10:43:04.000Z","possibly_sensitive":false,"text":"RT @URPLWMiPB: Message to healthcare professionals - Protelos and Osseor  http://t.co/ayLhQQsXaR","conversation_id":"334257550834941952","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"334243989412773888","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":59,"end":67,"tag":"measles"},{"start":71,"end":77,"tag":"Wales"},{"start":97,"end":102,"tag":"H7N9"},{"start":114,"end":126,"tag":"coronavirus"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-14T09:49:11.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: Check out our weekly threat report - Week 19: #measles in #Wales, avian influenza A(#H7N9) and novel #coronavirus http://t.co/…","conversation_id":"334243989412773888","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"334243521282338816"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334243151164346369","entities":{"mentions":[{"start":0,"end":16,"username":"FrancoisMaignen","id":"769373400"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-05-14T09:45:51.000Z","possibly_sensitive":false,"text":"@FrancoisMaignen Thanks. We've let them know.","conversation_id":"334223216191082496","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"334241896278941696"}],"in_reply_to_user_id":"769373400","attachments":{"media_keys":{}}},{"lang":"en","id":"334242906154098688","entities":{"mentions":[{"start":0,"end":10,"username":"URPLWMiPB","id":"556679074"},{"start":49,"end":65,"username":"FrancoisMaignen","id":"769373400"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-05-14T09:44:53.000Z","possibly_sensitive":false,"text":"@URPLWMiPB The link in your tweet isn't working! @FrancoisMaignen","conversation_id":"334216509482213377","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"334216509482213377"}],"in_reply_to_user_id":"556679074","attachments":{"media_keys":{}}},{"lang":"en","id":"334228478465568768","entities":{"mentions":{},"urls":[{"start":110,"end":132,"url":"http://t.co/0FKaQ1p610","expanded_url":"http://bit.ly/18Y86e9","display_url":"bit.ly/18Y86e9"}],"hashtags":[{"start":51,"end":63,"tag":"biosimilars"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"created_at":"2013-05-14T08:47:33.000Z","possibly_sensitive":false,"text":"Last week we released a draft revised guideline on #biosimilars for public consultation. Deadline 31/10/2013: http://t.co/0FKaQ1p610","conversation_id":"334228478465568768","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"334228278212694016","entities":{"mentions":{},"urls":[{"start":108,"end":130,"url":"http://t.co/DEjRbsasU0","expanded_url":"http://bit.ly/13yJ98H","display_url":"bit.ly/13yJ98H"}],"hashtags":[{"start":27,"end":34,"tag":"orphan"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-14T08:46:45.000Z","possibly_sensitive":false,"text":"No need for companies with #orphan medicines to pre-warn us any more about applications with a reduced fee: http://t.co/DEjRbsasU0","conversation_id":"334228278212694016","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"334226866498052096","entities":{"mentions":[{"start":0,"end":15,"username":"ScienceMonitor","id":"1352480185"}],"urls":[{"start":116,"end":138,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-14T08:41:09.000Z","possibly_sensitive":false,"text":"@ScienceMonitor Medicines under additional monitoring will need the black triangle later this year. More info here: http://t.co/ZzDNIqm0Nk","conversation_id":"327350396001595392","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"333892703295266816"}],"in_reply_to_user_id":"1352480185","attachments":{"media_keys":{}}},{"lang":"en","id":"334226243912359936","entities":{"mentions":[{"start":0,"end":6,"username":"Fiouw","id":"1367162942"}],"urls":[{"start":118,"end":140,"url":"http://t.co/1MKhhUqcDx","expanded_url":"http://bit.ly/16wqT3M","display_url":"bit.ly/16wqT3M"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"created_at":"2013-05-14T08:38:40.000Z","possibly_sensitive":false,"text":"@Fiouw We are still evaluating Scenesse; it's not refused. We will publish the outcome once we've finished assessing: http://t.co/1MKhhUqcDx","conversation_id":"333531395681054720","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"333531395681054720"}],"in_reply_to_user_id":"1367162942","attachments":{"media_keys":{}}},{"lang":"en","id":"334222497434173440","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-14T08:23:47.000Z","possibly_sensitive":false,"text":"RT @MHRAmedicines: Company-led drug recall: Drytec™ Tc-99m Generator (all sizes) - GE Healthcare Medical Diagnostics - CLDA (13... http://t…","conversation_id":"334222497434173440","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"333963552056561667"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334220546856333312","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":[{"start":97,"end":119,"url":"http://t.co/Ujnep4y3V6","expanded_url":"http://ow.ly/kXKSU","display_url":"ow.ly/kXKSU"}],"hashtags":[{"start":58,"end":68,"tag":"influenza"},{"start":76,"end":81,"tag":"H7N9"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-14T08:16:02.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: Updated rapid risk assessment on novel avian #influenza virus (#H7N9) - 8 May 2013: http://t.co/Ujnep4y3V6","conversation_id":"334220546856333312","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"333861792776327168"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"334220504066048001","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":69,"end":91,"url":"http://t.co/lWOHiKSeZI","expanded_url":"http://bbc.in/12ke4nA","display_url":"bbc.in/12ke4nA"}],"hashtags":{},"annotations":[{"start":12,"end":18,"probability":0.5581,"type":"Other","normalized_text":"Malaria"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-14T08:15:52.000Z","possibly_sensitive":false,"text":"RT @EFPIA: 'Malaria hope: Bacteria that make mosquitoes resistant' - http://t.co/lWOHiKSeZI","conversation_id":"334220504066048001","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"333860195073683456"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"332179677319929856","entities":{"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T17:06:21.000Z","possibly_sensitive":false,"text":"RT @TOPRANEWS: Now Booking: Day 1 of annual workshop on the Enpr-EMA at the EMA, organised with the assistance of TOPRA - more info: http:/…","conversation_id":"332179677319929856","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"332165211811368960"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"332163581892239361","entities":{"mentions":[{"start":3,"end":17,"username":"WHO_Europe_TB","id":"920721606"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T16:02:23.000Z","possibly_sensitive":false,"text":"RT @WHO_Europe_TB: Welcome to apply and if not, then repost | WHO e-Recruit - Medical Officer, TB and MDR-TB (UKR) (EURO/13/FT178) https://…","conversation_id":"332163581892239361","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"332152554110726144"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"332149640415817729","entities":{"mentions":{},"urls":[{"start":111,"end":133,"url":"http://t.co/DEjRbsasU0","expanded_url":"http://bit.ly/13yJ98H","display_url":"bit.ly/13yJ98H"}],"hashtags":[{"start":15,"end":22,"tag":"orphan"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T15:06:59.000Z","possibly_sensitive":false,"text":"Companies with #orphan medicines no longer need to inform us in advance about applications with a reduced fee: http://t.co/DEjRbsasU0","conversation_id":"332149640415817729","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"332143290981953536","entities":{"mentions":{},"urls":[{"start":82,"end":104,"url":"http://t.co/0FKaQ1p610","expanded_url":"http://bit.ly/18Y86e9","display_url":"bit.ly/18Y86e9"}],"hashtags":[{"start":44,"end":56,"tag":"biosimilars"}],"annotations":{}},"public_metrics":{"retweet_count":17,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-05-08T14:41:46.000Z","possibly_sensitive":false,"text":"We've released a draft revised guideline on #biosimilars for public consultation: http://t.co/0FKaQ1p610","conversation_id":"332143290981953536","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"332118707054723073","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":83,"end":105,"url":"http://t.co/tY1IlLpbcH","expanded_url":"http://tinyurl.com/d3qoc7a","display_url":"tinyurl.com/d3qoc7a"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T13:04:05.000Z","possibly_sensitive":false,"text":"RT @LV_MPA: Regulatory News - The Newsletter from the Innovation Office is out now http://t.co/tY1IlLpbcH","conversation_id":"332118707054723073","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"332116945149251586"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"332094007209496577","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/lUGbCWqSCc","expanded_url":"http://bit.ly/16gfxkj","display_url":"bit.ly/16gfxkj"}],"hashtags":[{"start":23,"end":34,"tag":"phthalates"},{"start":39,"end":48,"tag":"parabens"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T11:25:55.000Z","possibly_sensitive":false,"text":"New recommendations on #phthalates and #parabens in human medicines: public consultation open until October: http://t.co/lUGbCWqSCc","conversation_id":"332094007209496577","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"332093384015622144","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/Fs4nBeaQJA","expanded_url":"http://bit.ly/10LyqVP","display_url":"bit.ly/10LyqVP"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":46,"end":56,"tag":"scientist"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T11:23:27.000Z","possibly_sensitive":false,"text":"Two days left to apply for our #vacancy for a #scientist in quality of medicines - deadline is 10 May: http://t.co/Fs4nBeaQJA","conversation_id":"332093384015622144","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"332093325551235072","entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/DmmKWwkvKP","expanded_url":"http://bit.ly/Z84eWv","display_url":"bit.ly/Z84eWv"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":114,"end":128,"tag":"dataarchitect"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T11:23:13.000Z","possibly_sensitive":false,"text":"Two days left to apply for our #vacancy for a Lead Data Architect - deadline is 10 May: http://t.co/DmmKWwkvKP    #dataarchitect","conversation_id":"332093325551235072","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"332093248279552000","entities":{"mentions":{},"urls":[{"start":101,"end":123,"url":"http://t.co/RgpojR6Kwy","expanded_url":"http://bit.ly/Z84rJd","display_url":"bit.ly/Z84rJd"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T11:22:55.000Z","possibly_sensitive":false,"text":"Two days left to apply for our #vacancy for a Lead IT Infrastructure Architect - deadline is 10 May: http://t.co/RgpojR6Kwy","conversation_id":"332093248279552000","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"332093163265224704","entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/Hac1zI88cT","expanded_url":"http://bit.ly/10JSF7I","display_url":"bit.ly/10JSF7I"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":116,"end":134,"tag":"businessarchitect"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T11:22:34.000Z","possibly_sensitive":false,"text":"Two days left to apply for our #vacancy for a Lead Business Architect - deadline is 10 May: http://t.co/Hac1zI88cT  #businessarchitect","conversation_id":"332093163265224704","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"332093088728231936","entities":{"mentions":{},"urls":[{"start":90,"end":112,"url":"http://t.co/7ZMYqy0vn4","expanded_url":"http://bit.ly/ZmpAeJ","display_url":"bit.ly/ZmpAeJ"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T11:22:17.000Z","possibly_sensitive":false,"text":"Two days left to apply for our #vacancy for an IT Programme Manager - deadline is 10 May: http://t.co/7ZMYqy0vn4","conversation_id":"332093088728231936","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"332092977222656000","entities":{"mentions":{},"urls":[{"start":101,"end":123,"url":"http://t.co/BRRNLVoTHo","expanded_url":"http://bit.ly/10SJ0ZN","display_url":"bit.ly/10SJ0ZN"}],"hashtags":[{"start":33,"end":41,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T11:21:50.000Z","possibly_sensitive":false,"text":"Two weeks to go to apply for our #vacancy for Head of our IT Development Sector. Deadline is 22 May: http://t.co/BRRNLVoTHo","conversation_id":"332092977222656000","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"332059346139758592","entities":{"mentions":{},"urls":[{"start":107,"end":129,"url":"http://t.co/lUGbCWqSCc","expanded_url":"http://bit.ly/16gfxkj","display_url":"bit.ly/16gfxkj"}],"hashtags":[{"start":38,"end":49,"tag":"phthalates"},{"start":54,"end":63,"tag":"parabens"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":1,"like_count":1,"quote_count":0},"created_at":"2013-05-08T09:08:12.000Z","possibly_sensitive":false,"text":"We've released new recommendations on #phthalates and #parabens in human medicines for public consultation http://t.co/lUGbCWqSCc","conversation_id":"332059346139758592","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"332055674517323777","entities":{"mentions":{},"urls":[{"start":109,"end":131,"url":"http://t.co/ubMTaY83pV","expanded_url":"http://bit.ly/17JBR3B","display_url":"bit.ly/17JBR3B"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T08:53:36.000Z","possibly_sensitive":false,"text":"We will be closed tomorrow and Friday. We have an out-of-hours emergency number for problems with medicines: http://t.co/ubMTaY83pV","conversation_id":"332055674517323777","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"332055463569018880","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/Fs4nBeaQJA","expanded_url":"http://bit.ly/10LyqVP","display_url":"bit.ly/10LyqVP"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":46,"end":56,"tag":"scientist"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T08:52:46.000Z","possibly_sensitive":false,"text":"Last few days to apply for our #vacancy for a #scientist in quality of medicines - deadline is 10 May: http://t.co/Fs4nBeaQJA","conversation_id":"332055463569018880","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"332055373534093312","entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/DmmKWwkvKP","expanded_url":"http://bit.ly/Z84eWv","display_url":"bit.ly/Z84eWv"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":113,"end":127,"tag":"dataarchitect"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T08:52:24.000Z","possibly_sensitive":false,"text":"Last few days to apply for our #vacancy for a Lead Data Architect - deadline is 10 May: http://t.co/DmmKWwkvKP   #dataarchitect","conversation_id":"332055373534093312","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"332055290130350080","entities":{"mentions":{},"urls":[{"start":101,"end":123,"url":"http://t.co/RgpojR6Kwy","expanded_url":"http://bit.ly/Z84rJd","display_url":"bit.ly/Z84rJd"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T08:52:05.000Z","possibly_sensitive":false,"text":"Last few days to apply for our #vacancy for a Lead IT Infrastructure Architect - deadline is 10 May: http://t.co/RgpojR6Kwy","conversation_id":"332055290130350080","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"332055218449707008","entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/Hac1zI88cT","expanded_url":"http://bit.ly/10JSF7I","display_url":"bit.ly/10JSF7I"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":115,"end":133,"tag":"businessarchitect"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T08:51:48.000Z","possibly_sensitive":false,"text":"Last few days to apply for our #vacancy for a Lead Business Architect - deadline is 10 May: http://t.co/Hac1zI88cT #businessarchitect","conversation_id":"332055218449707008","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"332055101139202048","entities":{"mentions":{},"urls":[{"start":90,"end":112,"url":"http://t.co/7ZMYqy0vn4","expanded_url":"http://bit.ly/ZmpAeJ","display_url":"bit.ly/ZmpAeJ"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T08:51:20.000Z","possibly_sensitive":false,"text":"Last few days to apply for our #vacancy for an IT Programme Manager - deadline is 10 May: http://t.co/7ZMYqy0vn4","conversation_id":"332055101139202048","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"332054632492830720","entities":{"mentions":{},"urls":[{"start":100,"end":122,"url":"http://t.co/BRRNLVoTHo","expanded_url":"http://bit.ly/10SJ0ZN","display_url":"bit.ly/10SJ0ZN"}],"hashtags":[{"start":32,"end":40,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T08:49:28.000Z","possibly_sensitive":false,"text":"Two weeks left to apply for our #vacancy for Head of our IT Development Sector. Deadline is 22 May: http://t.co/BRRNLVoTHo","conversation_id":"332054632492830720","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"332052764370808833","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":32,"end":37,"tag":"nCoV"}],"annotations":[{"start":116,"end":127,"probability":0.774,"type":"Place","normalized_text":"Saudi Arabia"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T08:42:02.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: Novel coronavirus (#nCoV) update, 7 May: In the last 5 days, 13 new confirmed cases reported by MOH of Saudi Arabia http://t.c…","conversation_id":"332052764370808833","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"332049580847951875"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"332052588772081665","entities":{"mentions":[{"start":3,"end":15,"username":"EU_Consumer","id":"39516018"}],"urls":{},"hashtags":[{"start":59,"end":72,"tag":"animalhealth"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-08T08:41:21.000Z","possibly_sensitive":false,"text":"RT @EU_Consumer: The huge number of legal acts relating to #animalhealth would be streamlined into a single law. Proposal page updated http…","conversation_id":"332052588772081665","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"332048366315917312"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"331764768056680449","entities":{"mentions":[{"start":3,"end":18,"username":"cochranecollab","id":"20429156"}],"urls":[{"start":109,"end":131,"url":"http://t.co/0HW5mUXZzB","expanded_url":"http://ow.ly/kMEHw","display_url":"ow.ly/kMEHw"}],"hashtags":[{"start":20,"end":31,"tag":"Multimedia"},{"start":45,"end":55,"tag":"educating"},{"start":71,"end":83,"tag":"medications"},{"start":90,"end":99,"tag":"Cochrane"},{"start":132,"end":137,"tag":"ebhc"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-07T13:37:39.000Z","possibly_sensitive":false,"text":"RT @cochranecollab: #Multimedia programs for #educating patients about #medications | New #Cochrane Review | http://t.co/0HW5mUXZzB #ebhc #…","conversation_id":"331764768056680449","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"331756083603447808"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"331764168145371137","entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/ubMTaY83pV","expanded_url":"http://bit.ly/17JBR3B","display_url":"bit.ly/17JBR3B"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-07T13:35:16.000Z","possibly_sensitive":false,"text":"We will be closed this Thursday and Friday. We have an out-of-hours emergency number for problems with medicines: http://t.co/ubMTaY83pV","conversation_id":"331764168145371137","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"331728275682500608","entities":{"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"urls":{},"hashtags":[{"start":25,"end":38,"tag":"breastcancer"}],"annotations":[{"start":96,"end":105,"probability":0.9316,"type":"Person","normalized_text":"M. Piccart"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-07T11:12:38.000Z","possibly_sensitive":false,"text":"RT @myESMO: Personalised #breastcancer medicine: time for a new renaissance. Video interview w/ M. Piccart, ESMO President http://t.co/fGHr…","conversation_id":"331728275682500608","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"331727285352796160"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"331727972220420096","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"hashtags":{},"annotations":[{"start":98,"end":114,"probability":0.4279,"type":"Organization","normalized_text":"Martindale Pharma"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-07T11:11:26.000Z","possibly_sensitive":false,"text":"RT @MHRAmedicines: Class 4 Drug Alert (Caution in Use): Aurum Pharmaceuticals Limited (trading as Martindale Pharma) - Adrenaline... http:/…","conversation_id":"331727972220420096","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"331718747817639938"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"331727945997623298","entities":{"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":27,"end":36,"username":"UBIOPRED","id":"453922574"}],"urls":{},"hashtags":[{"start":110,"end":117,"tag":"asthma"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-07T11:11:20.000Z","possibly_sensitive":false,"text":"RT @IMI_JU: In IMI project @UBIOPRED, patients are contributing to research into personalised meds for severe #asthma http://t.co/8ue8itXVA…","conversation_id":"331727945997623298","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"331717799653285888"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"331696646159208448","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":106,"end":128,"url":"http://t.co/XDy2iJnjqe","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/industria/2013/NI-MUH_06-2013-actualizacion_autorizacion_fast-track.htm","display_url":"aemps.gob.es/informa/notasI…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-05-07T09:06:57.000Z","possibly_sensitive":false,"text":"RT @AEMPSGOB: National marketing-authorisation applications for human medicines by 'fast-track' procedure http://t.co/XDy2iJnjqe","conversation_id":"331696646159208448","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"331692470821855232","entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":18,"end":27,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-07T08:50:22.000Z","possibly_sensitive":false,"text":"RT @eurordis: New @EMA_News report shows sharp decline of European patients in clinical trials pointing to reform of CT Directive http://t.…","conversation_id":"331692470821855232","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"331692352852865024"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"331430831740567554","entities":{"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"urls":{},"hashtags":{},"annotations":[{"start":19,"end":21,"probability":0.865,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-06T15:30:42.000Z","possibly_sensitive":false,"text":"RT @FDA_Drug_Info: FDA warns about potential medication errors resulting from confusion regarding nonproprietary name for  Kadcyla. http://…","conversation_id":"331430831740567554","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"331428062715604992"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"331420558455611392","entities":{"mentions":[{"start":3,"end":15,"username":"FDAMedWatch","id":"205847300"}],"urls":[{"start":114,"end":136,"url":"http://t.co/IXuUAVL8rT","expanded_url":"http://go.usa.gov/TvTY","display_url":"go.usa.gov/TvTY"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-06T14:49:53.000Z","possibly_sensitive":false,"text":"RT @FDAMedWatch: Kadcyla (ado-trastuzumab emtansine): Drug Safety Communication - Potential Name Confusion Errors http://t.co/IXuUAVL8rT #F…","conversation_id":"331420558455611392","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"331420206968737792"}],"attachments":{"media_keys":{}}},{"lang":"es","id":"331407415134257152","entities":{"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":84,"end":106,"url":"http://t.co/YC9ef47nfr","expanded_url":"http://www.aemps.gob.es/informa/circulares/medicamentosUsoHumano/vacunas/2013/docs/circular_2-2013.pdf","display_url":"aemps.gob.es/informa/circul…"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-06T13:57:39.000Z","possibly_sensitive":false,"text":"RT @AEMPSGOB: Circular no. 2/2013: Influenza-vaccine standards (2013/2014 campaign) http://t.co/YC9ef47nfr","conversation_id":"331407415134257152","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"331378901496508416","entities":{"mentions":[{"start":3,"end":18,"username":"cochranecollab","id":"20429156"}],"urls":[{"start":113,"end":135,"url":"http://t.co/JtKw4dp08L","expanded_url":"http://ow.ly/kJb9z","display_url":"ow.ly/kJb9z"}],"hashtags":[{"start":34,"end":46,"tag":"antibiotics"},{"start":65,"end":74,"tag":"hospital"},{"start":94,"end":103,"tag":"Cochrane"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-06T12:04:21.000Z","possibly_sensitive":false,"text":"RT @cochranecollab: Improving how #antibiotics are prescribed in #hospital settings | Updated #Cochrane Review | http://t.co/JtKw4dp08L #eb…","conversation_id":"331378901496508416","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"331363290036973568"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"331343322918567936","entities":{"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":75,"end":97,"url":"http://t.co/mSnHmPTin7","expanded_url":"http://bit.ly/18p3Ner","display_url":"bit.ly/18p3Ner"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-06T09:42:58.000Z","possibly_sensitive":false,"text":"RT @EU_ECHA: ECHA's first topical scientific workshop kicks off on Tuesday http://t.co/mSnHmPTin7","conversation_id":"331343322918567936","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"331342997734178816"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"331343305214406656","entities":{"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"urls":{},"hashtags":[{"start":13,"end":18,"tag":"EFSA"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-06T09:42:54.000Z","possibly_sensitive":false,"text":"RT @EFSA_EU: #EFSA’s commitment to transparency:Want to attend the next FEEDAP and ANS Plenary meetings as an Observer? More info http://t.…","conversation_id":"331343305214406656","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"331341180061233152"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"331332398379843586","entities":{"mentions":{},"urls":[{"start":100,"end":122,"url":"http://t.co/jv3maHgXWb","expanded_url":"http://bit.ly/181BzpT","display_url":"bit.ly/181BzpT"}],"hashtags":[{"start":59,"end":74,"tag":"ResponsibleUse"}],"annotations":[{"start":27,"end":32,"probability":0.7797,"type":"Place","normalized_text":"Europe"},{"start":36,"end":49,"probability":0.9702,"type":"Person","normalized_text":"Declan O'Brien"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-06T08:59:34.000Z","possibly_sensitive":false,"text":"RT @IFAHEurope: Watch IFAH-Europe's Declan O'Brien explain #ResponsibleUse of medicines in animals: http://t.co/jv3maHgXWb","conversation_id":"331332398379843586","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"331326988738514945"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"331323367900729345","entities":{"mentions":[{"start":0,"end":8,"username":"yankeeu","id":"1260521084"},{"start":117,"end":129,"username":"EUombudsman","id":"873777758"}],"urls":[{"start":86,"end":108,"url":"http://t.co/O8fNdwvHKk","expanded_url":"http://bit.ly/Ywugka","display_url":"bit.ly/Ywugka"}],"hashtags":[{"start":109,"end":116,"tag":"ctdata"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-05-06T08:23:41.000Z","possibly_sensitive":false,"text":"@yankeeu Information on our work towards releasing data from clinical trials is here: http://t.co/O8fNdwvHKk #ctdata @EUombudsman","conversation_id":"326643289967190017","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"330689095875579904"}],"in_reply_to_user_id":"873777758","attachments":{"media_keys":{}}},{"lang":"en","id":"330359665688973312","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":109,"end":114,"tag":"H7N9"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T16:34:16.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: ECDC publishes interim case definition and case finding algorithm for reporting patients with A(#H7N9) virus: http://t.co/ueTc…","conversation_id":"330359665688973312","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"330353038072115200"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"330347373979107329","entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":64,"end":86,"url":"http://t.co/rwL90pYm2D","expanded_url":"http://1.usa.gov/i4tw8I","display_url":"1.usa.gov/i4tw8I"}],"hashtags":[{"start":21,"end":32,"tag":"Veterinary"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T15:45:26.000Z","possibly_sensitive":false,"text":"RT @FDAanimalhealth: #Veterinary Master Files have been updated http://t.co/rwL90pYm2D","conversation_id":"330347373979107329","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"330345281516355584"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"330339899066687488","entities":{"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":46,"end":68,"url":"http://t.co/wkzAbY5DwK","expanded_url":"http://bit.ly/158yd5p","display_url":"bit.ly/158yd5p"}],"hashtags":[{"start":69,"end":76,"tag":"newjob"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-05-03T15:15:44.000Z","possibly_sensitive":false,"text":"RT @LV_MPA: Group manager for clinical trials http://t.co/wkzAbY5DwK #newjob","conversation_id":"330339899066687488","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"330330467037487104","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":[{"start":94,"end":116,"url":"http://t.co/qcTbTZILk6","expanded_url":"http://reut.rs/10vdd0h","display_url":"reut.rs/10vdd0h"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T14:38:15.000Z","possibly_sensitive":false,"text":"RT @EFPIA: Addressing antibiotic resistance: 'Programs to reduce antibiotic use often work' - http://t.co/qcTbTZILk6","conversation_id":"330330467037487104","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"330329884289282048"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"330330334010933250","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":46,"end":51,"tag":"H7N9"}],"annotations":[{"start":61,"end":65,"probability":0.9978,"type":"Place","normalized_text":"China"}]},"public_metrics":{"retweet_count":32,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T14:37:43.000Z","possibly_sensitive":false,"text":"RT @WHO: Daily number of laboratory-confirmed #H7N9 cases in China reported to WHO and for whom the date of onset is known http://t.co/ERzP…","conversation_id":"330330334010933250","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"330324274210541568"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"330330290679595009","entities":{"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"urls":[{"start":110,"end":132,"url":"http://t.co/ZwcRXH7Jez","expanded_url":"http://1.usa.gov/mP8iV3","display_url":"1.usa.gov/mP8iV3"}],"hashtags":[{"start":40,"end":51,"tag":"Veterinary"},{"start":60,"end":65,"tag":"Drug"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T14:37:33.000Z","possibly_sensitive":false,"text":"RT @FDAanimalhealth: Updated Cumulative #Veterinary Adverse #Drug Experience (ADE) Reports are now available  http://t.co/ZwcRXH7Jez","conversation_id":"330330290679595009","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"330323848073449473"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"330329741653585920","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":110,"end":132,"url":"http://t.co/ERzPyyhBUS","expanded_url":"http://goo.gl/jNHfv","display_url":"goo.gl/jNHfv"}],"hashtags":[{"start":42,"end":47,"tag":"H7N9"}],"annotations":{}},"public_metrics":{"retweet_count":94,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T14:35:22.000Z","possibly_sensitive":false,"text":"RT @WHO: Geo map of locations affected by #H7N9 as well as corresponding number of people infected and deaths http://t.co/ERzPyyhBUS","conversation_id":"330329741653585920","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"330318278922760192"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"330329580449693697","entities":{"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"urls":{},"hashtags":[{"start":73,"end":78,"tag":"H7N9"},{"start":96,"end":106,"tag":"outbreaks"},{"start":110,"end":118,"tag":"measles"},{"start":123,"end":128,"tag":"hepA"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T14:34:43.000Z","possibly_sensitive":false,"text":"RT @ECDC_EU: Weekly disease threats report is out: read the updates on A(#H7N9) and the ongoing #outbreaks of #measles and #hepA http://t.c…","conversation_id":"330329580449693697","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"330306841168998400"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"330329251737899008","entities":{"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"urls":[{"start":105,"end":127,"url":"http://t.co/oORn5zycmD","expanded_url":"http://1.usa.gov/12I8QmD","display_url":"1.usa.gov/12I8QmD"}],"hashtags":[{"start":13,"end":17,"tag":"FDA"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T14:33:25.000Z","possibly_sensitive":false,"text":"RT @FDACBER: #FDA study reinforces no safety concerns from residual formaldehyde in some infant vaccines http://t.co/oORn5zycmD.","conversation_id":"330329251737899008","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"330299207384719360"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"330293581573128192","entities":{"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/IR4BUXAQbH","expanded_url":"http://bit.ly/135RVdV","display_url":"bit.ly/135RVdV"}],"hashtags":{},"annotations":[{"start":63,"end":64,"probability":0.921,"type":"Place","normalized_text":"UK"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-05-03T12:11:41.000Z","possibly_sensitive":false,"text":"Our website will be unavailable tomorrow from 9.00am to 5.30pm UK time because of maintenance: http://t.co/IR4BUXAQbH","conversation_id":"330293581573128192","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"330293437813374976","entities":{"mentions":{},"urls":[{"start":106,"end":128,"url":"http://t.co/Fs4nBeaQJA","expanded_url":"http://bit.ly/10LyqVP","display_url":"bit.ly/10LyqVP"}],"hashtags":[{"start":34,"end":42,"tag":"vacancy"},{"start":49,"end":59,"tag":"scientist"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T12:11:06.000Z","possibly_sensitive":false,"text":"Just 1 week left to apply for our #vacancy for a #scientist in quality of medicines - deadline is 10 May: http://t.co/Fs4nBeaQJA","conversation_id":"330293437813374976","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"330293375465058304","entities":{"mentions":{},"urls":[{"start":91,"end":113,"url":"http://t.co/DmmKWwkvKP","expanded_url":"http://bit.ly/Z84eWv","display_url":"bit.ly/Z84eWv"}],"hashtags":[{"start":34,"end":42,"tag":"vacancy"},{"start":116,"end":130,"tag":"dataarchitect"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T12:10:51.000Z","possibly_sensitive":false,"text":"Just 1 week left to apply for our #vacancy for a Lead Data Architect - deadline is 10 May: http://t.co/DmmKWwkvKP   #dataarchitect","conversation_id":"330293375465058304","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"330293308188393473","entities":{"mentions":{},"urls":[{"start":95,"end":117,"url":"http://t.co/Hac1zI88cT","expanded_url":"http://bit.ly/10JSF7I","display_url":"bit.ly/10JSF7I"}],"hashtags":[{"start":34,"end":42,"tag":"vacancy"},{"start":120,"end":138,"tag":"businessarchitect"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T12:10:35.000Z","possibly_sensitive":false,"text":"Just 1 week left to apply for our #vacancy for a Lead Business Architect - deadline is 10 May: http://t.co/Hac1zI88cT   #businessarchitect","conversation_id":"330293308188393473","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"330292526307233792","entities":{"mentions":{},"urls":[{"start":104,"end":126,"url":"http://t.co/RgpojR6Kwy","expanded_url":"http://bit.ly/Z84rJd","display_url":"bit.ly/Z84rJd"}],"hashtags":[{"start":34,"end":42,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T12:07:29.000Z","possibly_sensitive":false,"text":"Just 1 week left to apply for our #vacancy for a Lead IT Infrastructure Architect - deadline is 10 May: http://t.co/RgpojR6Kwy","conversation_id":"330292526307233792","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"330292455448645634","entities":{"mentions":{},"urls":[{"start":93,"end":115,"url":"http://t.co/7ZMYqy0vn4","expanded_url":"http://bit.ly/ZmpAeJ","display_url":"bit.ly/ZmpAeJ"}],"hashtags":[{"start":34,"end":42,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T12:07:12.000Z","possibly_sensitive":false,"text":"Just 1 week left to apply for our #vacancy for an IT Programme Manager - deadline is 10 May: http://t.co/7ZMYqy0vn4","conversation_id":"330292455448645634","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"330274104387182593","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":90,"end":112,"url":"http://t.co/Q352Vog3Z9","expanded_url":"http://bit.ly/O15CaG","display_url":"bit.ly/O15CaG"}],"hashtags":[{"start":49,"end":59,"tag":"Parkinson"},{"start":62,"end":70,"tag":"Disease"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T10:54:17.000Z","possibly_sensitive":false,"text":"RT @euparkinsons: Stay up-2-date with the latest #Parkinson's #Disease research articles: http://t.co/Q352Vog3Z9","conversation_id":"330274104387182593","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"330271013696843776"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"330258498699030528","entities":{"mentions":{},"urls":[{"start":61,"end":83,"url":"http://t.co/IR4BUXAQbH","expanded_url":"http://bit.ly/135RVdV","display_url":"bit.ly/135RVdV"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T09:52:16.000Z","possibly_sensitive":false,"text":"Our website will be unavailable tomorrow due to maintenance: http://t.co/IR4BUXAQbH","conversation_id":"330258498699030528","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"330257834988154880","entities":{"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"urls":{},"hashtags":[{"start":45,"end":57,"tag":"euopendoors"}],"annotations":{}},"public_metrics":{"retweet_count":32,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T09:49:38.000Z","possibly_sensitive":false,"text":"RT @EU_Commission: Come visit us tomorrow at #euopendoors. Here @BarrosoEU , @EUHvR &amp; @MartinSchulz explain how it all works: http://t.…","conversation_id":"330257834988154880","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"330252062212386816"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"330257772060999680","entities":{"mentions":{},"urls":{},"hashtags":[{"start":59,"end":71,"tag":"EUOpenDoors"}],"annotations":[{"start":29,"end":43,"probability":0.4636,"type":"Organization","normalized_text":"EU Institutions"}]},"public_metrics":{"retweet_count":31,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T09:49:23.000Z","possibly_sensitive":false,"text":"RT @euHvR: Want to learn how EU Institutions work? Come to #EUOpenDoors tomorrow &amp; watch @BarrosoEU, @MartinSchulz &amp; me explain: ht…","conversation_id":"330257772060999680","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"330250802893557761"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"330249896210857984","entities":{"mentions":{},"urls":[{"start":75,"end":97,"url":"http://t.co/ArVgJmDyXT","expanded_url":"http://bit.ly/ZZxuz7","display_url":"bit.ly/ZZxuz7"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":1,"like_count":0,"quote_count":0},"created_at":"2013-05-03T09:18:05.000Z","possibly_sensitive":false,"text":"We have announced first details of  the planned reorganisation of the EMA: http://t.co/ArVgJmDyXT","conversation_id":"330249896210857984","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"330248370239201280","entities":{"mentions":{},"urls":[{"start":88,"end":110,"url":"http://t.co/DmmKWwkvKP","expanded_url":"http://bit.ly/Z84eWv","display_url":"bit.ly/Z84eWv"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":112,"end":126,"tag":"dataarchitect"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T09:12:01.000Z","possibly_sensitive":false,"text":"One week left to apply for our #vacancy for a Lead Data Architect - deadline is 10 May: http://t.co/DmmKWwkvKP  #dataarchitect","conversation_id":"330248370239201280","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"330245259785273344","entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/Fs4nBeaQJA","expanded_url":"http://bit.ly/10LyqVP","display_url":"bit.ly/10LyqVP"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":46,"end":56,"tag":"scientist"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T08:59:40.000Z","possibly_sensitive":false,"text":"One week left to apply for our #vacancy for a #scientist in quality of medicines - deadline is 10 May: http://t.co/Fs4nBeaQJA","conversation_id":"330245259785273344","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"330245136565014528","entities":{"mentions":{},"urls":[{"start":101,"end":123,"url":"http://t.co/RgpojR6Kwy","expanded_url":"http://bit.ly/Z84rJd","display_url":"bit.ly/Z84rJd"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T08:59:10.000Z","possibly_sensitive":false,"text":"One week left to apply for our #vacancy for a Lead IT Infrastructure Architect - deadline is 10 May: http://t.co/RgpojR6Kwy","conversation_id":"330245136565014528","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"330245038615449601","entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/Hac1zI88cT","expanded_url":"http://bit.ly/10JSF7I","display_url":"bit.ly/10JSF7I"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":116,"end":134,"tag":"businessarchitect"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T08:58:47.000Z","possibly_sensitive":false,"text":"One week left to apply for our #vacancy for a Lead Business Architect - deadline is 10 May: http://t.co/Hac1zI88cT  #businessarchitect","conversation_id":"330245038615449601","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"330244926514270208","entities":{"mentions":{},"urls":[{"start":90,"end":112,"url":"http://t.co/7ZMYqy0vn4","expanded_url":"http://bit.ly/ZmpAeJ","display_url":"bit.ly/ZmpAeJ"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T08:58:20.000Z","possibly_sensitive":false,"text":"One week left to apply for our #vacancy for an IT Programme Manager - deadline is 10 May: http://t.co/7ZMYqy0vn4","conversation_id":"330244926514270208","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"330243265070759936","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":116,"end":138,"url":"http://t.co/lHyIYcQC7X","expanded_url":"http://goo.gl/FJD2U","display_url":"goo.gl/FJD2U"}],"hashtags":[{"start":65,"end":73,"tag":"vaccine"},{"start":74,"end":82,"tag":"viruses"}],"annotations":{}},"public_metrics":{"retweet_count":30,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T08:51:44.000Z","possibly_sensitive":false,"text":"RT @WHO: New consensus allows the expedited release of candidate #vaccine #viruses before completing safety testing http://t.co/lHyIYcQC7X …","conversation_id":"330243265070759936","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"330241088684163072"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"330243179943174144","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":35,"end":43,"tag":"viruses"}],"annotations":{}},"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T08:51:24.000Z","possibly_sensitive":false,"text":"RT @WHO: WHO recommended candidate #viruses are usually released to manufacturers for vax dev't, production after tests http://t.co/lHyIYcQ…","conversation_id":"330243179943174144","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"330237077604167680"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"330243101627125760","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":[{"start":103,"end":125,"url":"http://t.co/lHyIYcQC7X","expanded_url":"http://goo.gl/FJD2U","display_url":"goo.gl/FJD2U","status":500,"unwound_url":"https://www.who.int/influenza/vaccines/virus/en/"}],"hashtags":[{"start":126,"end":131,"tag":"H7N9"}],"annotations":{}},"public_metrics":{"retweet_count":41,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-03T08:51:05.000Z","possibly_sensitive":false,"text":"RT @WHO: Vaccine response to the avian influenza A(H7N9) outbreak: update on candidate vaccine viruses http://t.co/lHyIYcQC7X #H7N9","conversation_id":"330243101627125760","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"330233849705533440"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"329980227814043649","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-02T15:26:31.000Z","possibly_sensitive":false,"text":"RT @MHRAmedicines: Safety warnings and messages for medicines: Information sent to healthcare professionals in April about the sa... http:/…","conversation_id":"329980227814043649","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"329977323841531906"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"329980166946304003","entities":{"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":[{"start":32,"end":37,"tag":"H7N9"}],"annotations":{}},"public_metrics":{"retweet_count":85,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-02T15:26:17.000Z","possibly_sensitive":false,"text":"RT @WHO: To date, there are 128 #H7N9 laboratory-confirmed cases, incl. 26 deaths","conversation_id":"329980166946304003","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"329973863435878400"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"329948512160714752","entities":{"mentions":[{"start":3,"end":17,"username":"MHRAmedicines","id":"960436586"}],"urls":[{"start":111,"end":133,"url":"http://t.co/hdz3alZAWW","expanded_url":"http://tinyurl.com/chem35m","display_url":"tinyurl.com/chem35m"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-02T13:20:30.000Z","possibly_sensitive":false,"text":"RT @MHRAmedicines: Class 4 Drug Alert (Caution in Use): Ativan Injection 4mg/ml - Pfizer Limited - EL (13)A/14 http://t.co/hdz3alZAWW","conversation_id":"329948512160714752","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"329948439683145729"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"329928446312607744","entities":{"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":99,"end":121,"url":"http://t.co/Ouqa5Oavm1","expanded_url":"http://fb.me/1aZ0SI40p","display_url":"fb.me/1aZ0SI40p"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-05-02T12:00:46.000Z","possibly_sensitive":false,"text":"RT @URPLWMiPB: Informationon the suspension in trading of medicinal products containing tetrazepam http://t.co/Ouqa5Oavm1","conversation_id":"329928446312607744","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"329914207577468929","entities":{"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"urls":[{"start":99,"end":121,"url":"http://t.co/Ouqa5Oavm1","expanded_url":"http://fb.me/1aZ0SI40p","display_url":"fb.me/1aZ0SI40p"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"created_at":"2013-05-02T11:04:11.000Z","possibly_sensitive":false,"text":"RT @GCessak: Information on the suspension in trading of medicinal products containing tetrazepam: http://t.co/Ouqa5Oavm1","conversation_id":"329914207577468929","source":"TweetDeck","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"329908734207852545","entities":{"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"urls":[{"start":101,"end":123,"url":"http://t.co/AEjntHtIyX","expanded_url":"http://bit.ly/O15QOZ","display_url":"bit.ly/O15QOZ"}],"hashtags":[{"start":42,"end":52,"tag":"Parkinson"},{"start":67,"end":72,"tag":"EPDA"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-02T10:42:26.000Z","possibly_sensitive":false,"text":"RT @euparkinsons: Did u know that all the #Parkinson's info on the #EPDA website is free 2 access? - http://t.co/AEjntHtIyX","conversation_id":"329908734207852545","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"329908627831914497"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"329901670358192128","entities":{"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"},{"start":85,"end":94,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":129,"end":136,"tag":"ctdata"}],"annotations":[{"start":20,"end":47,"probability":0.388,"type":"Organization","normalized_text":"The Italian Medicines Agency"}]},"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-02T10:14:22.000Z","possibly_sensitive":false,"text":"RT @Aifa_ufficiale: The Italian Medicines Agency (AIFA) confirms its full support to @EMA_News transparency policy on release of #ctdata ht…","conversation_id":"329901670358192128","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"329901442532007938"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"329901523377201153","entities":{"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-02T10:13:47.000Z","possibly_sensitive":false,"text":"RT @EFPIA: From the Efpia Blog - 'The HIV Story: When Research Faces Setbacks, Look to Previous Advances for Inspiration' - http://t.co/gds…","conversation_id":"329901523377201153","source":"TweetDeck","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"329897085052784640"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"329897400623828993","entities":{"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"urls":[{"start":98,"end":120,"url":"http://t.co/9KpoCbAnoS","expanded_url":"http://bit.ly/11Xuvr0","display_url":"bit.ly/11Xuvr0","status":200,"unwound_url":"https://www.euro.who.int/en/health-topics/communicable-diseases/influenza/news/news/2013/05/human-infections-with-avian-influenza-ah7n9-virus-in-china-update-2"}],"hashtags":[{"start":16,"end":21,"tag":"H7N9"},{"start":82,"end":92,"tag":"influenza"},{"start":93,"end":97,"tag":"flu"}],"annotations":[{"start":31,"end":35,"probability":0.9919,"type":"Place","normalized_text":"China"}]},"public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-02T09:57:24.000Z","possibly_sensitive":false,"text":"RT @WHO_Europe: #H7N9 virus in China – new weekly update for the European Region  #influenza #flu http://t.co/9KpoCbAnoS","conversation_id":"329897400623828993","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"329879523992678401"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"329897336723611648","entities":{"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":45,"end":54,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-05-02T09:57:08.000Z","possibly_sensitive":false,"text":"RT @eurordis: EURORDIS TV Video of the week: @EMA_News explain how patient reps can participate in a Scientific Advisory Meeting. http://t.…","conversation_id":"329897336723611648","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":[{"type":"retweeted","id":"329896865975898113"}],"attachments":{"media_keys":{}}},{"lang":"en","id":"329246171644170241","entities":{"mentions":{},"urls":[{"start":64,"end":86,"url":"http://t.co/Mx5NWUHzku","expanded_url":"http://bit.ly/ZTNq64","display_url":"bit.ly/ZTNq64"}],"hashtags":{},"annotations":[{"start":0,"end":2,"probability":0.5936,"type":"Organization","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":17,"reply_count":1,"like_count":2,"quote_count":0},"created_at":"2013-04-30T14:49:39.000Z","possibly_sensitive":false,"text":"EMA publishes final advice from clinical trial advisory groups: http://t.co/Mx5NWUHzku","conversation_id":"329246171644170241","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"329243602091909120","entities":{"mentions":{},"urls":[{"start":53,"end":75,"url":"http://t.co/0Rka6WtNjs","expanded_url":"http://bit.ly/13IYVgJ","display_url":"bit.ly/13IYVgJ"}],"hashtags":[{"start":76,"end":87,"tag":"alzheimers"},{"start":88,"end":98,"tag":"memantine"}],"annotations":[{"start":38,"end":50,"probability":0.2982,"type":"Person","normalized_text":"Memantine LEK"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-04-30T14:39:26.000Z","possibly_sensitive":false,"text":"European public assessment report for Memantine LEK: http://t.co/0Rka6WtNjs #alzheimers #memantine","conversation_id":"329243602091909120","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"329243362177732608","entities":{"mentions":{},"urls":[{"start":55,"end":77,"url":"http://t.co/aiv7LhYllq","expanded_url":"http://bit.ly/ZQb2Km","display_url":"bit.ly/ZQb2Km"}],"hashtags":[{"start":78,"end":89,"tag":"alzheimers"},{"start":90,"end":100,"tag":"memantine"}],"annotations":[{"start":38,"end":52,"probability":0.4867,"type":"Organization","normalized_text":"Memantine Mylan"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-04-30T14:38:29.000Z","possibly_sensitive":false,"text":"European public assessment report for Memantine Mylan: http://t.co/aiv7LhYllq #alzheimers #memantine","conversation_id":"329243362177732608","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"329215497855959042","entities":{"mentions":{},"urls":[{"start":114,"end":136,"url":"http://t.co/yQTHeEvLhm","expanded_url":"http://bit.ly/18jrKkm","display_url":"bit.ly/18jrKkm"}],"hashtags":{},"annotations":[{"start":0,"end":2,"probability":0.657,"type":"Organization","normalized_text":"EMA"},{"start":59,"end":60,"probability":0.4635,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":2,"quote_count":0},"created_at":"2013-04-30T12:47:45.000Z","possibly_sensitive":false,"text":"EMA receives interim decisions of the General Court of the EU on access to clinical and non-clinical information: http://t.co/yQTHeEvLhm","conversation_id":"329215497855959042","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"329212393693528064","entities":{"mentions":{},"urls":[{"start":117,"end":139,"url":"http://t.co/yQTHeEvLhm","expanded_url":"http://bit.ly/18jrKkm","display_url":"bit.ly/18jrKkm"}],"hashtags":{},"annotations":[{"start":63,"end":64,"probability":0.4418,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"created_at":"2013-04-30T12:35:25.000Z","possibly_sensitive":false,"text":"We have received interim decisions of the General Court of the EU on access to clinical and non-clinical information http://t.co/yQTHeEvLhm","conversation_id":"329212393693528064","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"329171091790635011","entities":{"mentions":{},"urls":[{"start":50,"end":72,"url":"http://t.co/MOGPueOGrB","expanded_url":"http://bit.ly/13IknCy","display_url":"bit.ly/13IknCy"}],"hashtags":[{"start":73,"end":84,"tag":"alzheimers"},{"start":85,"end":95,"tag":"memantine"},{"start":96,"end":104,"tag":"generic"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-04-30T09:51:18.000Z","possibly_sensitive":false,"text":"We published the EPAR for Nemdatine this morning: http://t.co/MOGPueOGrB #alzheimers #memantine #generic","conversation_id":"329171091790635011","source":"Twitter Web Client","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"328859929148530688","entities":{"mentions":{},"urls":[{"start":34,"end":56,"url":"http://t.co/9XZ801scjY","expanded_url":"http://bit.ly/16bZ7Je","display_url":"bit.ly/16bZ7Je"}],"hashtags":{},"annotations":[{"start":0,"end":2,"probability":0.3256,"type":"Person","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"created_at":"2013-04-29T13:14:51.000Z","possibly_sensitive":false,"text":"EMA will be closed on 1 May 2013: http://t.co/9XZ801scjY","conversation_id":"328859929148530688","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}},{"lang":"en","id":"328831694692028416","entities":{"mentions":{},"urls":[{"start":76,"end":98,"url":"http://t.co/hcWMG6I2ZH","expanded_url":"http://bit.ly/Zvc6C8","display_url":"bit.ly/Zvc6C8"}],"hashtags":{},"annotations":[{"start":70,"end":73,"probability":0.474,"type":"Person","normalized_text":"CMDh"}]},"public_metrics":{"retweet_count":25,"reply_count":0,"like_count":2,"quote_count":0},"created_at":"2013-04-29T11:22:40.000Z","possibly_sensitive":false,"text":"Recommendation to suspend tetrazepam-containing medicines endorsed by CMDh  http://t.co/hcWMG6I2ZH","conversation_id":"328831694692028416","source":"bitly bitlink","author_id":"116716199","referenced_tweets":{},"attachments":{"media_keys":{}}}]
